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Current meshes used for soft-tissue repair are mostly composed of single 
component, nonabsorbable yarn constructions, limiting the ability to modulate their 
properties.  This situation has left the majority of soft tissue repair load-bearing 
applications to suffer distinctly from undesirable features associated, in part, with mesh 
inability to (1) possess short-term stiffness to facilitate tissue stability during the 
development of wound strength; (2) gradually transfer the perceived mechanical load as 
the wound builds mechanical integrity; and (3) provide compliance with load transfer to 
the remodeling and maturing mesh/tissue complex.  The likelihood of long-term 
complications is reduced for fully absorbable systems with degradation and absorption at 
the conclusion of their intended functional performance. 
The primary goal of this dissertation was to develop and characterize a fully 
absorbable bicomponent mesh (ABM) for hernia repair which can modulate 
biomechanical and physical properties to work with the expected needs of the wound 
healing process.  The first study reviewed the current state of hernioplasty and proposed 
the subject device.  The second study investigated different knitting technologies to 
establish a mesh construction which temporally modulated properties.  To this end, a 
novel construction using warp knitting was developed where two degradable copolyester 
yarns with different degradation profiles were coknit into an initially interdependent knit 
construction.  The developed knit construction provided an initial high level of structural 
stiffness; however, upon degradation of the fast-degrading yarn the mesh comprised of 
the slow-degrading yarn was liberated and affords high compliance.  In the third study, 
 iii 
the segmented, triaxial, high-glycolide copolyester used as the fast-degrading yarn was 
optimized to retain strength for greater than 18 days.  As such, the ABM physical and 
biomechanical transition was designed to temporally coincide with the expected 
commencement of wound strength. 
The fourth study investigated the in vivo tissue response and integration of the 
developed degradable copolyester yarns in a novel construct to simulate the ABM.  
Results indicated a strong initial inflammatory response which resolved quickly and an 
integration process that produced a dense, compacted, and oriented collagen capsule 
around the implant during the transition phase.  For the final study, the clinically-relevant 
biomechanical properties of two different ABM constructions were compared against 
traditional hernia meshes.  Using a novel synthetic in vitro simulated mesh/tissue 
complex, the ABM were found to provide significantly greater early stability, subsequent 
biomechanics that approximated that of the abdominal wall, and evidence of restoring 
endogenous tension to the surrounding tissue.  These results were in marked contrast to 
traditional hernia meshes which showed stress shielding and significantly greater stiffness 
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Over one million surgical procedures for hernia repair using a mesh are completed 
every year worldwide.  Despite the frequency of this procedure, the efficacy of hernia 
repair remains a challenge with high recurrence rates and a substantial percentage of 
patients that experience long-term complications which impact quality of life.  Scientific 
literature is replete with animal and clinical studies which demonstrate the unmet need 
for a hernia mesh with improved biocompatibility. 
This dissertation describes a bioengineering approach that was used to develop 
and evaluate a novel hernia mesh which considers the temporal needs of the wound 
healing process, as well as the device functional needs to improve biocompatibility.  
Specifically, a bicomponent fully-absorbable warp knit mesh was proposed which 
temporally modulates its physicomechanical properties and will (1) possess short-term 
structural stiffness to facilitate tissue stability during the development of wound strength; 
(2) gradually transfer the perceived mechanical loads as the wound is building 
mechanical integrity; (3) provide force-extension properties similar to the abdominal wall 
resulting in load transfer to the remodeling and maturing mesh/tissue complex; and (4) 
minimize the likelihood of long-term complications with complete degradation and 
absorption at the conclusion of the meshes intended function. 
This dissertation consists of five chapters which cover the unmet clinical needs, 
conceptual evaluation, and the design and development history for the subject absorbable 
bicomponent mesh (ABM).  The first chapter provides a detailed review of the wound 
healing process, anatomy and biomechanics of the abdominal wall, hernia development 
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and surgical intervention using meshes, etiology and pathology of hernia development, 
knitting technologies for meshes, meshes as biomaterials, mesh biocompatibility, and 
new opportunities based on currently unmet needs.  In summary, Chapter 1 details the 
background including the current challenges associated with traditional hernia repair 
meshes and a proposed novel concept which evolved further in subsequent chapters. 
Chapters 2 through 5 represent individual studies written in the format found in 
most scientific journals.  Each chapter details a step in the development process for the 
ABM.  In Chapter 2, two different mesh constructions were knit to determine the effect 
of knit construction on the temporal modulation of physicomechanical properties during 
the in vitro conditioned degradation of the fast-degrading yarn.  The outcome resulted in 
the adoption of a novel warp knit construction whereby two initially interdependent knit 
constructions provide a high level of structural stiffness.  However, the substantial 
degradation of the fast-degrading yarn yields an autonomous, structurally stable and 
compliant slow-degrading mesh.  The study in Chapter 3 focuses on the development and 
optimization of a segmented, triaxial, high-glycolide copolyester for use as the fast-
degrading yarn which retained strength for greater than 18 days to temporally coincide 
the biomechanical transition with the expected commencement of wound strength. 
The second and third chapters detail the work completed to establish the 
necessary absorbable copolyesters and knit technology required to meet the initially 
proposed design concept described in Chapter 1.   In Chapter 4, an ABM mesh was 
prototyped using a simplified knit construct to complete a preliminary in vivo study.  In 
this study the tissue response to the simulated ABM was investigated with specific 
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emphasis placed on the integration of the mesh into the host tissue using evaluation time 
periods which bracket the critical biomechanical transition from structural stiffness to 
high extensibility.  In Chapter 5, a mesh biomechanical study investigated the effect of 
two different ABM knit constructions on physicomechanical properties with comparison 
to two traditional hernia meshes.  As part of this investigation, a novel simulated mesh 
tissue/complex using a synthetic material was developed to demonstrate the change in 
mesh biomechanics following infiltration with the extracellular matrix in vivo.  
Additionally, the strength retention of the slow-degrading yarn was determined to be 
load-bearing for greater than 9 months, which is the expected time period for the 
sufficient maturation of the infiltrated collagen. 
The completed work described in this dissertation is an initial effort to develop a 
novel ABM with expected improved mechanical biocompatibility.  The intellectual 
property associated with this dissertation is the subject of patent applications in several 
countries worldwide, a limited 40 patient clinical study in Sweden initiated in early 2009, 
and 510K approval from the Food and Drug Administration for clinical use in the United 
States in early 2010.  Additionally, the contents of Chapter 1 were used to develop a 
chapter in the book “Mechanobiology Handbook” edited by Dr. Jiro Nagatomi which is 
currently in press.  Results from Chapter 2 were presented at the 2008 Clemson 










The Wound Healing Process 
Wound healing is characterized by several overlapping, predictable stages that are 
strongly interlinked and contribute to the common goals of the elimination of foreign 
microorganisms, wound debridement, cell proliferation, matrix deposition, contraction, 
and maturation resulting in mechanical integrity. 
 
Stages of Wound Healing 
 The major stages of wound healing include inflammation (generally 2-5 days post 
insult), proliferation (generally 2 days to 3 weeks post insult), and remodeling/maturation 
(generally 3 weeks to 2 years post insult).  The timeframes are approximated because of 
the complex and often case specific nature of wound healing.  Many factors affect the 
timing of the wound healing process, including the location and extent of injury, level of 
wound contamination and infection, rate of fluid perfusion, level of local pH, presence of 
foreign bodies, host comorbidities, and the regenerative capacity of proximal cells.
1,2
  
The wound healing process is sequentially similar throughout the body with differences 
specific to the length of each stage and cell autocrine and paracrine signaling often 
resulting in anatomical site specific cell responses such as atrophy, hypertrophy, 
hyperplasia, metaplasia, and/or phenotype changes.  The end result of orderly and timely 
wound healing is ideally tissue with minimal fibrosis yet structural integrity, minimal to 
 2 
no wound contraction, and pre-injury function.  Often with the implantation of medical 
devices the measure of their biocompatibility is graded on the local resolution of the 
wound healing process in a timely manner.  To better understand this process a brief 
review of the typical, wound healing process is helpful. 
  Injury to vascularized tissue triggers coagulation and the initiation of the 
inflammation process of wound healing.  The inflammation process rapidly increases to a 
maximum at 2-3 days and then gradually resolves over the next couple of weeks.  
Overall, the inflammatory process can be divided into two stages of (1) vasomotor-
vasopermiability and (2) leukocyte signaling and infiltration.
3
   The initial vascular 
response to injury is a short lived vasoconstriction intended to minimize blood loss 
followed by a period of local vasodilation.  Vasodilation increases the pressure and flow 
of blood to the area and causes the release of serum fluid through permeable vascular 
walls resulting in tissue oedema.  Within the newly formed interstitial space created by 
the exudate, proteins such as fibronectin are deposited which will create the initial 
scaffolding for subsequent cellular migration and locomotion into and within the wound.
3
  
Within the wound site, the formation of a blood clot via the coagulation cascade blocks 
the continued loss of blood and provides additional scaffolding for cellular activity during 
the remodeling phase.  The blood clot is constructed from fibrin, an insoluable, 
crosslinked product of fibrinogen, and activated platelets.  During the formation of the 
blood clot, activated platelets release a myriad of cytokines including platelet derived 
growth factors (PDGF)
4
 and transforming growth factor (TGF-β)
5
 which result in the 
chemotaxis of leukocytes and fibroblasts.  The first cell type to aggregate at the wound 
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site is the neutrophil.  The primary role of the neutrophil is to clean the wound by 
removing bacteria and initiating debridement.
3,6
  Neutrophils accomplish this goal 
through the release of free oxygen radicals and lysosomal enzymes from within their 
many intracellular granules.  Neutrophils are short lived within wounds, especially when 
bacterial infiltration is minimal, and quickly (generally by day 3) become secondary in 
number to monocytes differentiating to macrophages.  Macrophages continue to 
phagocytize tissue and bacterial debris taking over where the neutrophils left off; 
however, macrophages have the added responsibility of being crucial to cellular 
proliferation and recruitment.  Once the wound is clear of bacteria and debris the 
rebuilding process can begin with the repopulation of cells. 
The proliferation and remodeling phase is characterized by the increase in 
fibroblasts followed by the deposition of extra cellular matrix (ECM) in the wound.  
Proliferation is driven by macrophages that secrete growth factors such as PDGF, TGF-β, 
interleukins (IL), and tumor necrosis factor (TNF) which play key roles in the migration 
and activation of local fibroblasts.
3
  Fibroblasts, which originate from mesenchymal cells 
located in loose tissue around blood vessels and fat, differentiate and migrate in response 
to these cytokines.
7
  Theses newly formed fibroblasts use the fibrin/fibronectin network 
previously established for locomotion within the wound.   In addition to collagen, 
fibroblasts produce glycoaminoglycans (GAGs) and proteoglycans which form the tissue 
“ground substance”.  Initially fibroblasts are primarily focused on replication and 
recruitment with minimal collagen synthesis.  Within the first 4-6 days following insult, 
fibroblasts become the primary cell type and the deposition of collagen increases rapidly 
 4 
for the next three weeks.
6
  Concurrently during the three week time period of collagen 
deposition, angiogenesis progresses to provide the wound with nourishment and oxygen 
while removing metabolic and waste products.  Macrophages and fibroblasts provide the 
stimulus for the progression of capillaries, arterioles, and venules toward the wound 
space.  The generation of fibroblast growth factor (FGF) and vascular endothelial growth 
factor (VEGF) from macrophages are the primary, and most studied, cytokines 
responsible for angiogenesis.
8
  Over time capillaries slowly regress as collagen fills the 
wound space and mature, avascular scar tissue is formed. 
Wound remodeling and maturation is characterized by a gradual strengthening 
and reorganization of the collagen matrix over a period as short as 3 weeks or as long as 2 
years.  During this time, Type III collagen, so called immature collagen because of its 
smaller fiber diameter, greater elasticity, and lower strength, is replaced by Type I 
collagen.  Prior to the deposition of Type I collagen the wound has essentially no 
mechanical integrity.  During the wound maturation/remodeling process no net gain in 
collagen content is achieved; instead, the production of collagen is matched by the 
degradation of collagen by matrix metalloproteinase‟s (MMPs).  With the turnover of 
Type III collagen to Type I collagen the wound site develops mechanical strength and the 
cells attempt to replicate the preinjury tissue characteristics by contributing to the 
developing structure and orientation along the lines of tension.  However, typically the 
wound site never fully obtains the original tissue structure, while values of approximately 





The Role of Fibroblasts and Collagen in Soft  
Tissue Wound Healing 
 
 Collagen is the most widespread protein present in humans and consists of fibrils 
embedded in an amorphous gel-like matrix composed of proteoglycans and water.  Fiber 
forming collagen, such as Types I and III, function to transmit and dissipate loads and 
store elastic strain energy applied to the joints of the body.
9
  The mechanical 
characteristics of collagen lie in its unique and somewhat complex structure. 
 The development of collagen, the structural component to soft tissue, is 
paramount to effective and efficient resolution in wound healing.  Collagen is synthesized 
by fibroblasts in a multiple step process that starts with intracellular assimilation of 
peptide chains and is completed with extracellular collagen fiber and fiber bundle 
formation into macroscopic structures such as tendons or fascia. 
 Within wounds, collagenous tissue function is highly dependent on its structure.  
Collagen fibrils are highly oriented and thus strong but they can be considered essentially 
inextensible.
10
  The conformation of collagen fibrils is essential to determining tissue 
function.  For example, highly oriented structures such as tendons transmit force quickly 
and efficiently while randomly oriented fibers in the dermis allow considerable extension 
before resistance is achieved.  Therefore, the aggregation of fibrils into fibers and their 
resultant diameter as wells as the construction of the aggregate fibers gives soft tissue its 
mechanical properties and anatomically specific characteristics.  The stress-strain curve 
for collagen tissue is non-linear and can be divided into three distinct regions, each of 
which can be attributed to a different structural element.  In tendon and ligament the 
curve has been characterized by a low strain non-linear toe region, a curved mid-region, 
 6 
and then a linear yield and failure region.
11
  In the toe region, low stress is required to 
remove macroscopic crimp in the form of gradual straightening of collagen fibers that 
have varying degrees of undulations.
12
  The second region is characterized by collagen 
fibers that begin to line-up in the direction of the load and provide increasing resistance.  
In addition, disordered molecules in the lateral gap region between fibrils reorganize.
13
  
In the third region, stretching of the triple-helices and crosslinks between helices produce 
side-by-side gliding of neighboring collagen molecules leading to structural changes at 
the level of the collagen fibrils.
14
  Under typical conditions, physiologic levels are within 
the toe region of the stress-strain curve, resulting in a shock absorbing system, where low 
levels of stress are required to achieve deformations in the absence of significant 
molecular stretching of the fibers.
10
 
Like synthetic polymers, biopolymers such as collagen are viscoelastic.  The 
hierarchical structure of collagen, from triple-helix to tissue, provides structural 
components that have elastic and viscous characteristics.  For example, ligament 
viscoelasticity under uniaxial tensile loading is attributed to the inherent viscoelasticity of 
the collagen fibrils (bond rotation and stretching), the local extracellular matrix, 
interfibrillar crosslinking, and the movement of fluid within and in/out of the tissue.
15
  
The degree of crosslinking between fibrils has been linked to viscoelastic properties, with 
low levels dominating viscous behavior and high levels dominating elastic behavior 
through the stretching of nonhelical ends, crosslinks, and the triple helix.
9
  Furthermore, 
it has been determined that the overall strain in a tendon is always larger than the strain of 
 7 





Influence of Mechanical Stimulation in the Soft Tissue  
Wound Healing Process 
 
 Mechanical forces are fundamental in maintaining and regulating the structure 
and function of tissue.  The importance of the mechanical loading of bone has been 
realized for many years; more recently, the importance of mechanical stimulation on 
other tissues such as ligament, tendon, skeletal muscle, intervertabral disc, and meniscus 
is being realized.
16
  The influence of mechanotransduction in cellular signaling is still not 
fully understood.   However, the influence of mechanical stimulation on fibroblasts has 













, and the release of matrix 
metalloproteinases
25
.  From a biochemical aspect, observed changes in animal tendons 
and ligaments from joint immobilization studies include increases in the rate of collagen 
turnover, reduced levels of crosslinking, slight mass loss, a reduced amount of 
proteoglycans and hyaluronic acid, and decreased water content.
26
  Biomechanically, the 
result of these changes is a reduction in tangent modulus, cross-sectional area, and 
ultimate strength.
26
  Hannafin and coworkers compared static and mechanically cycled 
canine flexor digitorum profundus tendons in vitro and demonstrated that cells in static 
samples had altered morphology and decreased number; furthermore, cell and collagen 
alignment was modified, resulting in decreases in tensile modulus over an eight week 
period.
27 
  Fibroblast-matrix interactions control cell shape and orientation and also 
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directly regulate cellular functions, primarily through integrin receptors that cells use to 
adhere to and receive mechanical energy from the extracellular matrix.
28
  In addition, it 
has been shown that elongated tendon fibroblasts, as they appear in a homeostatic, 
mechanically stressed extracellular matrix, produce greater amounts of collagen Type I as 
compared to less elongated cells.
29
 
 Mechanical stimulation also has a role in wound contraction.  A cell 
subpopulation will differentiate into myofibroblasts as fibroblasts increase in number 
within the wound site.  Myofibroblasts express different sets of cytoskeletal proteins, 
such as α-smooth muscle actin (α-SMA), that play an important role in contraction.  
Myofibroblasts are stimulated to differentiate by a combination of TGF-β1 and ED-A 
fibronectin (ED-A FN), both of which are critical to the induction of α-SMA expression 
but are not sufficient to maintain myofibroblast differentiation in the absence of 
mechanical stimulation.
30
   It has been suggested that, for normally strained tissues such 
as tendons, wound contraction is an attempt to restore the physiologic condition of 
tension.
31
  However, excessive contraction can distort and disrupt tissue structure, 
resulting in undesirable consequences.  The contractility of rat tissue occurs in a three 
stage process.
30
  Slow contractility occurs from 1-6 days post-wounding, is characterized 
by an increase in the expression of ED-A FN, and is said to be independent of 
myofibroblast influence.
32
  Next, a steep increase is realized, with the increased 
expression of α-SMA.  This phase lasts during a period from 3-10 days, initiating at 
earlier timepoints and persisting longer when the wound site is mechanically stressed.  
After approximately 10 days, a reduction in the α-SMA expression occurs, followed by 
 9 
contraction.  Contractility correlates with the level of α-SMA expression, being higher 
when granulation tissue is subjected to greater levels of tension.
30
  Tension within the 
wound site is said to prevent apoptosis of myofibroblasts
33
, but once stress forces are 
relieved apoptosis of myofibroblasts will occur even if growth factors are added to the 
wound.
34
  Overall, mechanical stimulation is crucial to the biomechanical quality of 
collagen and myofibroblast modulation of the wound contraction process. 
 
Anatomy and Biomechanics of the Abdominal Wall 
Relevant Anatomical Features of the Abdominal Wall 
  The abdominal cavity is approximated by the spine and back muscles 
posteriorly, the pelvic cavity inferiorly, and the thoracic cavity superiorly.  The ventral 
side of the abdominal wall, from superficial to deep, is comprised of (1) skin, (2) 
subcutaneous tissues, (3) superficial fascia (Scarpa fascia), (4) anterior rectus fascia, (5) 
rectus abdominis muscle, (6) posterior rectus fascia, (7) extraperitoneal adipose tissue, 
and (8) peritoneum with the linea alba constructing the anterior midline.  Moving 
laterally, the lower abdominal wall in the inguinal region is comprised of the (1) skin, (2) 
subcutaneous tissues, (3) superficial fascia (Scarpa fascia), (4) innominate fascia, (5) 
intercrural fibers, (6) external oblique muscle, (7) internal oblique muscle, (8) transversus 
abdominis muscle/fascia, (9) transversalis fascia, and (10) peritoneum.  Theoretically 
these structures provide the necessary support to resist herniation of the anatomic hole 
located in the inguinal region.  This anatomic hole, as described by Fagan and Awad
35
, is 
known as the myopectineal orifice.  The myopectineal orifice is quadrangular in shape 
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and is divided superiorly and inferiorly by the inguinal ligament which runs from the 
anterior-superior iliac spine to the pubic tubercle (Figure 1.1). 
 
 
Figure 1.1  




The myopectineal orifice is perforated in the medial-lateral triangle by the 
spermatic cord and in the femoral triangle by the femoral artery and vein.  The inguinal 
canal is created from the passage of the spermatic cord, including the vas deferens exiting 
the abdominal cavity, and transcending to the testes in the scrotum.  The location where 
the spermatic cord initially enters the abdominal wall is called the deep inguinal ring.   
 The pelvis is constructed of the iliac bones, pubic bones, ischial bones, and the 
sacrum, forming a complete circle and providing a conduit between the torso and lower 
extemeties.
35
  The pelvis provides an anchor for the aponeurosis of the abdominal wall.  
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In addition, the inguinal ligament, an important anatomical landmark and structural 
component for the spermatic cord, travels from the anterior-superior iliac spine to the 
pubic tubercle. 
 When examining the abdominal wall from superficial to deep, the first structural 
component is the Scarpa fascia.  The Scarpa fascia is a membranous sheet of areolar 
tissue that forms a discrete structure separating the superficial and deep subcutaneous fat.  
Next, the innominate fascia covers the external oblique muscle and spermatic cord.
35
  
However, neither the Scarpa nor innominate fascia are considered primary load bearing 
structures within the abdominal wall; this function is primarily attributed to the 




Posterior view of the inguinal region demonstrating a weak medial area caused by 




The rectus abdominus is comprised of two ventrally located vertical pillars 
segmented on the midline by the linea alba.  Attached to the rectus abdominis is a triple 
layer of flat muscles extending laterally and creating a cylindrical abdominal cavity that 
withstands internal pressure as well as external insults.
36
  From superficial to deep these 
muscles include the external oblique, internal oblique, and transversus abdominus.  The 










The rectus sheath is divided by the posterior and anterior layer relative to the 
rectus abdominis muscle and is comprised of the aponeurosis from each layer of the triple 
flat abdominal muscles.  The anterior layer of the rectus sheath is made up of primarily 
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aponeurosis fiber from the external and internal oblique muscles and the posterior layer is 
comprised of aponeurosis fibers from the internal oblique and transversus muscles above 
the level of arcuate line.  The arcuate line is generally located midway between the 
umbilicus and pubis and represents the transition zone in which the aponeurosis of the 
external oblique, the internal oblique, and the transversus abdominis muscles all pass 
anterior to the rectus muscle.
38
  Below the arcuate line the posterior sheath of the rectus 
abdominis lacks strength as it is comprised of only transversalis fascia, areolar tissue, and 
peritoneum.
38
  It should be noted that aponeurosis are like tendons or ligaments, with the 
major difference being that they originate from large flat muscles and thus take on the 
form of large, flat, thin sheets.  Fascial layers on the other hand are considerably more 
extensible and primarily function to separate layers of tissue rather than provide load 
bearing structural support.  For this reason the myopectineal orifice is susceptible to 
herniation. 
 
Biomechanics of the Abdominal Wall 
 The abdominal wall mechanics traditionally have been characterized by (1) the 
physiologic maximum force generated within the wall and (2) the extension or strain 
associated with that maximum physiologic force.  Peiper and coworkers determined that 
loading of the inguinal region of the abdominal wall is predominately related to increases 
in intra-abdominal pressure and not muscular contraction.
39
  If one assumes that intra-
abdominal pressure only governs the resistive strength required in the abdominal wall, 




  Human abdominal pressures range from 0.2 kPa (resting) to 20 kPa 
maximum.  According to Laplace’s law, a thin-walled sphere where the total vessel wall 
tension [(pressure x vessel radius)/2) is independent of the layer thickness (wall 
thickness/vessel radius << 1) can be described by, F = p x d/4 (N/cm) where d = 
diameter, p = pressure, and F = wall tension/cm of circumference.  If the longitudinal 
diameter of the human abdominal wall is 32 cm, a tensile force of 16 N/cm is produced at 
the maximum pressure.  To define the physiologic strain associated with a 16 N/cm load, 
Junge and coworkers, analyzed the abdominal wall of 14 fresh corpses and determined 
that longitudinally the average extension was 25% ± 7%.
41
  However, Cobb and 
coworkers directly measured the intra-abdominal pressure of 10 healthy male and 10 
healthy female subjects performing various activities, including coughing and jumping, 
two known activities that produce maximum intra-abdominal pressures.  These 
measurements indicated that the maximum tensile force ranged from 11 to 27 N/cm.
42
  
Wolloscheck and colleagues investigated the tissue burst force of individual layers of the 
lower abdominal wall.  Their findings include burst force values for the transversalis 
fascia, peritoneum including the pre-and sub-peritoneal tissue, the aponeurosis of the 
internal oblique, and the aponeurosis of the external oblique measured as 10.5N, 46.6N, 
51.7N and 92.6N, respectively.
43
  This suggests that the transversalis fascia is the weakest 
of the load bearing tissues; further evidence of the minimal support provided by the 




Hernia Development and Surgical Intervention Using Meshes 
Surgical hernia intervention is the most common elective procedure in general 
surgery with inguinal hernioplasty performed at the annual rate of 800,000 in the United 
States, 200,000 in Germany, 100,000 in France, 80,000 in the United Kingdom, and 
12,000 in Finland.
44-46
  The most important modern advancement in hernia surgery has 
been the development of so-called tension-free repair using meshes.
47
   
 
Anatomical Classification of Hernias 
 Hernias of the abdominal wall form at areas susceptible to a loss of mechanical 
integrity through acquired or congenital pathologies.  The weak points of the abdominal 
wall are the inguinal, umbilical, and femoral canal regions.  From epidemiology data, it is 
known that the prevalence rates for abdominal wall hernias are approximately 73% 
inguinal, 9.5% umbilical, 6.2% incisional, 2.7% femoral, and 8.6% other types such as 
spigelian, hiatal, or epigastric.
48
  Inguinal hernias are classified as direct or indirect. 
Indirect inguinal hernias occur when a visceral sac leaves the abdominal cavity, 
enters the deep inguinal ring, and transcends the spermatic cord.   The hernial sac 
contains peritoneum and viscera such as adipose tissue, intestinal loops, or omentum and 
is surrounded by all three fascial coverings of the spermatic cord. The hernia can traverse 
the entire inguinal canal and exit through the superficial inguinal ring.  In severe cases the 
hernial sac enters the scrotum.  Indirect inguinal hernias can occur in women, but they are 
twenty times more likely in males.   
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Direct inguinal hernias occur when the peritoneum with subperitoneum tissues 
and/or abdominal viscera herniate through a weak point in the abdominal wall.  The 
typical location of direct inguinal hernias is within the confines of the medial triangle of 
the myopectineal orifice.
35
   The hernial sac is formed by distention of the transversalis 
fascia lateral to the rectus abdominus muscle and it emerges to reach the superficial 
inguinal ring, gaining an outer covering of external spermatic fascia inside or parallel to 
that on the cord.  It rarely enters into the scrotum.  Direct hernias are most common in 
elderly men.   
 Femoral hernias occur within the femoral triangle of the myopectineal orifice and 
result from the distension or the rupture of the transversalis fascia.
49
  It is generally 
accepted that they are the result of elevated intra-abdominal pressure and/or an enlarged 
femoral ring which facilitates the peritoneum and preperitoneal adipose tissue to protrude 
through the femoral ring.
50
  Subsequently, the hernial sac may travel along the femoral 
vessels and settle in the anterior thigh.
51
  Femoral hernias are more frequent in women 
than men (4:1).
52
   
Umbilical hernia prevalence in adults has a female to male ratio of 3:1 with 
particular frequency in obese, multiparous women.
53
  The etiology of umbilical hernias in 
adults is believed to initiate during embryonic development through defects in the closure 
of the embryo‟s abdominal orifice from which the umbilical cord emerges after the 
obliteration of the celomic sac.  Over time this weakness manifests itself at the superior 
aspect of the umbilicus, becoming susceptible to increased intrabdominal pressure which 
 17 
may drive forward gobbets of preperitoneal fat or an incipient sac.  This condition 
stretches the fascia before it into a funnel and eventually progresses into a hernia.
54
 
An incisional hernia is one that appears at the site of an incision from a previous 
abdominal operation.  An incisional hernia can appear within months or take many years 
to become evident to the patient.  Incisional hernias are sometimes referred to as ventral 
hernias, due to their typical position between the rectus abdominal muscles and through 
the linea alba, the preferred midline incision used by surgeons for visceral access during 
laparotomy. 
 
The Surgical Repair of Hernias 
Early attempts at primary intention tissue repairs of groin hernias resulted in 
unacceptably high recurrence rates due to dehiscence.  The endogenous tissue tension of 
the abdominal wall accounted for the poor results in primary repairs.  Primary intention 
repair is still performed for small defects but is outside of the scope of this review.  For 
the last three decades, surgical repair with meshes has been considered the gold standard 
for any sizable hernia defect.
36
  Hernia surgical repairs can be divided into two 
classifications; (1) open repairs and (2) laparoscopic repairs. 
 Two commonly used open repairs for inguinal hernioplasty are the Lichtenstein 
repair and the giant prosthetic reinforcement of the visceral sac repair.  Lichtenstein 
repair is the most frequently performed hernia repair worldwide due to its short learning 
curve and ease with which general surgeons can obtain acceptable results.
44
  The 
Lichtenstein procedure uses an anterior approach with, most commonly, a polypropylene 
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mesh.  The mesh is placed in an onlay position
55
 and to accommodate the spermatic cord, 
a slit is placed in the mesh with the two tails overlapping behind the spermatic cord to 




Mesh placement for the Lichtenstein procedure.  A - internal oblique muscle, B - 
polypropylene mesh, C - inguinal ligament, D - internal oblique aponeurosis, E - lesser 




The giant prosthetic reinforcement of the visceral sac (GPRVS) procedure
56,57
 was 
developed to repair bilateral and complex recurrent inguinal hernias due to its use of a 
large mesh that covers both inguinal regions.  The GPRVS‟s alternate approach to the 
Lichtenstein procedure eliminated the need to operate through distorted anatomy and scar 
tissue from the previous surgical site.
58
  The procedure obtains preperitoneal access 
through a midline subumbilical incision allowing access to the preperitoneal space for 
blunt dissection.  Short term fixation is assured by dissection pocket size, friction, and 
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hydrostatic pressure, all combining to achieve long-term security from tissue ingrowth.
59
  
The result is bilateral mesh coverage within the preperitoneal space of sufficient size to 
span all of the potential hernia defects of the myopectineal orifice: indirect, direct, and 
femoral.
60,61
  The effectiveness of the GPRVS procedure was noticed by minimally 
invasive surgeons and the concept became the basis for laparoscopic procedures. 
Currently, there are two types of laparoscopic hernia repair; the transabdominal 
preperitoneal (TAPP) repair and the totally extraperitoneal (TEP) repair,
62
 with the TAPP 
repair being more common.
63
  The advantage of laparoscopic techniques are decreased 
postoperative pain, faster recovery, quicker return to daily activities, coverage of all 
potential hernia defects, and minimal fixation required due to assisted stabilization from 
intra-abdominal pressure.
64
  Critics of the process cite increased cost, the use of general 
anesthesia, the need for advanced skills that require a long learning curve to master, and 
rare but disastrous potential complications.
64,65
  For the TAPP procedure, the peritoneal 
cavity is accessed with an incision with the subsequent creation of a pneumoperitoneum.  
Next, a peritoneal incision is made above the hernia defect to enter the preperitoneal 
space.  Dissection is completed when a pocket of adequate size to cover the myopectineal 
orifice is achieved.  The mesh is inserted and fixed, typically with staples.
66




The laparoscopic techniques for hernia repair. (A) The transabdominal preperitoneal 
(TAPP) technique using preperitoneal mesh placement through a peritoneal incision and 
(B) the totally extraperitoneal technique (TEP) using a mesh placement procedure that 
does not enter the peritoneal cavity.
66
   
  
The TEP procedure uses the same preperitoneal mesh placement with the 
exception that access to the hernia is created through the preperitoneal space using 
dissection to produce a pneumo-preperitoneum.
66
  The TEP approach is technically more 
difficult but it avoids the potential risk of damaging intra-abdominal organs and no 
additional incisions are made into the peritoneum. 
 
Complications Associated with Surgical Hernia  
Repair Using a Mesh 
 
The introduction of non-absorbable mesh for hernia repair has reduced the 
incidence of recurrence, but its presence as a permanent biomaterial has produced several 
short-term and long-term complications, all of which have inherent interdependency.  
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Short-term complications include hematoma
67














the defect site.  Long-term complications are of great interest due to their significant 
impact on patient quality of life and include neuralgia (chronic pain and paraesthesia), 
chronic inflammation, mesh shrinkage, stiffness or reduced abdominal wall mobility, 
secondary mesh migration, fistula or mesh adhesion, and recurrence. 
Chronic postoperative pain caused by neuralgia is one of the main long-term 
complications following inguinal hernia repair and regarded to be the most common 
failure of groin hernia surgery.
77,78
  Recent literature reviews, comparing trials with 
follow-ups greater than 3 months, have reported that chronic pain after inguinal hernia 
operation may occur in 10-62% of patients, with considerable impact on a patient‟s daily 
quality of life.
45,79,80 
 Suggested etiological factors for neuralgia include irritation or 
damage to inguinal nerves by incisions or dissections, severance by sutures or tacks, a 
chronic inflammatory reaction to the mesh, or entrapment/compression of nerves from 
scar tissue development.
45,78,81,82
  Data suggests that intraoperative nerve damage may be 
the most important mechanism for developing chronic pain; however, a nerve lesion is 
not the only factor leading to neuralgia, as many more patients have paraesthesia or 
sensory abnormalities, rather than pain, after inguinal hernia repair.
83
  As many as fifty 
percent of patients with a large mesh prosthesis complain of paresthesia at the palpable 
stiff edges of the mesh.
84
  These more prevalent sensory abnormalities may originate 
from the chronic inflammatory response and subsequent fibrosis and/or shrinkage of the 
mesh.  Historically, it was believed that mesh repairs reduced chronic pain compared to 
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primary repair but recent long-term investigations suggest that there is no statistical 
difference between patient complaints about mesh and primary repair.
85
 
The characteristic chronic inflammatory response to non-absorbable meshes is at 
least in part responsible for several additional complications.  Mesh shrinkage has been 
explored extensively following observations during revision surgeries that significant 
folding and shrinking of the mesh was apparent.  Mesh size reduction resulting from 
myofibroblast activity reduces the pore size and causes buckling and folding of the 
prosthesis.  Pore size and overall mesh length has been observed to reduce by 20% in 
meshes explanted from patients.
68
  Furthermore, a study conducted by Klinge and 
coworkers, using polypropylene mesh on the posterior sheath of the rectus fascia within 
the preperitoneal space of dogs, produced an overall reduction in area of 46% within 4 
weeks of implantation.
86
  The extent of mesh shrinkage has been shown to be directly 
proportional to the degree of inflammatory response.
87
 
In addition to shrinkage, the inflammatory response to typical mesh biomaterials 
results in significant fibrosis that increases the rigidity and stiffness of the abdominal 
wall.
88
  As reviewed by Welty and coworkers, 50% of patients report some form of 
physical restriction of the abdominal wall.
89
  Chronic inflammation is also responsible for 
slow and gradual secondary migration of mesh through trans-anatomical planes due to 
foreign-body reaction induced erosion of local tissue.
68,73
  In addition, from a mechanical 
point of view, irritation and inflammation from a hard material in contact with soft tissue 
can induce erosion in the latter.
90
  This is especially true in the case of stiff and rigid 
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monofilament polypropylene mesh. Consequently, mesh can enter the abdominal cavity 




Etiology and Pathology of Hernia Development 
 Is the development of abdominal wall hernias the result of an anatomical defect or 
collagen disease?  Historically, hernia genesis was attributed to a mechanical disparity 
between visceral pressure and resistance of the structures within the myopectineal orifice.  
Which of these factors are significant contributors?  Increasingly, hernia etiopathology is 
described as a multifactorial process linking an evolutionary anatomical weakness, 
predisposed defects, and dynamic factors such as increased abdominal pressure.  The 
influence of each of these factors in the primary formation and recurrence of hernias is an 
area of significant debate. 
 
Mechanisms in the Development of Primary Hernias 
 Evolution has clearly left human beings with a section of the abdominal wall that 
is weaker in comparison to the rest of the abdominal wall: the majority of hernias occur 
in the myopectineal orifice of the inguinal region.  The thin and weak transversalis fascia 
of the groin coupled with the lack of fascial sheath below the arcuate line together form 
the argument for an intrinsic defect in the human abdominal wall.
92
  Many surgeons 
believe the transversalis fascia does not even resemble fascia or any tendinous-like 
structure; the transversalis fascia is a thin, fibro-membranous peritoneum with markedly 
reduced strength as compared with typical fascia.
92
  The myopectineal orifice is sealed by 
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the transversalis fascia; thus all groin hernias are the result of the displacement of this 
fascia by a peritoneal sac. 
 Hernia development can be congenital in the case of indirect hernias.  In this case 
a visceral sac leaves the abdominal cavity and transcends the spermatic cord.  Congenital 
predisposition in males originates during the descent of the fetal testes into the scrotum.  
Interruptions in the closure of the deep inguinal ring can develop into a potential defect 
later in life.
51
  Indirect hernias are more common on the right side than left.  The right 
testicle descends from its position near the kidney into the scrotum after the left testicle 
has already completed its descent.  The delay in the closure of the deep inguinal ring on 
the right side is believed to be responsible for its side-specific hernia predominance.
92
 
 Increased intra-abdominal pressure is believed to be a contributing factor in the 
pathogenesis of herniation.
93
  Risk factors include obesity and chronic constipation.  
Often hernias are thought to be the result of a single event (e.g. lifting a heavy object) but 
in fact repetitive mechanical strain is likely the damaging factor.
94
  It is possible that 
chronic mechanical strain, not prior biologic defects, may induce secondary changes in 
structural tissue cellular and molecular function.
95
  However, increased intra-abdominal 
pressure is speculative in nature with no clinical study to confirm its contribution to 
hernia formation.
93
  Furthermore, no adequate animal model exists that can simulate 
hernia formation or replicate the increased intra-abdominal pressure from erect posture 






The Role of Biochemical Mediators and  
Collagen in Hernia Formation 
 
 Collagen is an active living tissue that is in a constant balanced state of production 
and degradation. Because collagen has a long half-life and is the primary biomechanical 
strength component in connective tissue, collagen has become the critical component for 
investigation in the search for hernia genesis.  So-called collagen disease is thought have 
two pathologies, (1) a metabolic defect and/or (2) structural abnormalities in any of the 
steps related to collagen fiber formation.   
Imbalances in the connective tissue metabolic pathways are being investigated to 
explain whether the quality of collagen is caused by the presence of destructive enzymes 
or by the lack of inhibitors to those destructive enzymes.  Collagens are mainly degraded 
by matrix metalloproteinases (MMPs) and under normal conditions, are required for the 
proper progression and maturation of wound healing.
96
  MMP-1 and MMP-13 are the 
primary collagenases responsible for type I and type III collagen turnover.
97
  Klinge and 
coworkers found that skin of patients with groin hernias had significantly different 
upregulated levels of MMP-1 and MMP-13 compared to controls.
98
  In another study by 
Klinge and coworkers, the expression level of MMP-1 in excised hernial sacs of patients 
with either direct or indirect hernias was not different compared to that of peritoneum 
control samples.
99
  In addition, MMP-13 was absent from either the hernial sac or control 
tissue.  Rosch and coworkers analyzed MMP-1 and MMP-13 in cultured fibroblasts from 
the skin of patients and concluded that neither was involved in primary inguinal hernia.
100
  
Overall, the implications of MMP-1 and MMP-13 in hernia formation are mixed and 
inconclusive. 
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MMP-2 and MMP-9 have been identified as enzymes that break down collagen 
Types IV and V as well as gelatin, elastin, fibronectin, and other matrix components.  
Both are derived from neutrophils and have been found local to direct hernias but not 
indirect hernias.
101
  In addition, MMP-2 overexpression in fibroblasts from the 
transversalis fascia has been observed in young patients with direct hernias but not in 
indirect hernia patients.
102,103
  The increased levels of MMP-2 and MMP-9 have also been 
related to diminished levels of tissue inhibitors of matrix metalloproteinases, e.g. TIMP-1 
and TIMP-2 are generally linked to elderly patients
104
 as well as indirect and direct hernia 
patients.
105
  Evidence suggests that MMP-2 and MMP-9 may have a link to direct hernia 
formation, especially in elderly patients. 
Connective tissue quality is significantly influenced by the quantity and ratio of 
Type I/III collagen synthesis and deposition.
106
  Altered collagen composition with 
increased levels of Type III has profound effects on tissue elasticity and resistance to 
applied stresses.  The genetic expression of Type I or Type III procollagen mRNA affects 
the Type I/III ratio.  The different genetic expression pathways are poorly understood, 
emphasizing that genetic influences on hernia formation are still not clear.  In an attempt 
to determine whether metabolic or gene transcriptional defects are the primary factors for 
an altered Type I/III collagen ratio, studies have been conducted using the skin of 
incisional and inguinal hernia patients.
98,100,107-109
  Each of these studies concluded that a 
statistically significant downward shift in the Type I/III ratio was evident in hernia 
patients as compared to controls or non-hernia patients, strengthening the position that a 
systemic collagen disorder may predispose patients to hernia disease.  However, it should 
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be noted that these studies are better characterized as observations of small numbers of 
patients and more extensive, prospective studies are required to completely understand if 
aberrations within the collagen gene expression profile supports a transcriptional 
dysregulation relevant to hernia disease.
110
 
The collagen fibril formation process is critical to collagen quality as fibrils are 
the principle source of structural integrity.
110
  The extent of hydroxylation of lysine and 
glycosylation of hydroxylysine provides the intermolecular and intramolecular covalent 
bonds responsible for the bulk strength of mature collagen.
111
   During remodeling and 
maturation, collagen fibers increase in diameter reflecting the change in the ratio of 
Types I and III collagen.
107
  Differences in the rectus sheath ultrastructure of hernia 
patients compared to non-hernia patients have been the target of several studies.
112,113
  
Results indicated that for hernia patients, the ultrastructure of the rectus sheath had 
irregularly arranged fibers that exhibited disturbed collagen hydroxylation, fibers with 
caliber differences, and fewer collagen fibers that were replaced with ground substance.  
Unfortunately, not enough is known about the structural and molecular-cell basis of 




Causes of Recurrent Hernias 
In approximately 60% of all excised meshes, recurrence is the reason for 
extraction.
114
  The recurrence of hernia repairs has frustrated surgeons for many years, 
especially incisional hernia recurrence with rates of 11-15% within the first year and a 
doubling of the high initial rates within the first nine years.
115
  The stated causes of 
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recurrence include stress applied to the wound prior to the development of mechanical 
integrity, shear stresses at the margins of the mesh during collagen maturation, collagen 
metabolism disorders, infection, and surgical technical errors.  Immediate gross failure in 
most cases is attributed to surgeon technical failure or infection, while longer term (> 3 
months) failure stems primarily from abnormal wound healing such as varied collagen 
metabolism and the progress of acute wound disruptions into symptomatic failures. 
 There is evidence that hernia recurrence of mesh-repaired laparotomies is the 
result of external stresses applied to the wound site prior to the development of tissue 
integration and wound strength (first 2-3 weeks post insult).  As reviewed by Franz, one 
prospective study of primary repaired incisional hernias found that the total rate of acute 
wound disruption was about 11% at post-operative day 30 with the majority (94%) later 
developing into incisional hernias.
95
  Primary repaired incisional hernias fail by wound 
dehiscence from sutures pulling through the wound edges.  Similarly, mesh acute wound 
failures also occur from stressed suture lines at the margins of the mesh creating mesh-
fascial dehiscence.  The result of the failure is a loss in tension applied across the wound.  
The loss of mechanical load signaling may impair fibroblast biology which promotes 




Recurrent hernias develop 99% of the time at the margins of the implanted 
mesh.
87,114,116-118
  Owing to the significant strength of most meshes, central mesh ruptures 
are a documented but extremely rare occurrence.
119,120
  The nonphysiologically low 
stretching capability of the mesh/tissue complex contrasts with the highly elastic 
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abdominal wall resulting in shear forces at the margins of the mesh.  These forces 




Incisional hernias are also being investigated as an abnormal wound healing 
response with an inability to produce abundant, quality, strong collagen.  As with primary 
hernias, metabolic factors are being investigated; however, more evidence supports 
collagenase as a central agent involved with the development of incisional hernias when 
compared to primary hernia formation.
97
  Though this may be, it is hard to accept 
metabolic factors as the primary pathway to recurrent hernia when the majority of 
patients do not have a history of wound healing defects and do not express any defects in 
organs local to the surgical site or the vascular system. 
 
Knitting Technologies and Their Relevance to  
the Properties of Surgical Meshes 
 
Knit textile structures come in two general forms; (1) weft knit and (2) warp knit.  
Mesh construction can be dramatically different between the two structures, but the 
concept of using intermeshing loops of yarn is the same for both.  The properties of a 
knitted structure are largely dependent on the interaction of each stitch with its 
neighboring stitches in the course and wale directions.  The course is the cross direction 





Weft Knit Mesh 
 The simple weft knit structure is formed by loops created by needles knitting fiber 
across the width of the fabric with each loop being created by pulling it through the 
previous loop in the same direction (Figure 1.6a).  Needle movements are simply up and 
down and are controlled by a cam.  When the needles are in the up position, each weft 
fiber is fed at an angle to the direction of fabric formation, single or multiple ends of fiber 
can be fed into the mesh at one time but each end knits the same pattern with no overlap 
or variation. 
Looking at a cross-sectional view of the structure, all the loops are bent into the 
third dimension due to the manner in which loops are pulled through each other.  This 
configuration results in an unbalanced structure which causes the mesh to curl at the 
edges in an attempt to release some of the strains within the loops.
121
  The simplicity of 
the weft knit structure with minimal cross-over points between courses and wales makes 
it strong in burst strength, extremely porous, highly drapable, and highly elastic.  
However, the greatest obstacle for the weft knit construction in use for medical 













Warp Knit Mesh 
 Warp knitting differs from weft knitting in that loops are formed by every needle 
in the needle bar during the same knitting cycle from series of warp fibers that are fed 
parallel to the direction of mesh formation (Figure 1.6b).  The so-called warp, is a sheet 
of fiber with ends wrapped concentrically in parallel on a cylindrical beam prepared in a 
creel prior to being mounted on the knitting machine.  The warp fibers lap the needle bar 
simultaneously by a series of guide bars that move through and then laterally to the 
needle bar.  Lateral movements include underlaps which are produced on the mesh 
production side of the needle bar and overlap on the alternate side.  The number of guide 
bars is pattern-specific but generally varies between one and four.   
Warp knit meshes provide versatile pattern selection, control of elasticity, 
unraveling resistance, good drapability, control of porosity, good dimensional stability, 
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and high strength.  Medical meshes used in hernia applications are constructed in such 
configurations as the queenscord, tricot lapping, atlas lapping, and the sand-fly net.
123
   
 
Mesh Properties as Determined from Knitting  
Type and Construction 
 
The elasticity and strength of a weft knit mesh is controlled by the number of 
needles per inch, i.e.  gauge, and the stitch length, which controls the number of courses 
per inch.  The gauge is typically set by the machine configuration leaving the stitch 
length as the only adjustable variable.  Although elasticity and strength can be somewhat 
adjusted, there is no structural variability to further modify the weft knit properties. 
 The variability available with warp knitting allows extensive modulation of the 
physical and mechanical properties.  To produce elastic or stretchable structures, the 
mesh must be designed with either (1) short underlaps or (2) an open mesh 
construction.
124
  The most basic example of short underlaps is a single guide bar, one 
needle underlap and one needle overlap, commonly referred to as a half-tricot stitch.  
Increases in the underlap movement reduce extensibility and increase stability.  The half 
tricot pattern produces a dimensionally stretchable mesh with relatively small pores.  To 
produce larger openings in the mesh, loops can be formed continuously on the same 
needle such that there are no connections by adjacent wales (underlaps) followed by a 
lateral interlace after a specific number of courses.
125
  Different size and shape openings 
can be produced with symmetrical pores when knit using partial threading of two guide 
bars that are lapping in opposition.  Another significantly less extensible open work mesh 
that can be created is a lay-in mesh, i.e. a marquisette construction.  Lay-in constructions, 
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at the most basic level, consist of a chain stitch, or series of stitches from one needle in 
the course direction, joined together by laying-in yarn between the loops.  The lay-in yarn 
does not form a stitch because it does not have lateral movement during the overlap, only 
during the underlap.  As such, the fiber does not enter the hook of the needle but rather is 






Examples of (a) a short underlap mesh (half-tricot), (b) an open work mesh (sand-fly net), 





Stabilization of Mesh Constructions using Heat Setting 
Mesh dimensional stability and refinement of the fiber microstructure 
morphology are accomplished using a heat setting process.  The effect of heat setting is 
affected by the temperature, time, and tension applied during the process with the most 
significant factor being temperature.
126
  Fiber morphology is altered by relieving induced 
stress from orientation and increasing the fibers entropy.  As a result, stresses in the 
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construction of the mesh are relaxed improving dimensional stability, heat stability from 
entropy driven shrinkage, handling characteristics, and in many cases the softness of the 
mesh.   
 
Meshes as Biomaterials 
 An ideal mesh material should be strong, compliant, non-allergenic, sterilizable, 
chemically inert to the biologic environment, resistant to infection, dimensionally and 
chemically stable in vivo, non-carcinogenic, cost effective, and should stimulate 
fibroblastic activity for optimum incorporation into the tissue with no long-term reaction. 
 
Clinically Relevant Mesh Materials 
Each material used for the construction of hernia meshes has its advantages; 
however, all of them reveal some disadvantages.  Currently there is no ideal mesh 
material, but polypropylene is most common regardless of certain drawbacks.   
 
Polypropylene (PP) 
 Polypropylene is a linear aliphatic hydrocarbon with a methyl group attached to 
alternate carbon atoms on the chain backbone (-C3H6-).  As a result it is nonpolar and 
highly hydrophobic.  The addition of the methyl group has many physico-mechanical, 
structural, and chemical implications.  Physico-mechanically the methyl group stiffens 
the chain by reduced molecular mobility from this relatively bulky side group.  
Polypropylene derives its mechanical properties from chain entanglement and 
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intermolecular secondary bond forces (van der Waals-London forces) from induced 
dipole hydrogen bonds between chains.
127
  Structurally the methyl group produces 
tacticity with medical grade PP being highly isotactic with approximately 95% 
crystallinity.  All of the methyl groups are configured to one side of the carbon backbone 
in the isotactic form, thereby creating a regular structure and facilitating crystallinity.  
Steric hindrance from the methyl group forms crystals in helical conformations, unlike 
the planar zigzag form of polyethylene.  The presence of the methyl group also affects its 
chemical nature, providing a tertiary carbon atom that is susceptible to oxidation and 
chain scission.
128
  However, overall PP is considered to be an inert, stable material that 
provides an adequate service life in vivo as a mesh material. 
 
Polyethylene Terephthalate (PET) 
 Polyethylene terephthalate was introduced as a mesh material for hernia repair 
more than 30 years ago and continues to be used today, although its use is limited in most 
countries, with the exception of France.
129
  PET is a heterochain linear aromatic polymer 
with repeat units comprised of ester groups on either side of its ring and two ethylene 
moieties added to one side (-C10H8O4-).  As such, the polymer is slightly polar, more 
hydrophilic, and hygroscopic than homochain hydrocarbon polymers.  The characteristic 
feature of PET is its two ester linkages in the backbone of the polymer chain.  Chemically 
the ester groups create chemically liable sites that are susceptible to hydrolysis and thus 
chain scission.  However, the local hydrophobic moieties slow this reaction considerably.  
Physico-mechanically the stronger dipole-dipole type van der Waals-London forces 
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between adjacent carbonyl groups contribute to its high strength characteristics.
127
  
Structurally PET is a semicrystalline polymer with crystallization kinetics such that the 
level of crystallinity can be controlled through thermal history and strain-induced 
crystallization.  The second most important characteristic is its aromatic ring which adds 
stiffness to the backbone of the chain enhancing its physical and mechanical properties.  
Accordingly, PET is typically processed into fine multifilaments rather than 
monofilament fibers in surgical meshes. 
 
Expanded Polytetrafluoroethylene (ePTFE) 
 Expanded polytetrafluoroethylene is not a widely used material for hernia meshes.  
Its application is generally limited to surgical situations where visceral adhesion is of 
major concern.  Polytetrafluoroethylene (PTFE) is a linear homochain polymer 
constructed of a carbon backbone saturated with fluorine atoms (-CF2-).  The 
characteristic feature of PTFE is its inert nature, due to the extreme stability of the 
carbon-fluorine bond.  PTFE is highly crystalline; however, although the structure is 
similar to polyethylene, crystallites are not formed in the planar zigzag form.  Instead, a 
modified form of a twisted zigzag is created due to steric hindrance from the increased 
size of the fluorine atom compared to hydrogen.
130
  The intermolecular attraction 
between PTFE molecules is very small and thus its bulk properties do not possess the 
high rigidity and tensile strength associated with other hernia mesh materials.  Also, the 
physical form of PTFE is the exception to the typical fiber form of hernia mesh materials.  
The morphological difference is due to the high crystalline melting point of PTFE being 
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very close to its degradation temperature leaving no melt processing window.  
Accordingly, ePTFE is manufactured by stretching and sintering a solid melt-extruded 
sheet while at the same time producing a node-fibril structure that results in micropores.  
This process gives rise to the “expanded” precursor designation. 
 
Partially Absorbable Mesh Constructions 
 The intent of partially absorbable mesh constructions is to reduce the amount of 
biomaterial, e.g. polypropylene, in an attempt to reduce the foreign body response.  
Meshes constructed from a combination of a 10/90 copolymer of poly(L-lactide-co-
glycolide) and polypropylene have become the most common form of partially 
absorbable mesh and are the most investigated.  Theoretically the reduced level of 
resident mass results in less fibrosis, structural changes that result in larger pores, and less 
chronic inflammation.
131
  Partially absorbable meshes are constructed by plying the 
different filaments together and then knitting the plied yarn to produce a mesh with 
approximately 50% absorbable polymer.
84
  The high polyglycolide copolymer is a linear, 
aliphatic polyester comprised of a single ester and ethylene group (-CH2COO-).  The 
ester group in the chain backbone is readily hydrolyzed due to its somewhat hydrophilic 
nature and a lack of any side chain structures that provide steric hindrance.  Polyglycolide 
produces relatively high levels of crystallinity from planar zigzag crystallites which give 
the material excellent stiffness.  Mechanical properties are typically reduced about 50% 
in 2-3 weeks with complete absorption within 90 days. 
 
 38 
Mesh Characteristics Pertinent to Biocompatibility 
 The design characteristics of meshes include construction, fiber form, fiber 
surface, and bulk chemistry.  Collectively these characteristics significantly influence the 
biocompatibility of a mesh and its mechanical suitability for a particular application.  
However, although the design characteristics of meshes have produced significant debate 
with regard to their respective influences, no study has been completed which isolates 
each characteristic.  For example, an in vivo study that compares the same construction 
and yarn form and differing chemistry does not exist.  To date, studies have been 
conducted using commercially available meshes, and each has a different construction, 
fiber form, and fiber chemistry making it difficult to isolate the influence of individual 
mesh design variables.  However, observations about mesh design variables have 
provided insight into their general influence on biocompatibility. 
 
Mesh Construction 
 Mesh construction can be extensively varied and has implications on pore size, 
area weight, drape, extensibility, and strength, all which clinically translate into surgical 
handling characteristics, anatomical conformability, foreign body reaction, and the 
mechanical, cellular, and extra cellular matrix characteristics of the mesh/tissue complex. 
 The porosity of a mesh is best described as the amount of open space in a unit 
area of mesh.   However, this description does not provide a complete picture as the 
dimensions/area of individual pores, the distance between pores, and the size and quantity 
of interstitial pores, are also contributing factors to in vivo performance.  Porosity is a 
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rarely measured characteristic.  Recently, a study using digital imaging was conducted in 
order to better characterize the overall porosity and the distribution of different pore sizes 
for clinically relevant meshes.
132
    The porosity of meshes is a primary determinant for 
tissue response, with pore size implicated in affecting long-term abdominal wall mobility.  
It has been suggested that pores smaller than 1mm lead to extensive inflammation and 
fibrosis, resulting in a bridging of collagen between adjacent pores.
84,114,133
  Ultimately 
this occurrence produces a dense, continuous outer fibrotic capsule covering the whole 
mesh.  Several investigations using a rat
134-136
 and a porcine
137
 animal model have 
concluded that larger pores result in increased abdominal wall mobility due to reduced 
fibrotic bridging.  In addition, the absence of a complete capsule covering the mesh 
facilitates improved fluid transport through the mesh, as well as improved vascularization 
and organization of connective tissue.
138
  Based on increasing evidence, porosity is a key 
factor in the incorporation of the mesh into the surrounding tissue, and thus an important 
prerequisite to its biocompatibility. 
Area weight, measured as the mass per area (g/m
2
), is a determination of the total 
amount of biomaterial implanted for a given area.  Theoretically, lower area weights 
induce a milder foreign body reaction, improved abdominal wall compliance, less 
contraction or shrinkage, and allow better tissue incorporation; as a result, the use of 
lighter weight or partially absorbable meshes has been investigated to improve hernia 
repair outcomes.  However, the available data is contradictory and controversial.  The 
outcomes from partially absorbable meshes are mixed.  Early investigations in a rat 




  However, Weyhe and coworkers have 
investigated the changes in foreign body reaction in both a rat animal model
140
 and in 
vitro
141,142
 and determined that simple reduction of the mesh mass was not the main 
determinant of biocompatibility; rather, pore size and material composition were better 
indicators.  Clinical trials have produced conflicting outcomes as well.  Several studies 
have found no significant differences between typical polypropylene meshes and partially 
absorbable meshes in multicenter studies using Lichtenstein hernioplasty.
143,144
  Conze 
and coworkers found similar outcomes when comparing partially absorbable and standard 
polypropylene meshes; however, partially absorbable mesh had a trend toward increased 
hernia recurrence.
145
  Other authors have reported improvements in some aspects of pain 
and discomfort using partially absorbable meshes,
146
 but in addition to less chronic pain, 
an increase in recurrence has also been reported.
147
  In a recent review of current 
randomized controlled trials and retrospective studies, partially absorbable meshes seem 
to have some advantage with respect to post-operative pain and foreign body sensations, 
but their use is associated with increased recurrence rates.
148
  The movement toward the 
use of lower weight meshes has shown researchers and clinicians that long-term, lower 
area weight meshes appear to reduce some complications but at the cost of an apparent 
increase in recurrence. 
The mesh construction in vivo can influence the mechanical properties of the 
mesh/tissue complex.  When a mesh is stressed, the mesh filaments show minimal if any 
elasticity, while the mesh itself produces extensive elongation from geometric 
deformation within the pores perpendicular to the applied stress.  Thus, the elastic 
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characteristics of a mesh and the ability to match those of the natural abdominal wall are 
predominately influenced by construction.  In a study conducted by Greca and coworkers 
a polypropylene light weight, macroporous mesh (19 g/m
2
) was compared to a typical so 
called „heavy weight‟ mesh (85 g/m
2
) in the repair a full-thickness abdominal wall defect 
in a dog animal model.  Although the heavy weight mesh had 3.6 times the initial burst 
strength of the light weight mesh, after 90 days in vivo the mesh/tissue complex for the 
light weight mesh produced marginally greater average burst strengths than the heavy 
weight mesh.
149
  The authors attributed the increased strength to a higher concentration of 
mature type I collagen developed around the light weight mesh.  The mechanical 
characteristics of the mesh construction are important factors, as the maturation of the 
mesh/tissue complex is a critical indicator of biocompatibility. 
The strength of a mesh is not only characterized by yarn diameter or denier, 
number of yarns, and tenacity of the yarn, but construction also affects the burst strength.  
The nature and extent of yarn looping within the mesh construction affects the burst 
strength due to stress concentrations.  For a given mesh construction, stronger mesh yarn 
does not always translate linearly to increased mesh burst strength.  Construction can play 
a limiting role in the strength of the construct. 
 
Type of Yarn 
  Monofilament-based meshes have marked stiffness, whereas multifilament 
meshes have improved softness, less surface texture, and better drape characteristics for 
adaptation to anatomical curvatures.  Multifilaments physically have a pronounced 
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increase in surface area, which influences their biocompatibility.  In vivo testing in a rat 
animal model has suggested a more intense acute inflammatory response and increased 
fibrosis to multifilament yarn than monofilament yarn.
150-152
  The authors attributed the 
upregulated response to the increased tissue/biomaterial surface contact area.  Patients 
implanted with either multifilament or monofilament polypropylene meshes for inguinal 
hernioplasty were investigated for inflammatory response differences.  Blood samples 
were collected before surgery and up to 168 hours post-surgery, and were analyzed for 
pro-inflammatory mediators.  Results indicated a more intense acute inflammatory 
response to the multifilament mesh.
153
  The increased response may be in part the result 
of the increased adsorption of host proteins to the implant, which in turn triggers the 
increased activation of inflammatory cells.  Long-term, multifilaments have not been 
identified as triggering an increased level of chronic inflammation as compared with 
monofilaments, in fact, more leukocytes and larger multinucleated giant cells have been 
observed to be associated with monofilament meshes.
154
 
 Multifilament based mesh constructions have been implicated as producing a 
higher incidence of infection.  Amid suggested that the infiltration and proliferation of 
bacteria within multifilament meshes is due to interstices or pores that are less than 10 
microns.
68
  The result is the development of infection by the housing of bacteria which 
have sizes averaging 1 micron and the exclusion of macrophages and neutrophils of 10-
15 microns in size.  In fact, infection associated with multifilament meshes often 
necessitates the removal of the mesh to alleviate the problem, while infection associated 




  However, a rat study to investigate Amid‟s claim determined that pore size 
alone does not predict infection and suggested that collagen fibers and macrophages 
penetrated and surrounded multifilament fibers at two weeks.
154
  Pore size alone is not 
the only variable in infection prevention.  The ability of a mesh to resist infection is also a 
function of the surface area available for bacterial attachment, biomaterial composition 
and hydrophobicity, and the interaction with the local host tissue defenses.
156,157
  
Infection always starts with bacterial adhesion, which is influenced by the surface 
roughness, hydrophobicity, and the material‟s inherent ability to generate electro-static 
forces or an electric charge that transfers between the polymer surface and the bacterial 
wall, resulting in attraction.
158,159
  Klinge and coworkers determined that the surface area 
of multifilament meshes was increased by a factor of at least 1.57 in comparison to 
monofilament, thus providing significantly more area for bacterial adhesion.  The authors 
indicated that the increased surface area associated with multifilaments was the primary 
reason for the persistence of bacteria in the implant bed.
160
  In the same study, rats were 
implanted with monofilament and multifilament meshes which were inoculated with 
Staphylococcus aureus prior to implantation.  No increased infection rates were observed 
between the two fiber forms as compared to controls.  Overall, it should be noted that 
both monofilament and multifilament yarn forms have produced good clinical 





Yarn Surface and Bulk Chemistry 
 The surface and bulk properties of a yarn can be dramatically different.  Surfaces 
are physically unique environments with varied mechanical, morphological, barrier, and 
electrical properties.  The surface of a biomaterial is the interfacial transition between 
bulk chemistry and the in vivo environment.  The surface provides the only direct 
chemical or biophysical interaction with the biologic environment.  Surface properties are 
influenced by unsaturated secondary bonds of atoms comprising the surface and their 
interaction with opposing surfaces or molecules.
161
  For the polymers used in meshes, 
their hydrophobic or hydrophilic nature is derived from unassociated polar and nonpolar 
groups at the surface.  Bulk properties, on the other hand, arise from composition and 
morphology of everything below a few atoms deep of the surface, determining such 
properties as elastic modulus, toughness, yield strength, and hardness.   
Chemical degradation that results in reduced physical and mechanical properties 
is the primary obstacle to long-term mesh stability.  Due to the foreign body reaction, the 
mesh material is continuously exposed to super oxides.  As previously discussed, 
polypropylene is susceptible to oxidative degradation.  Continuous exposure of 
polypropylene to these oxidants can lead to chain scission, production of radicals, and 
degradation to the surface and bulk chemical structure.  In one study, 85% of explanted 
polypropylene meshes exhibited cracks, surface roughness, and peeling of the surface 
from oxidation.
162
  Surface oxidative degradation of polypropylene has been shown to 
result in bulk property changes such as a loss of mass, a lowering the glass transition and 




  Moreover, both polypropylene and polyethylene terephthalate 
have been shown to absorb squalene, palmitic acid, and, in some cases cholesterol.
127
  
These small organic molecules may act as plasticizers and further decrease yield stress.  
The bulk degradation and fracture of polyethylene terephthalate yarn from hydrolysis has 
been realized for vascular grafts and meshes.
167-169
  In the future, it is possible that 
eventual bulk degradation will be realized in polypropylene, which will limit its service 
life, especially in young patients for whom the mesh is expected to hold for several 
decades.  Remarkably these finding are in contradiction to the widely accepted belief that 
non-absorbable mesh materials, particularly polypropylene, are stable and inert. 
 
Biocompatibility – Meshes and the Biologic Environment 
 The word biocompatibility is used extensively, yet a great deal of uncertainty 
exists about what it actually means and about the mechanisms that collectively control 
the concept.  Several definitions have been proposed, with none gaining widespread 
acceptance.  Historically, the biocompatibility of long-term implanted devices has been 
graded on their ability to be chemically and biologically inert and do no harm to the 
surrounding host tissue.  As knowledge of the biologic environment has grown, more 
emphasis is placed on functionally stimulating or avoiding specific cellular or tissue 
responses.  A recent re-definition of biocompatibility has been suggested by Williams: 
“Biocompatibility refers to the ability of a biomaterial to perform its desired function 
with respect to a medical therapy, without eliciting any undesirable local or systemic 
effects in the recipient or beneficiary of that therapy, but generating the most appropriate 
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beneficial cellular or tissue response in that specific situation, and optimizing the 
clinically relevant performance of that therapy”.
170
  The following sections explore the 
current status of mesh biocompatibility. 
 
Early Phases of Wound Healing and Mesh Integration 
 The early phases of normal wound healing include hemostasis and acute 
inflammation characterized by fibrin clot formation, bacterial clearing, and wound 
debridement followed by proliferation, which includes the formation of granulation tissue 
and wound contraction.  Granulation tissue is made up of a cellular, randomly ordered 
extracellular matrix containing new blood vessels from angiogenesis.  When the acute 
inflammation phase does not resolve in a timely manner it is said to enter a state of 
chronic inflammation. 
 
Acute and Chronic Inflammation – Responses to Meshes 
Tissue disruption and bleeding during mesh implantation results in fibrin clot 
formation and a burst of inflammatory cytokines that attract monocytes/macrophages, 
polymorphonuclear cells, and lymphocytes.  From the instant that the mesh is placed in 
situ, surface protein adsorption is initiated followed by a reorganization of the protein 
layer as described by the Vroman effect.  Resident tissue cells such as mast cells and 
macrophages become activated and respond to the biomaterial.  It is believed that these 
phagocytes attach and interact with the adsorbed proteins rather than with the material 
itself.
114
  Phagocytes attempt but are unable to remove the mesh due to its size and 
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relatively inert nature.  As a result, the healing response moves into the chronic 
inflammation phase due to the continued presence of the mesh.  Consequently, the 
proliferation phase initiates, but with the continued presence of inflammatory cells.
171
 
Within the first few hours, neutrophil activity is initiated with bloodborne 
neutrophils entering the local tissue by diapedesis.  For the ensuing weeks the presence of 
the mesh stimulates neutrophil activity beyond the time of its normal resolution.  Blood 
samples from mesh and primary repaired hernia patients, up to 168 hours postoperative, 
suggest the presence of a mesh significantly increases the neutrophil count.
153
  Neutrophil 
activity is detrimental to the healing wound site because of the excessive generation of 
matrix metalloproteinases favoring the degradation of local and newly formed tissue.
172
  
Neutrophil activity investigated in a rat animal model using a simulated mesh hernia 
repair peaked in activity at 3 days and steadily decreased in numbers until 14 days.
173
  An 
investigation by Rosch and coworkers using a rat animal model determined that, in the 
early phases, the wound area contains predominately macrophages with persistent T-cell 
activity that lasts through 90 days.
174
  In addition, within the first week, mast cell activity 
is elevated.  The mast cell‟s role in inflammation is mostly credited to the recruitment of 
inflammatory cells from the release of their granular products including histamine.  
Furthermore, mast cell release of histamine facilitates increased blood flow and cell 
infiltration through dilation of arterials and increased permeability of venules.
175
  The 
continuous cytokine generation, which is said to peak between 7 and 14 days, progresses 
the wound healing response into the proliferation phase as the host tissue attempts to 
isolate the mesh through encapsulation. 
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Proliferation – Tissue Integration and Collagen Development 
 The proliferation phase is primarily characterized by the increased presence of 
fibroblasts that produce significant amounts of extracellular matrix with maximum 
deposition at 2-3 weeks.  Consequently, the bulk of the collagen is deposited in the 
proliferation stage; however, even under normal wound healing conditions, high quality 
collagen is not formed until later in the maturation phase.  Wound mechanical integrity 
begins to develop as the level of crosslinking increases.  Unfortunately, the overlap of the 
acute wound healing trajectory may further delay the recovery of wound tensile 
strength.
176
  Wound inflammation is primarily a protective response; studies suggest that 
the mechanisms used to destroy bacteria and remove debris delay tissue repair.
177
  Fascial 
tissues within the abdominal wall have been shown to develop strength faster than dermal 
wounds.  Fibroblasts extracted from rat fascial wounds show enhanced cell proliferation 
and increased wound collagen deposition compared to dermal fibroblasts.
178
  
Mechanisms for accelerated fascial healing include earlier activation of fascial fibroblasts 
and earlier induction of collagen synthesis compared to dermal wounds.
179
  Macrophages 
play a fundamental role in the process of extracellular matrix development through direct 
or indirect fibroblast signaling.  Results from animal studies have suggested that the 
absence of macrophages results in defective scar formation.
180
  On the other hand, 
increases in the time and intensity of inflammation are associated with increased levels of 
scarring
181
; however, the amount of collagen present at the wound site is not a good 
indicator of mechanical integrity.  The bulk of extracellular matrix production occurs 
during the proliferation stage, but this does not represent the time at which the 
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extracellular matrix is complete.  Significant changes in orientation and conformation of 
fiber bundles have yet to occur during the remodeling and maturation stage in order to 
develop quality collagen. 
 
Development of Vascular Structures – Angiogenesis 
 Wound repair and normal healing depends on an adequate arterial circulation 
supplying the newly forming tissue with oxygen.  Angiogenesis begins during the 
proliferation phase.  Vasculature in the wound periphery develop small buds or sprouts 
that grow into the fibrin/fibronectin-rich wound clot and, within a few days, organize into 
a microvascular network within the granulation tissue.  Several factors including vascular 
endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), platelet-derived 
growth factor (PDGF), and transforming growth factor (TGF-β) induce angiogenesis,
182 
which is then directed to the wound area by low oxygen tension gradients and elevated 
lactic acid levels.
183
  The development of new blood vessels is critical since healing will 
not proceed unless new, functioning blood vessels supply oxygen and nutrients to the 
developing tissue and remove metabolic waste.  However, the distribution of oxygen by 
neovascularization goes beyond nutritional support.  There are several posttranslational 
steps in collagen synthesis that are oxygen dependent and responsible for the 
development of tensile strength in healed wounds.
184,185
  At the end of the proliferative 
phase, cellular activity is decreasing and there is less need for a rich vascular supply.  
Consequently, some capillaries aggregate into larger vessels but most of the recently 
formed blood vessels quickly involute through apoptosis of endothelial cells.  Overall, 
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wound angiogenesis represents a response to coagulation, inflammation, and the 
temporary increased metabolic need of the wound area that is well beyond the capacity of 
the vessels that once fed the site.
186
 
 Laschke and coworkers
187
 developed a novel, quantitative method of investigating 
angiogenesis for mesh implantation in a rat animal model and found that by day 3 of 
implantation the protrusion of capillary buds and sprouts had originated from the host 
microvasculature.  Until day 10, the sprouts interconnected to form loops and a new 
microvascular network.  By day 14, the vascular ingrowth was complete with venular 
diameters and volumetric blood flow comparable to those in the host tissue, distant from 
the mesh.  In a study to investigate the effect of yarn diameter on tissue response, fibrotic 
capsule thickness around individual yarns was reduced when vascular structures were 
observed close to the filament.
188
  The finding is consistent with the expectation that 
tissue response is more favorable if nutrients are available locally.  Additionally, vascular 
constructs in close proximity to the mesh improve the cellular response to infection.  For 
other implanted, mesh-like constructions such as vascular grafts, investigations have 
found that the potent cytokines secreted by chronically active macrophages are inhibitors 
to angiogenesis.
189
  This suggests that intense acute inflammation may inhibit 
angiogenesis.  In conclusion, the extensive vascularization of an implanted mesh is 





Contraction of the Mesh/Tissue Complex 
Collagen deposition is accompanied by wound contraction as a natural 
phenomenon that decreases the area of the wound defect.  For mesh hernia repair, it is an 
undesired consequence that initiates during the second week and is associated with 
recurrence, migration, and pain.
190,191
  The etiology is largely unknown but it has been 
suggested that during proliferative scars the impaired activity of myofibroblasts renders 
them unable to control normal fibrillar arrangement; in addition, excessive production of 
TGF-β during chronic inflammation increases contraction.
192
  Early and complete 
integration of the mesh into the surrounding tissue may decrease mesh shrinkage.  In a 
swine study to investigate the association between tissue ingrowth and mesh contraction, 
suture detachment from fixation points was observed, indicating that shrinkage occurred 
before the mesh had time to integrate into the tissue.
190
  On the other hand, meshes that 
exhibited strong integration into the surrounding tissue exhibited the least amount of 
contraction.  As reviewed by Garcia-Urena, in a study comparing mesh shrinkage with or 
without fixation after 90 days, the meshes in the fixation group shrank less and retained 
their original shape indicating the importance of mesh stability to shrinkage.
191
  As 
previously indicated, the extent of mesh shrinkage has been shown to be directly 
proportional to the degree of inflammatory response.
87
  It is also known that extensive 
inflammation delays the proliferative phase of tissue deposition, which may reduce the 
integration of the mesh into the surrounding tissue.  Together, the physical consequences 
of delayed tissue ingrowth due to inflammation and inadequate mesh stability have 
potential contributing roles in mesh shrinkage. 
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Meshes and the Immune Response 
The immune system protects the body from potentially harmful substances by 
recognizing and responding to antigens or non-self molecules.  For meshes, the immune 
response is a rarely investigated topic because synthetic materials are not considered 
immunogenic.  However, fluids from the in vivo environment can facilitate mesh yarn 
swelling which results in the leaching of low molecular weight particles such as 
impurities, antioxidants, plasticizers, and unreacted monomer.  These particles 
themselves are not immunogenic, but if they covalently bond to a secretory protein or 
protein on a cell surface they become haptens and the complex is then recognized as an 
antigen by the immune system.  Another potential pathway is from activated 
macrophages, at or near the surface of the polymer, which release highly reactive radicals 
that damage the polymer surface and create degradation products that can act as haptens 
to adsorbed proteins.
193,194
  Depending on the physicochemical properties of the implant 
surface and type of absorbed proteins, the rate of degradation and thus the immune 
response will be variable.
114
  The immunologic response triggers the activation of 
macrophages, which respond by releasing pro-inflammatory chemokines that attract 
additional immune cells.  Furthermore, immune cells under typical wound healing 
conditions have a role in wound resolution.  It has been demonstrated that T lymphocytes 
have an active role in cytokine production at the wound site and are essential to a 
successful healing process.
195
  T-lymphocytes have been shown to have a nonspecific 
reaction against biomaterials with influences in macrophage recruitment, formation of 
giant cells, and the phagocytosing activity of macrophages and giant cells.
174
  On the 
 53 
other hand, there is no evidence that B lymphocytes play a significant role in wound 
healing.
196
  In all, the adaptive immune response to synthetic meshes is thought to be 
minimal, and only a small part of the overall acute inflammatory response.  A more 
significant nonspecific or innate role is played by T-lymphocytes, with influences over 
macrophage activity. 
 
Mesh/Tissue Complex Stability and Applied Tension 
The surgical repair of hernias with mesh results in a lower level of tension applied 
to the wound.  Unlike primary repair, the edges of the hernia are not completely 
approximated; instead, the mesh is sutured in place with the defect forming what is 
known as a hernia ring that is spanned on all sides by the mesh.  The mesh then becomes 
the scaffold, allowing extracellular matrix to develop within and around the hernia ring.  
The reduced wound tension of mesh repairs compared to primary repair has increased the 
clinical use of meshes for incisional hernia repair from 35% in 1987 to 66% in 1999.
197
  
This shift is due to an observed reduction in recurrence, which has been attributed to 
lower levels of wound tension.  The most common cause of wound failure in primary 
repair is dehiscence, from the tearing of suture through the fascia.  Although less 
common, the mechanism exists for meshes because of the endogenous tension of the 
tissue being repaired.  However, early biomechanical wound disruption for meshes 
occurs almost exclusively at the suture line located at the margins of the mesh.  For 
example, during the first few weeks after hernia repair, minimal extracellular matrix 




  Concurrently, recovering surgical patients return to physical activity, 
placing increased loads across the acute wound during its weakest phase.
39,199
  Therefore, 
suture integrity at the margins of the mesh must exclusively resist the applied stresses.  
Failure to resist the applied stress results in mesh-fascial dehiscence. 
The general clinical consensus is that wound tension should be minimized during 
early post-operative periods.
200
  Burger and coworkers, using computed tomography 
scans in a retrospective study, determined that, although incisional hernias in some cases 
are not realized until several months or years after surgery, the hernia process starts 
during the first postoperative month with observable separation of the rectus abdominal 
muscles.
201
  These defects may initiate small and asymptomatic, but can steadily increase 
in size, eventually allowing the protrusion of abdominal contents and visible bulging.  
DuBay and coworkers designed a rat surgical model that produces acute fascial 
separation following the rapid dissolution of cat gut suture.
202
  The ensuing incisional 
hernias have a well defined hernia ring, protruding hernia sac, and visceral adhesions, 
providing all of the characteristics that clinically develop in humans.  Following mesh 
repair of the induced hernia, animals were evaluated on post operative days 7, 14, 28, and 
60 for the development of recurrent incisional hernias.  It was determined that 16% of the 
total 21% recurrences occurred by post operative day 7.
202
  The authors concluded that 
recurrent incisional hernia formation is an early postoperative occurrence. 
In addition to recurrence, wound biomechanical disruptions can affect 
angiogenesis.  During the early stages of angiogenesis, capillary sprouts lack full 
thickness which renders them delicate and easily disrupted.  Budding vessels are so 
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fragile that collagen fibers must surround them to prevent rupturing when blood pressure 
is imposed by arterial inflow.
182
  Immobilization of the granulation tissue is essential 
through the proliferation phase to permit vascular regrowth and prevent 
microhemorrhages.
7
  The prevention of these microhemorrhages facilitates the 
progression of the wound healing process without the release of additional pro-
inflammatory cytokines.  Wound stability during the early postoperative period is critical 
to preventing wound disruptions at the suture line that can evolve into recurrences and is 
critical for optimal wound site vascularization. 
 
Advanced Phases of Wound Healing and Maturation 
 The so-called maturation phase of wound healing is characterized by a decrease in 
cell density and metabolic activity followed by balanced collagen degradation and 
deposition process whereby the wound site is remodeled through collagen fiber bundle 
organization based on chemical and mechanical stimulation. 
 
The Long-Term Foreign Body Response to Meshes 
All meshes demonstrate a chronic, persistent foreign body reaction.  The long-
term tissue reaction at the interface to the mesh is independent of implantation time and 
characterized by many macrophages, granulomas, and foreign body giant cells.
203
  
Aggregated, activated, and frustrated macrophages lead to macrophage fusion and the 
formation of foreign body giant cells on the surface of implanted biomaterials.
193
  Foreign 
body giant cells are the predominant cell type of the long-term foreign body reaction, 
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with their numbers more than doubling from 2 months to 6 months around polypropylene 
filaments in a swine animal study.
204
  This process initiates early and persists for years, 
being observed in explanted meshes 15 years after patient implantation.
205
  Patients with 
polyethylene terephthalate mesh hernia repairs were biopsied during later operations to 
study the tissue response.
206
  At 16 months, a layer of foreign body giant cells developed 
around the yarns, macrophages collected in an intermediate layer of mature granuloma 
with fine fibrillar collagen, and a denser outer border of collagen bundles aligned along 
stress lines and was populated by fibroblasts.  The partial volume of cells and physical 
nature of the foreign body response has been reported to be affected by the type of mesh 
material.  Polyethylene terephthalate induced tissue reactions show comparatively little 
inflammation but have heavily macrophage populated granulomas, whereas 
polypropylene shows an increased amount of inflammation and connective tissue.
203
  It 
should be noted that the yarn form, construction, pore sizes, and so on, are different 
between typical polyethylene terephthalate and polypropylene meshes; other factors 
beyond material type likely influence long-term foreign body reaction.  Altogether, non-
absorbable mesh causes a persistent, long-term inflammatory reaction at the interface 
between polymer yarn and host tissue; the reaction is comprised mostly of foreign body 






Wound Maturation – Collagen Reorganization and Crosslinking 
 The wound site extracellular matrix surrounding the mesh progresses from a 
blood-based provisional matrix of fibrin clot and serum protein deposition (inflammation 
phase), to a loose, disorganized, weak collagen network that, after several weeks begins 
to crosslink and develop strength (proliferation), to finally a complete replacement and 
reorganization of the collagen fibers and fiber bundles and established integrity of the 
local tissue.  During remodeling, collagen turnover allows the randomly deposited scar 
tissue to be rearranged and restore some level of functionality.  To achieve this goal, 
quality collagen is produced by adequate synthesis, degradation, crosslinking, and 
remodeling of collagen fibrils in response to mechanical stimulation. 
The goal of hernioplasty should be to restore the morphology and functions of the 
abdominal wall such that the prosthesis provides a substitute with characteristics closest 
to the tissue‟s normal function, with a low elastic modulus more relevant to performance 
than the relative strength of the mesh.
207
  Increasingly, it is being recognized that the 
growth and remodeling of fibrotic tissue that supports mechanical loads is governed by 
the same principles as Wolffs‟ Law for bone.
171
  A lack of stress produces atrophy while 
excessive stress results in necrosis.  Ideally, low forces produce extracellular matrix 
distention, providing endogenous stress that fibroblasts maintain under tensional 
homeostasis.
208
  Meshes begin to significantly decrease the mobility of the abdominal 
wall 2-3 weeks after implantation from the induction of the scar plate.
208
  In the uniaxial 
direction, typical meshes have low initial elastic modulus due to deformations within the 
pores.  However, biaxially, with fixation on all sides, current meshes have a high elastic 
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modulus with very low elongation even at maximum physiologic conditions.  
Consequently, the mesh absorbs most of the mechanical load and the stress-deprived 
extracellular matrix will not efficiently remodel or mature.  Matching of the implant 
load/extensional characteristics to the tissue should create a fibrotic capsule that is 
substantial and strong, with elastic properties that more closely match those of the 
surrounding tissue.  Furthermore, when two contacting materials have marked differences 
in their elastic moduli, the result is high shear stress concentrations at the interface.
171
  
This difference is evidenced in reports of collagen fibers, which orientate along stress 
lines, aligning parallel to individual filaments of yarn and around the outer fibrotic 
capsule around the mesh
203,205
, but with little or no orientation reported within the pores.  
Relative motion at the mechanical interface may also be responsible in part for the 
foreign body response to meshes.  Increased shear stresses and a lack of mechanical 
stability at the interface may cause load mediated cell necrosis and general irritation to 
the tissue stimulating inflammation.
171
   
 A mesh/tissue complex that has firm attachment and close matching of the mesh 
and tissue elastic moduli is critical to the long-term mesh/tissue complex mechanical 
properties and the level of foreign body response to the mesh.  Mechanical stimulation 
significantly influences the remodeling of the mesh/tissue complex and the development 





New Opportunities Based On Currently Unmet Needs 
Since the development of absorbable sutures over three decades ago, there has 
been interest in using absorbable multifilament yarn for constructing absorbable meshes.  
However, this interest has been limited by unsuccessful attempts to repair load bearing 
soft tissues such as abdominal wall hernia repairs.  Meshes constructed of only fast 
absorbing polyglycolide or 90/10 poly(glycolide-co-lactide) provide inadequate strength 
beyond three to four weeks of breaking strength retention.  In addition, development of 
meshes constructed from relatively slow degrading high-lactide yarn has generated little 
to no interest.  This situation has left the majority of soft tissue repair load bearing 
applications to be filled by non-absorbable materials, which suffer distinctly from 
undesirable features associated, in part, with their inability to (1) possess short-term 
stiffness to facilitate tissue stability during the development of wound strength; (2) 
gradually transfer the perceived mechanical loads as the wound is building mechanical 
integrity; (3) provide compliance with load transfer to the remodeling and maturing 
mesh/tissue complex; and (4) minimize the likelihood of long-term complications with 
their degradation and absorption at the conclusion of their intended functional 
performance.  Wound healing is a dynamic process that results in different criteria at 
different phases for the optimal development of the mesh/tissue complex.  Current non-
absorbable or partially absorbable meshes may not provide adequate early stability and 
then a sufficient level of long-term mechanical stimulation to the remodeling and 
maturing collagen. 
 60 
Absorbable medical meshes in the form of multicomponent systems possessing 
different degradation rates can produce modulated mechanical, chemical, and physical 
properties which individually or collectively may improve the wound healing process.  
Figure 1.8 illustrates the characteristics of a multicomponent mesh that has two different 
strength profiles compared to the wound strength profile and typical phases of wound 






The modulated mechanical characteristics of a multicomponent mesh superimposed  
with the wound healing response. 
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The mesh wound stability phase continues through the inflammation and 
proliferation phases.   Early stiffness of the mesh may facilitate uninterrupted tissue 
integration and angiogenesis, while reducing the risk of recurrence from applied wound 
stresses prior to the development of wound strength.  In addition, the added stiffness and 
stability may resist and/or minimize the wound contraction process.  As the wound 
develops load bearing capability, stress is slowly transferred as the fast degrading 
component loses strength.  Once the fast degrading component of the mesh is removed, 
the long lasting component is well encapsulated in the extracellular matrix.  The mesh is 
positioned in a relaxed configuration such that the newly deposited collagen becomes 
load bearing and tensional homeostasis is returned to the abdominal wall.  Over the 
ensuing months the remodeling/maturing process of collagen degradation and synthesis 
adapts the tissue to the loading conditions.  Finally, the slow degrading component loses 
its mechanical integrity by hydrolysis and is metabolized, leaving the wound site without 
the continuous foreign body response.  Ultimately, the abdominal wall is left with a 
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EFFECT OF MESH CONSTRUCTION ON THE PHYSICOMECHANICAL 
PROPERTIES OF BICOMPONENT KNIT MESH USING YARNS  




 The efficacy of hernia repair has challenged surgeons for decades.  The high 
recurrence and complication rate for hernia repair has resulted in the clinical exploration 
of many surgical procedures, debate over the etiology and pathology of hernia formation, 
and an evolution toward mesh repairs from the use of primary closure.  Recently, the 
deficiencies of meshes and their role in hernia recurrence and patient complications have 
been well documented.
1-10
  In part, these deficiencies are a result of a mesh/tissue 
complex which is less compliant than the abdominal wall due to the design of traditional 
meshes.
11-13
  Furthermore, traditional meshes used for hernia repair are chemically inert 
and permanent.  As a result, absorbable polymers made from degradable copolyesters are 
not routinely used in hernia repair, despite the fact that their use may hold significant 
advantages.  Consequently, a focused investigation of the physicomechanical 
characteristics of new mesh designs, that employ different knit technologies which 
consider the temporal characteristics of the wound healing process, may improve the 
clinical outcome of hernioplasty.   
When a mesh is placed in vivo the host produces a wound healing response 
simultaneously with a foreign body response against the mesh.  The typical wound 
healing process has overlapping, temporal stages including inflammation, proliferation, 
and maturation/remodeling.  During the early phases of inflammation and proliferation, 
 81 
cellular responses clear the site of bacteria, fibroblasts migrate to the site and form 
extracellular matrix (ECM), and vascular structures infiltrate to facilitate the local 
increase in cellular metabolism.  However, during the first 2-3 weeks the ECM acts as a 
scaffold for cellular motility but lacks significant mechanical integrity.  For the next 
several months during the maturation/remodeling phase, deposited collagen begins to 
strengthen as collagen is degraded and reformed, crosslinked, and fibril diameters 
increase as the tissue adapts to the perceived mechanical loading conditions.  
Consideration for the specific needs of each stage within the wound healing process may 
hold the potential for improving mesh biocompatibility.  Traditional and proposed 




Traditional and Proposed Additional Design Criteria for a Hernia Mesh 
 
Traditional Design Criteria Proposed Additional Design Criteria 
 Chemically Inert 
 Permanent 
 Low levels of inflammatory response 
 Compliant to the required anatomical form 
 Structurally stable 
 Adequately porous for tissue integration 
 Non-immunogenic 
 Resistant to mechanical strains 
 Sterilizable 
 Resistant to infection 
 Promote collagen deposition and tissue 
remodeling 
 Absorb fully to minimize potential long-term 
complications 
 Maintain structural stiffness during the early 
phases of wound repair to provide stability to 
developing tissue 
 Replicate the extensional properties of the 
abdominal wall to provide mechanical 
stimulation for the remodeling extracellular 
matrix 
 Establish homeostatic conditions with 
endogenous tension restored within and 




The chemical biocompatibility and efficacy of linear aliphatic copolyesters, such 
as those produced from glycolide and lactide, is well established with decades of clinical 
use as sutures.  For hernia repair, the use of fast-degrading absorbable meshes, as well as 
the absence of a slow-degrading alternative, has resulted in unacceptably high hernia 
recurrence rates for fully absorbable meshes.  The use of a high-glycolide mesh for hernia 
repair does not provide adequate strength to the remodeling ECM in sufficient time to 
produce structurally supportive, self-sustaining collagen.
14
  As a consequence, the use of 
these meshes has been discouraged by surgeons, with the exception of use in temporary 
closure of the abdominal wall.
15
  Alternatively, the use of high-lactide yarns may provide 
the necessary healing time to facilitate the development of mature collagen, making the 
necessity of permanent implants limited to individuals that have a compromised wound 
healing response.  To date, there are no commercially available high-lactide meshes, 
although their development has been explored for soft tissue repair.
16-18
  Compared to 
glycolide, lactide‟s methyl group makes the polymer more hydrophobic and provides 
steric hindrance to water molecules, partially shielding the labile ester bond.  
Consequently, using lactide as the primary yarn chemical constituent will significantly 
slow the rate of hydrolysis and improve its strength retention with time.  Strength 
retention greater than 50% at 6 months is obtainable with high-lactide yarn.  In a like 
manner, the slow degradation rate of lactide polymers is routinely leveraged in 
orthopedic devices where healing times typically require strength retention for several 
months.  Moreover, the use of a fully absorbable hernia mesh may alleviate long-term 
complications due to the complete absorption of the mesh following its intended function.  
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Subsequent surgical procedures local to the implantation of a non-absorbable mesh pose 
significant surgical challenges, may not even be possible, and add to patient risk. This is 
well documented for certain vascular and urological operations.
19-22
 
Stress applied to the hernia repair site prior to the development of tissue 
integration and wound strength (first 2-3 weeks post insult) can result in acute wound 
failure.  At this early stage, anchoring devices, such as sutures, absorb the majority of the 
applied stress.
23
  Consequently, suture loops can pull through tissue, creating disruptions 
that later result in a hernia recurrence.
24
  From an engineering perspective, a distribution 
of applied loads across the mesh and wound site is required to avoid a stress 
concentration around a small number of suture points.  A stiff mesh may better distribute 
applied loads through its non-compliant structure to several suture points.  Furthermore, 
wound stability within the confines of the mesh during the inflammation and proliferation 
phases may prevent the disruption of developing, delicate connective tissue and vascular 
structures. 
The long-term (>3 weeks) strength and integrity development of the mesh/tissue 
complex requires dynamic, mechanical stimulation.  To date, the majority of meshes used 
in hernioplasty are polypropylene meshes,
25
 designed with significant strength, and 
constructed from stiff monofilament yarn to establish a perceived robust repair site.  
More recently, reduced mass and increased porosity have been investigated to improve 
the biocompatibility of these so-called heavy-weight meshes.  Reduced mass has been 
reported to lessen the long-term foreign body response
26-29
 to permanent meshes while 
increased porosity minimizes the bridging of collagen between pores
30-32
, where bridged 
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collagen results in a continuous, rigid scar plate.  However, minimal attention has been 
given to replicating the mechanics of the abdominal wall within the mesh/tissue complex.  
In part, this lack of attention can be attributed to the design limitations of single-
component, non-absorbable meshes to meet the temporal needs associated with hernia 
repair.  An extremely high level of mesh extensibility is required to match that of the 
abdominal wall, especially once the mesh extensibility is reduced after being 
encapsulated in tissue.  To further complicate matters, the long-term requirement for a 
mesh to match the high extensibility of the abdominal wall means that it will lack initial 
handling stability making surgical placement difficult, and will provide minimal support 
to developing, fragile tissue. 
The force-extension characteristics of a mesh, and the ability to match those of the 
abdominal wall, are predominately influenced by construction.  When a mesh is stressed, 
the mesh filaments show minimal if any elongation, while the mesh itself produces 
significant extension from geometric deformation within the pores perpendicular to the 
applied strain.  However, to establish normal tissue function in and around the implant, 
the mechanical properties of the mesh/tissue complex must closely match those of the 
abdominal wall.  Mismatch in the compliance properties of the mesh/tissue complex and 
local tissue is clinically believed to be a significant contributing factor in mesh failures.  
Most of these failures are due to marginal mesh-fascial dehiscence from fatigue.
10,32-35
  
Cyclic stresses at the margins of the mesh which are well below maximum failure values 
result from differences in stiffness within, and around the mesh/tissue complex.  As a 
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consequence, the long-term extensional properties of the mesh have significant relevance 
to biocompatibility and thus efficacy. 
The objective of any hernia mesh repair should be to restore homeostatic 
conditions.  Mechanical homeostasis of the abdominal wall is a dynamic, endogenous 
state of tension established by cellular, mostly fibroblastic, interaction with the ECM.  
However, stress shielding will prevail if the stiffness of the mesh is greater than that of 
the forces generated within the ECM and those applied by the surrounding tissue.  
Increasingly, the importance of tension in connective tissues is being realized, this force 
is paramount during the remodeling process where the mechanical environment 
influences cell function and ECM structure.  Changes in the mechanical environment 
have been shown to influence cellular function during in vitro studies.
36-38
  For example, 
endogenous tension is purported to inhibit collagen degradation by reducing collagenases 
production
39




, and control fibroblast 
phenotype
42
.  Each of these cellular functions influences ECM remodeling and requires a 
mesh/tissue complex with sufficient compliance so as to not interfere with the 
development or transmission of tension through the repair site. 
Presented is a study focused on the in vitro conditioned modulation of 
biocompatibility-relevant physical and mechanical mesh properties using (1) degradable 
yarns with different degradation profiles and (2) different mesh constructions employing 
warp and weft knitting technologies.  Specifically, a novel bicomponent mesh was 
developed that modulates physicomechanical properties and that (1) possesses short-term 
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structural stiffness, (2) provides a gradual transition phase, and (3) possesses long-term 
compliance with force-extension properties similar to the abdominal wall. 
 
Materials and Methods 
Polymer Synthesis and Characterization 
Polymer Synthesis 
MG-9, the proposed fast-degrading yarn of the bicomponent meshes, was 
synthesized as a polyaxial, segmented, high-glycolide copolymer.  A two-step, solid state, 
ring-opening reaction method was used to polymerize MG-9.  The first step produced a 
trimethylolpropane-initiated, trimethylene carbonate (TMC) segment.  Next, the TMC 
segment was end-grafted using 95/5 (molar) glycolide/caprolactone (G/CL).  The weight 
ratio of the polymer initiator to the end-graft was 2/98.  A more detailed explanation of 
the polymerization process is described in U.S. Patent No. 7,129,319 (2006). 
SMC-7, the proposed slow-degrading yarn of the bicomponent meshes, was 
synthesized as a linear, segmented, high-lactide copolymer.  The 88/12 (molar) l-
lactide/TMC copolymer was prepared using a two-step, solid state, ring-opening reaction 
method.  Propanediol was used to initiate the TMC polymeric initiator that was then end 
grafted by l-lactide.  A more detailed explanation of the polymerization process is 
described in U.S. Patent No. 6,342,065 (2002). 
Both polymers were isolated, ground, dried, and purified using high vacuum (< 
1.5 torr) to remove traces of unreacted monomer. 
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Determination of Molecular Weight 
 The number average and weight average molecular weight of SMC-7 were 
assessed by gel permeation chromatography (GPC) analysis (Waters, 1515 Pump and 717 
Plus Autosampler).  A 4 mg/ml solution, with dichloromethane (DCM) as the mobile 
phase, was passed through a 0.4 micron syringe filter prior to analysis to remove any gel 
particles.  A portion of each solution was analyzed using the Waters GPC equipped with 
four columns (HR6, HR4, HR2, and HR0.5) at a flow rate of 1.0 ml/min with refractive 
index detector (Waters, RI detector 2414).    Chromatograms were compared against 
calibration curves for twenty poly(methyl methacrylate) (PMMA) standards to determine 
the relative number and weight average molecular weights.  GPC measurements for MG-
9 were not obtained due to its insolubility in DCM. 
 Solution viscosity according to ASTM D2857-95(2007) Standard Practice for 
Dilute Solution Viscosity of Polymers was used to characterize the molecular weight of 
SMC-7 and MG-9 by measuring inherent viscosity at the standard solution concentration 
of 0.1 g/dL. Measurements for SMC-7 and MG-9 were carried out in the mobile phases 
of chloroform and hexafluoroisopropanol (HFIP), respectively. 
 
Determination of Thermal Characteristics 
 A differential scanning calorimeter (DSC; Perkin Elmer, Pyris 6) was used to 
evaluate each polymer‟s melt temperature (Tm) and corresponding endothermic heat of 
fusion (ΔHm).  A sample weighing between 5-10 mg was heated from room temperature 
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to 240°C at a rate of 10°C/min.  Dry nitrogen was used as a purge gas to eliminate 
influences due to oxidation. 
 
Yarn Preparation and Properties 
Melt Extrusion of Multifilament Yarn 
Melt-extruded yarn was produced using a 3/4″ diameter screw extruder equipped 
with a 43-hole die for SMC-7 yarn.  MG-9 was melt-extruded using the same extruder 
with a 20-hole die.  The extruded multifilament yarns were further oriented using a series 
of heated Godets at temperatures between 100-120ºC prior to their use for knitted mesh 
construction.  
 
Yarn Physical and Mechanical Testing 
 Yarn denier, a unit measure of weight for the size of a bundle of filaments (g/9000 
m), was measured on the SMC-7 and MG-9 yarns by weighing 50 m of yarn and scaling 
this quantity to the equivalent of 9000 m. 
 A universal testing machine (MTS, Synergie 200) equipped with a 500 N load cell 
was used to obtain mechanical properties for each yarn.  Measurements were made using 
a gauge length of 70 mm and cross-head speed of 2.33 mm/s.  The maximum force and 
elongation at the maximum force were obtained from each stress-strain curve.  The 
maximum force and the denier of the yarn were used to calculate the yarn tenacity 
(tenacity = maximum force/denier).  Mechanical properties were reported as a range 
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determined from measurements made during the beginning, middle, and end of the 
extrusion. 
 
Mesh Knit Construction 
The weft knit mesh (DM1) was constructed using a single feed circular knitting 
machine (LAMB, LX96) equipped with a 171 needle knitting head of 113 mm diameter.  
The feed was a plied, single yarn comprised of one MG-9 and two SMC-7 ends.  SMC-7 
yarn was dyed violet (D&C violet #2) to assist in its identification. 
The warp knitted mesh (WK1) was prepared using a two step process of warping 
yarn onto beams and then constructing meshes using a raschel knitting machine 
(American LIBA, RACOP TR-6).  The warping process began by preparing 90 packages 
of each yarn type and transferring their yarn to beams using a creel and warper 
(American LIBA, GE203A).   In all, four beams, two wound with a two-ply SMC-7 yarn 
and two wound with a two-ply MG-9 yarn, were produced.   The knit patterns for each 
yarn type were coknit into a single interpenetrating construction. 
DM1 and WK1 knit mesh were heat set by stretching a tubular mesh over a 
stainless steel circular mandrel.  The DM1 weft knit mesh was knitted in the form of a 
tube and used as such.  However, to accommodate heat setting of the WK1 mesh on 
circular mandrels, the flat mesh sheet was edge sewn into a tube using a standard sewing 
machine (Brother International, LX3125) and high-strength polyethylene terephthalate 
yarn.  Heat setting was completed at 110°C for 1 hour while under high vacuum (< 1 
torr).  Meshes were then cut from the mandrel to produce a stabilized sheet of mesh.  
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Images of each mesh construction were obtained using a camera (Cannon USA, EOS 
20D) equipped with a macro lens and mounted to stand.  In addition, images were 
obtained of each bicomponent mesh and their respective structurally independent MG-9 
and SMC-7 mesh components.  Meshes of only MG-9 and SMC-7 were obtained by 
accelerated in vitro degradation of the MG-9 yarn and solvent extraction of the SMC-7 
yarn using DCM, each process is described below. 
 
Mesh Physical Properties 
Accelerated In Vitro Conditioned Degradation 
Long-term mesh physical properties (only the SMC-7 yarn component of the 
mesh) were determined for bicomponent meshes following the degradation and removal 
of the MG-9 yarn under accelerated in vitro degradation conditions to expedite 
processing.  A 0.1M solution of buffered sodium phosphate was pH adjusted using 5.0M 
sodium hydroxide to a target value of 12.0pH.  Using the prepared medium, samples 
were incubated in 50 mL tubes at 50ºC under static conditions for 5-7 days until the MG-
9 component was significantly hydrolyzed.  Thereafter, samples were scoured in 
isopropyl alcohol under ultrasonic agitation to remove MG-9 yarn fragments followed by 
drying under reduced pressure (< 1.5 torr) to a constant weight. 
 
Mesh Area Weight 
The determination of mesh area weight followed option C in ASTM D3776-07 
standard test method for mass per unit area of fabric.  Specifically, the area weight for 
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each mesh construction was determined by first using a lever arm fabric cutter to cut 10 
cm x 15 cm rectangular samples of annealed mesh.  Each sample was then weighed 
(Mettler Toledo, AB204-S) to the nearest one thousands of a gram.  The following 




 For meshes, thickness is measured as the distance between the upper and lower 
surfaces of two plates subjected to a specified pressure.  Mesh thickness was determined 
using the procedure as outlined in the ASTM D1777-96 standard test method for 
thickness of textile materials.  Using a lever arm fabric cutter, random 57 mm x 57 mm 
square samples of annealed mesh were obtained for evaluation.  Each sample was 
measured in the center of the mesh swatch using a comparator (B.C. Ames, 05-0191) 
gauge.  The comparator gauge was equipped with a 28.7 mm diameter foot and used a 9 
ounce weight to apply the standardized pressure to the mesh. 
 
Weight Ratio of the Bicomponent Constituents 
 The relative weight ratio of the fast- and slow-degrading yarns was determined 
from solvent extraction of SMC-7 from the composite using DCM.   Three random 57 
mm x 57 mm square samples of annealed mesh were obtained and weighed (Mettler 
Toledo, AB204-S).  Next, all three samples were placed in 200 mL of DCM for 30 
minutes while under constant orbital agitation at room temperature.  Samples were 
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removed from DCM, rinsed using acetone, and dried under reduced pressure (< 1 torr) to 
a constant weight.  The initial weight of the three composite samples (Wi) and the final 
weight of the MG-9 yarn component (Wf) were used in the following equation to 




 Mesh porosity was characterized as (1) a percentage of the mesh covered by pores 
and as (2) the mean pore size.  Photographic images were obtained using a microscope 
equipped with a camera (Cannon USA, EOS 20D) and evaluated using NIS Elements 
(Nikon Instruments, Inc) software.  The total pore area, or open apertures, for each mesh 
was calculated from an obtained image that contained at least 20 large apertures.  
Manipulation of the images was performed by high-contrast colorizing of the pores 
followed by software determination of the color covered area.  Using this information, 
the fraction of area covered by pores compared to the total area was determined as a 
percentage.  Using the same image, individual pores were analyzed with respect to area.  
Since pore shapes are highly variable, both within and among different meshes, the area 






Mesh Tensile and Burst Properties 
In Vitro Conditioned Degradation 
Samples evaluated for mechanical testing following in vitro degradation were 
conditioned using a 0.1 M solution of buffered sodium phosphate in 50 mL tubes at a 
7.2pH.  Buffered sodium phosphate was prepared by adding 23.3 grams of dibasic 
(K2HPO4) potassium phosphate and 9.0 grams of monobasic (KH2PO4) potassium 
phosphate into 2 liters of deionized water and stirred until dissolution.  A pH meter 
(Symphony, SB80PI) was used to verify a 7.2pH measurement and slight adjustments 
were made to using 0.5 N hydrochloric acid (HCl).  Tubes containing buffer and 4 to 5 
mesh samples were placed in racks and incubated at 37°C under constant orbital-agitation 
at a speed of 28 revolutions per minute (Innova 4300).  Bicomponent mesh samples were 




 Tensile testing of 2.5 cm wide strips of mesh was conducted using a universal 
testing machine (MTS, Synergie 200) and a set of wedge grips (Chatillon, GF-9).   
Meshes were tested using a gauge length of 25.4 mm and constant cross-head traverse of 
2.33 mm/s.  The maximum breaking force and extension at 16 N/cm were recorded.  
Force-extension data was extracted from the system software (TestWorks 4.0) and used 
to create force-extension profile curves.  Knitted meshes typically have directional 
structure and properties, regardless of the knitting process or pattern.  Therefore, mesh 
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tensile properties have been reported in the course and wale directions, which correspond 
to the cross-machine and machine knit direction, respectively. 
 
Burst Properties 
Burst mechanical testing was conducted using a universal testing machine (MTS, 
Synergie 200) equipped with a 1 kN load cell.  The ball burst test fixture geometry was 
determined from ASTM D3787-07 standard test method for bursting strength of textiles-
constant-rate-of-traverse ball burst test.  The MTS machine was connected to a data 
acquisition system that recorded the force and displacement of the steel ball.  Tests were 
performed using a 2.54 cm/min constant-rate-of-traverse for the ball.  Prior to the 
initiation of the test, a 0.1 N preload force was placed against the mesh by the ball.  For 
each test the maximum burst force (N) obtained during the test and the extension at 71 N 
load (mm) were recorded.  The extension at 71 N was used to determine the elongation at 
16 N/cm.  The value of 71 N is derived from the diameter of the opening in the clamp 
plate (4.44 cm x 16 N/cm = 71 N).  A detailed explanation of the mathematical 
expression, which relates the linear travel of the ball (mm) to the extension at 16 N/cm 
(%), can be found in Appendix A. 
 
Statistical Analysis 
Significant differences in physical properties between initial and in vitro 
conditioned meshes were determined using an independent, two-tailed Student t-test to 
compare means.  Two-factor analysis of variance (ANOVA) was used to test for effects 
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due to time during in vitro conditioned degradation and mesh construction, as well as 
their interaction, for each mechanical property response variable.  All analysis was 
completed using statistical analysis software (SAS, version 9.2) and p-values < 0.05 were 
considered to be statistically significant. 
 
Results 
Polymer Synthesis and Characterization 
Before conversion to yarn, two copolyester polymers were prepared and 





Polymerization Scheme and Analytical Data for MG-9 and SMC-7 
 





 TMC TMC 
Initiator, type Trimethylolpropane Propanediol 
Analytical Data: 
GPC:  Mn, Mw (kDa) 
>2,  >5 >30, >60 
Crystalline 
Copolyester 
Polymeric Initiator/Monomer Ratio (weight) 2/98  6/94 
Monomers, type
a
  (molar) 95/5 G/CL 96/4 L/TMC 
Analytical Data: 
GPC:  Mn, Mw (kDa) 
N/A 235, 436 





DSC:  Tm  (°C) 220 185 
ΔHm (J/g) 94 67 





To produce high quality yarn from the relatively high modulus lactide and 
glycolide polymer, copolymerization using trimethylene carbonate (TMC) was 
performed, as reported in Table 2.2.  However, to facilitate crystallinity, each polymer 
was segmented.  Results from DSC heat of fusion (ΔHm) measurements for MG-9 and 
SMC-7 showed high levels of crystallinity at 94 J/g and 67 J/g, respectively.  Polymer 
synthesis was completed successfully with near complete conversion of monomer, which 
resulted in high molecular weights (Mn, Mw, ηIhv) and melt temperatures (Tm) typical of 
high glycolide or lactide copolymers. 
 
Yarn Preparation and Properties 
Ground and purified polymers were converted into yarn and further orientated to 
optimize mechanical and physical properties.  The resultant properties of both MG-9 and 
SMC-7 yarn are listed in Table 2.3.  Yarn quality was assessed from the tenacity, a 
measure of strength normalized for yarn size, which exceeded 3.0 for both yarns.  
Furthermore, the elongation at maximum force, a measure of ductility, for both yarns was 





Typical Physical and Mechanical Properties of MG-9 and SMC-7 Yarn 
 
Description MG-9 SMC-7 
Filament count 20 43 
Denier (g/9000m) 55 - 60 80 - 100 
Tenacity (grams-force/denier) 4.2 - 4.6 3.0 - 3.4 
Elongation at maximum force (%) 25 - 35 20 - 30 
 
 
Mesh Knit Construction 
Figure 2.1 provides comparative images of each mesh construction following 
stabilization by heat setting.  The construction of the DM1 and WK1 meshes was similar 
in that each yarn type, MG-9 and SMC-7, was coknit together to form an interdependent 
structure; however, the mesh produced by each individual yarn type was also capable of 
functioning as an autonomous, structurally stable mesh.  Figure 2.2 provides comparative 
images of each mesh construction initially and following the removal of the MG-9 or the 
SMC-7 yarn using accelerated in vitro degradation and solvent extraction, respectively.  
In contrast to the DM1 mesh, the two yarn types within the WK1 mesh were knit in 
different patterns.  The DM1 mesh possessed the same knit pattern for both yarns due to 
the limitations of weft knitting.  Specifically, the DM1 mesh construction consisted of a 
pattern of interlocking loops comprised of a single, plied yarn of MG-9 and SMC-7.  On 
the other hand, the WK1 mesh was constructed from hundreds of yarn ends that were 
interlocked in a series of sequenced guide bar movements around the knitting needles.  
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Two guidebars of each yarn were used to knit two separate patterns that were constructed 






Images of the knit construction for the (a) DM1 and (b) WK1 mesh. (Red scale  







Images of the components of the DM1 and WK1 mesh.  (a) DM1 mesh (b) SMC-7 yarn 
component of the DM1 mesh (c) MG-9 yarn component of the DM1 mesh (d) WK1 mesh 
(e) SMC-7 yarn component of the WK1 mesh and (f) MG-9 yarn component of the WK1 
mesh (Red scale bars = 1 mm) 
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Mesh Physical Properties 
Mesh samples of each construction were quantitatively evaluated for their 
biocompatibility-relevant physical properties, both initially and following accelerated in 





Initial and In Vitro Conditioned Mesh Physical Properties for the DM1 and WK1  
Meshes (n = 5) 
 
Mesh Physical Property 





    Initial 
In Vitro 
Conditioned 
Mesh Thickness (mm) .421 ± .008 .316 ± .006 
 
.536 ± .005 .346 ± .006 
Ratio of Constituents    
(weight % of MG-9) 
24 ± 1 -- 
 
33 ± 2 -- 
Area Weight (g/m
2
) 131 ± 2 99 ± 3 
 
126 ± 3 83 ± 2 
Porosity: 
Pore Area (%) 34.2 ± .72 † 32.0 ± 2.56 †  29.6 ± .78 34.6 ± 1.28 
    Pore Diameter, Mean (µm) 
520 ± 33 ‡ 499 ± 33 ‡  698 ± 27 1045 ± 73 
Pore Diameter, Range of 
values (µm) 
495 - 585 390 - 547  320 - 1040 349 - 1548 
† ‡ Indicates changes in physical properties that were not found to be significantly different between initial and in vitro 
conditioned samples (p < .05) 
 
 
Results show that, for comparable initial area weights, the construction of the 
WK1 mesh possessed a greater weight fraction of MG-9 than did the DM1 mesh.  As a 
consequence, the WK1 mesh showed a greater reduction in area weight and thickness 
after in vitro conditioning.  Mean in vitro conditioned area weights of 99 g/m
2




 were significantly lower than the initial values for the DM1 and WK1 meshes, 
respectively.  The porosity measurement of total pore area increased from 29.6% to 
34.6% following in vitro conditioning for the WK1 mesh.  Additionally, the mean pore 
diameter increased from 698 µm to 1045 µm with a 50% increase in the maximum value 
of the range from 1040 µm to 1548 µm.  Due to the plied construction of the DM1 mesh, 
the degradation of the MG-9 yarn produced no significant change in porosity.  In 
contrast, the dramatic increase in porosity for the WK1 mesh was due to the opening of 
the large pores after the degradation of the MG-9 yarn.  On the whole, the use of two 
yarns with different degradation profiles facilitated the in vitro modulation of the 
thickness and area weight; however, only the WK1 mesh produced an increase in its 
porosity following the removal of the MG-9 yarn. 
 
Mesh Tensile and Burst Properties 
The initial structural stiffness of each mesh was evaluated both qualitatively and 
quantitatively.  Qualitative observations during tensile testing indicated that the edges of 
the WK1 mesh did not readily collapse.  On the other hand, the edges of the DM1 mesh 
immediately collapsed as the unrestrained pores deformed perpendicular to the applied 
strain.  These observations were reinforced by quantitative measures for the extension at 
16 N/cm (Figure 2.3) and force-extension data (Figure 2.4).  Using the theoretical 
maximum physiologic condition of 16 N/cm applied to initial samples under uniaxial 
tension, the WK1 mesh produced between 20% and 30% extension, which was less than 
half the value obtained for the DM1 mesh.  More importantly, from force-extension data, 
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it can be seen that for typical physiologic conditions which are a fraction of maximum 
values, the WK1 mesh produced immediate and substantial resistance to an applied strain 
in both the wale and course directions.  In contrast, the DM1 mesh showed significant 
extension before developing substantial resistance.   
The different initial response of the two meshes was construction dependent.  For 
instance, the different yarn knit patterns which comprise the bicomponent, coknit 
structure of the WK1 mesh restricted pore deformation.  As a consequence, under 
uniaxial strain the structural stiffness of the MG-9 yarn knit pattern, which was coknit 
into the WK1 mesh, exhibited significant structural stability and resistance to an 
externally applied strain.  In contrast, the knit pattern of the MG-9 yarn coknit into the 
DM1 mesh did not exhibit any significant resistance to the applied strain. 
 
 
‡ Indicates a significant difference (p < .05) between (‡) the DM1 and WK1 meshes, No difference was found between 




The initial extension at 16 N/cm in the wale and course directions for the DM1 and WK1 






Force-extension data for initial tensile testing of the DM1 and WK1 meshes in the wale 
and course directions. The dotted red line represents the 16 N/cm maximum abdominal 
wall loading condition. (25.4mm extension represents a strain equal to 1) 
  
 
The location of failure for tensile tested mesh samples was not centrally located; 
rather, it consistently occurred at one edge of the two grips.  No slipping of the mesh 
within the grips was observed.  The MG-9 yarn of each mesh was observable throughout 
the in vitro conditioning test period; however, fragmentation prior to testing was first 
observed at 14 days. 
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The temporal in vitro conditioned maximum breaking force in the course and wale 
directions for the DM1 and WK1 meshes during mechanical tensile testing. (7.2pH,37ºC) 
  
 
As seen in Figure 2.5, both the DM1 and WK1 mesh constructions showed a 
reduction in their maximum tensile breaking force in the course and wale directions 
during the first 14-21 days.  However, the reduction in maximum breaking force for the 
WK1 mesh was more dramatic, with 40-60% reductions compared to 20-25% for the 
DM1 mesh.  Beyond 21 days, no significant change in the maximum tensile breaking 
force was observed for either mesh (all p-values > .193). 
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The temporal in vitro conditioned extension at 16 N/cm in the course and wale directions 
for the DM1 and WK1 mesh during mechanical tensile testing. (7.2pH, 37ºC) 
 
  
The in vitro conditioned tensile extension at 16 N/cm of the DM1 mesh did not 
produce a pronounced change with time.  On the other hand, in the course direction the 
WK1 mesh showed a 6-fold increase in the extension at 16 N/cm between 7 and 14 days, 
a marginal decrease between 14 and 21 days, and no change thereafter.  These changes 
were paralleled in the wale direction with a significant increase, although less dramatic, 
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from 28% to approximately 50% between 14 and 28 days.  From 28 to 35 days, no 
difference was observed for either mesh. 
Collectively, observed changes in mechanical tensile properties were directly 
related to the degradation of the MG-9 yarn; however, the specific response of that 
change within each mesh was construction dependent.  For example, both mesh 
constructions experienced a reduction in breaking force as the MG-9 yarn lost breaking 
strength with time; however, the extension at 16 N/cm for the WK1 mesh was drastically 
different than that of the DM1 mesh.  Since the MG-9 and SMC-7 yarns were knit in 
different patterns, each construction contributed specific properties to the WK1 mesh.  
For instance, the traversing MG-9 yarn lay-in within the pores provided resistance to 
deformation from applied strains.  Specifically, this structural stiffness was derived from 
a chain stitch running in the wale direction and angled lay-in yarn connections that 
traverse the chain stitch in the course direction.  Moreover, being interlaced with the 
sandfly net pattern of the SMC-7 yarn further restricted the relative strain between 
different points within the mesh.  On the other hand, once liberated following the 
degradation of the MG-9 yarn, the knit pattern of the SMC-7 mesh possessed 
significantly greater extension at 16 N/cm.  The modulation in compliance resulted from 
the relaxed configuration of the SMC-7 yarn mesh being constrained by the marquisette 
pattern of the MG-9 yarn mesh, and its large, open pores that deform when strained.  As a 
result, the knit construction of each yarn type in the WK1 mesh produced two levels of 
extensibility during tensile testing, early structural stiffness with restricted mobility 
transitioning to a high degree of extension. 
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The temporal in vitro conditioned maximum burst force for the DM1 and WK1 mesh 
during mechanical burst testing. (7.2pH, 37ºC) 
 
  
The ball-burst test determines the strength and extensional characteristics of a 
constrained mesh subjected to a perpendicular force.  The failure mode of mesh samples 
was centrally located and at no time did slipping between the plates occur.  For all time 
points, the DM1 mesh exhibited a significantly greater maximum burst force with mean 
values at least 150 N greater than that of the WK1 mesh.  Both mesh types experienced 
significant reductions in maximum burst force up to 14 days with a leveling in burst force 
between 14 and 21 days.  During the time period from 21 to 28 days, the WK1 mesh 
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showed an increase of approximately 30 N (p < .001) while the DM1 mesh produced a 
slight decrease (p = .091) of 20 N.  No change for either mesh was experienced beyond 
28 days. 
The maximum burst force verifies the ability of a mesh to resist the expected in 
vivo mechanical loading conditions.  As found in the tensile test, both the DM1 and WK1 
meshes experienced a reduction in strength up to 14 days; however, both meshes 
exhibited the necessary strength required for clinical use.  For the specified geometry of 
the burst test fixture, a burst force of 71 N corresponds to the theoretical maximum 
physiologic condition.  The maximum burst force for the DM1 mesh was at least 5 times 
greater than the physiologic maximum. 
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The temporal in vitro conditioned extension at 16 N/cm for the DM1 and WK1 mesh 
during mechanical burst testing. (7.2pH, 37ºC) 
 
  
Figure 2.8 depicts the extension at 16 N/cm for the two mesh constructions during 
burst testing.  For the first 7 days of in vitro conditioning, the WK1 mesh maintained a 
constant, low level of extension.  Between 7 and 14 days and again between 14 and 21 
days, a statistically significant shift in the extension at 16 N/cm for the WK1 mesh was 
realized.  From 21 to 28 days the WK1 mesh extension reduced by 3.2% (p = .007).   
Beyond 28 days, no change for the WK1 mesh type was observed (p > .825).  The 
 110 
extension at 16 N/cm for the DM1 mesh construction did not change during the in vitro 
study (all p > .453). 
The burst test extension at 16 N/cm of the WK1 mesh revealed two levels of mesh 
stiffness with approximately a 7% extension until 7 days, a transition period from 7-14 
days, and a second plateau with approximately 20% extension.  These results show that 
the coknit structure of the WK1 mesh, where different degradation profile yarns are 
initially interdependent, will transition to exhibit independent, functional mechanical 
properties for the SMC-7 yarn with extensional characteristics that match the extension of 
the abdominal wall under maximum conditions.  The DM1 showed significant structural 
stiffness in the burst mode of testing, with only a slight, and not statistically significant, 
increase in mean extensional values at 16 N/cm. 
 
Discussion 
The ideal hernioplasty requires that the mesh provide support to the local tissue, 
without mechanical failure, and that it match the dynamic and multiaxial strains of the 
abdominal wall.  The former has historically not been an issue, with central mesh 
ruptures being a rare occurrence.
43,44
  In fact, the strength of most meshes is several 
orders of magnitude above clinical requirements.  However, the extensional 
characteristics of hernia meshes, and more importantly the resultant mesh/tissue complex, 
may provide inadequate stability to the developing ECM and then lack long-term 
extensibility.  For these reasons, this study has focused on developing a novel mesh for 
application in hernia repair using construction and absorbable polymers possessing 
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different degradation profiles to modulate the biocompatibility- and clinically-relevant 
physical and mechanical properties. 
The physical properties of area weight and porosity, and to a lesser extent 
thickness, are important mesh design variables that influence biocompatibility and tissue 
integration.  So called heavy-weight (HW) polypropylene meshes (>80 g/m
2
) produce a 
persistent, profound inflammatory response and scar production which has been linked to 
pain and discomfort, reduced abdominal wall compliance, and mesh contraction.
9,11,12
  As 
a result, there has been an initiative in recent years to reduce the area weight of typical 
polypropylene meshes in an effort to reduce the foreign body response.
31,45-48
  However, 
the overwhelming majority of meshes used clinically are HW meshes constructed from 
monofilament, polypropylene yarn
25
 of area weight within the range of 80 to 110 g/m
2
.  
Inclusive in this range is the slow absorbing SMC-7 yarn of the WK1 mesh.  However, as 
a fully absorbable mesh the overall area weight as a measure of long-term 
biocompatibility (> 3years) has less relevance.  Ideally, the tissue reaction to an 
implanted mesh can be divided into two stages.  Initially, a short-term, moderate reaction 
to the mesh is a desirable outcome and facilities the integration of the mesh into the 
abdominal wall; however, beyond the integration stage, a continuous inflammatory 
response is undesirable.  Fully absorbable meshes hold the potential to provide an initial 
inflammatory response but their absorption after their intended function will eliminate the 
long-term chronic foreign body response. 
Mesh porosity facilitates the infiltration of cells, ECM, and blood vessels within 
the mesh to (1) allow the diffusion and vascular transport of nutrients and waste and (2) 
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mechanically interlock the mesh into the abdominal wall, and (3) facilitate, in part, the 
extensibility of the mesh/tissue complex.  Porosity facilitates mesh extensibility in two 
ways.  First, as discussed previously, mesh extensibility is derived from geometric 
changes within the pores.  Consequently, meshes with larger pores produce greater 
uniaxial extension.  Second, porosity of adequate size minimizes the complete 
encapsulation of the mesh, which results in additional resistance to deformation of the 
mesh/tissue complex.  From experience to date, pore sizes greater than 1000 µm have 
been suggested by Junge and coworkers
49
 to avoid bridging of granulation tissue and the 
subsequent complete encapsulation of the mesh.  Although the DM1 mesh produced 
adequate size pores for the infiltration of cells and neotissue, the WK1 mesh possessed 
mean pore sizes greater than 1000 µm.  HW meshes exhibit about 50% porosity
50
 with an 
average pore size of 460 µm reported for one commonly used prosthesis.
51
  For the 
reasons stated, pore size is the major factor which affects in vivo mechanics.  In essence, 
the WK1 mesh will likely integrate forming a mesh/tissue complex whereby yarn 
filaments, rather than the entire mesh, are encapsulated, better preserving the inherent 
biomechanics of the mesh construction. 
The strength of HW meshes is several orders of magnitude higher than 
physiologic conditions.  Using a comparable burst test to that used in this study, values as 
high as 1165 N have been reported in literature.
52
  Therefore, a maximum physiologic 
burst force of 71 N produces a safety factor greater than 16.  Although the DM1 mesh is 
significantly stronger, the WK1 mesh provided adequate clinical strength with a steady 
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state burst force plateau of approximately 200 N, almost 3 times the theoretical 
physiologic maximum, beyond 28 days. 
A mesh which is structurally stiff during the inflammation and proliferation stages 
and transitions to become highly extensible is novel to soft tissue repair.  However, 
stability or immobilization of healing tissue is not a new concept, with many examples in 
the inherent pathology of wound healing and in clinical treatment.  For example, 
following a bone fracture the rapid formation of woven bone minimizes relative 
movement at the site.  In addition, the primary function of a scab is the stabilization of 
the delicate epidermal granulation tissue.
53
  These inherent processes are often augmented 
clinically with additional external stabilization (e.g. sutures, casting, pins, and plates).  
Consequently, the pathological approach to wound healing is to stabilize the delicate 
neotissue, which is often enhanced with clinical treatment.  Likewise, during the initial 
healing period the WK1 mesh showed a high degree of stiffness which was measured as 
resistance to both uniaxial and multiaxial strain.  It is novel for a mesh to resist uniaxial 
and multiaxial strain.  The DM1 mesh‟s lack of variation in knitting pattern resulted in a 
one dimensional response with only a reduction in breaking force and little or no change 
in extensional characteristics with time during in vitro conditioning.  Currently available 
hernia meshes do not possess a structure which opposes pore deformation.  As a result, 
they show minimal resistance during low levels of uniaxial applied strain, producing a 
similar response as that of the DM1 mesh, but remain structurally stiff in a multiaxial 
mode of deformation.  The structure of the WK1 mesh is unique in that it uses two 
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constructions which interpenetrate, whereby the pattern of one limits the deformation 
within the pores of the other.  This novel characteristic may hold several advantages.   
The early phases of wound healing and mesh integration are critical to the 
outcome of hernioplasty.  The acute wound healing phase is the timeframe when 
inflammatory and repair cells are recruited, but during which no meaningful tissue 
integrity is yet established.
54
  Mesh stress shielding, caused by restricted uniaxial and 
multiaxial extension, may better protect the neotissue from widespread micro-trauma or 
an isolated disruption of neotissue from a single overload event.  These disruptions have 
the potential to slow the progression of wound healing and stimulate the production of 
pro-inflammatory chemical factors. 
Although short-term meta-analysis studies continue to show lower recurrence 
rates associated with mesh use, recurrence continues to be a problem.
10
  Several authors 
have suggested that, in part, the origin of recurrence is associated with a defect created 
early in the mesh wound healing and integration process caused by stressed suture points 
disrupting local tissue at the margins of the mesh.
23,24,55-57
  For incisional hernias, these 
disruptions occur in the first month, starting small and asymptomatic, but increasing in 
size later.
58
  The immediate and significant transfer of load observed in uniaxial testing 
may have benefit in reducing recurrence.  The non-compliant nature of the WK1 mesh 
will allow the distribution of load applied at any single point to multiple attachment 
points as the mesh moves as one structure with minimal relative displacement between 
pores.  Consequently, a reduction in the load realized by any single attachment point will 
reduce the likelihood of early induced trauma. 
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A further benefit may be found in the wound healing response to tension applied 
during the proliferation stage.  Although tensional homeostasis exists in almost all 
connective tissues, under normal circumstances, loads seen by cells are minimal 
compared to their surrounding ECM.
59
  Cells stress shield themselves from bulk external 
loading.  Specifically, fibroblasts actively control the local mechanical environment by 
depositing collagen, contracting the matrix, and increasing the crosslink density of the 
ECM to either increase or decrease cellular reaction to local mechanical conditions.
60
  
The differentiation of fibroblasts to the myofibroblast phenotype is, in part, driven by 
high ECM stress.
61
  Myofibroblasts are characterized by their ability to secrete collagen 
and contract the ECM, which has undesirable results when unregulated.
62
  The modern 
study of mechanobiology has established a link between wound tension and its effect on 
myofibroblast activity.  Within the first week of wound healing, external applied tension 
has been shown to promote excessive fibrosis, with effects for 6 months thereafter, due to 
an inhibition of myofibroblast apoptosis.
63
  In a separate study by Hinz and coworkers, 
mechanical tension was found to be crucial for differentiation and maintenance of the 
myofibroblast phenotype.
64
  Stress shielding of proliferating myofibroblasts, as provided 
by the structurally stiff WK1 mesh, may reduce myofibroblast differentiation and/or 
promote apoptosis, effectively reducing the likelihood of the early developed and well 
documented excessive scar plate and mesh contraction.
9,65-68
  Unlike the initial stages of 
inflammation and proliferation, where cellular activity is high and ECM strength is 
minimal, a properly timed transition to tensional homeostasis and biomechanical 
stimulation provides the cues for remodeling and adaptation to develop functional tissue. 
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The clinical use of meshes requires that the force/extensional characteristics are 
evaluated against those approximated from human physiology.  It is of interest to 
characterize the extension of a mesh at the anticipated maximum physiologic condition, 
determined to be 16 N for each centimeter of width or 16 N/cm.
69
  At this theoretical 
maximum physiologic force the associated strain as determined from fresh cadavers was 
25% ± 7%.
70
  It is reasonable to expect that meshes in vivo experience multiaxial and 
uniaxial strain.  However, it should be noted that only low to moderate (strain < 1) levels 
of uniaxial deformation have clinical relevance.  Significant changes to the mesh 
length/width aspect ratio begin to negate the relevance of the test method since in vivo 
uniaxial deformation is limited by secured mesh edges and pores which are infiltrated 
with tissue.  More appropriately, ball burst testing applies a perpendicular applied stress 
to a mesh where the edges are fully constrained.  In addition, these conditions simulate 
the multiaxial expansion expected from increased abdominal pressure. 
  Optimized hernia repair will establish self-sustaining, functional tissue which will 
prevent hernia recurrence.  To accomplish this objective the biomechanical environment 
of the abdominal wall must be replicated.  Complications associated with traditional 
meshes are certainly a response to their lack of biomechanical compatibility, as 
traditional mesh materials are considered inert and do not illicit an immune response.
71
  
Increasingly, the importance of biomechanical stimulation for load-bearing connective 
tissues is being recognized as being governed by the same modern principles initially 
conceived as Wolffs‟ Law for bone.  Connective tissue morphology follows function, the 
magnitude and frequency of repetitive loads trigger remodeling, a lack of stress produces 
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atrophy while excessive stress results in hypertrophy.  Each of these pathological findings 
become circumvented when the implant stress shields the remodeling tissue, and thus 
prevents adaptation.  For example, as the compliance of vascular grafts approaches that 
of the native tissue their patency linearly increases.
72
  For traditional HW meshes, a 
significant decrease in the mobility of the abdominal wall is realized 2-3 weeks after 
implantation from the induction of the ECM.
73
  For the WK1 mesh, the timing of this 
event occurs 1-2 weeks later than the observed transition to its highly compliant structure.  
However, it should be noted that with chemical modification and/or further annealing 
optimization temporal breaking strength of the MG-9 yarn can be modulated to prolong 
the mesh transition point.  As the transition progresses, load is gradually transferred from 
the mesh to the ECM.  At this point in the wound healing process, the ECM has 
established sufficient strength and the remodeling process is initiated.  As a result of the 
coknit construction, the mesh is „set‟ in a relaxed configuration and encapsulated in the 
ECM.  This configuration is unique and only obtainable through the use of an absorbable 
component which degrades to realize this relaxation event.  Consequently, the mesh 
possesses both uniaxial and multiaxial extensibility as evidenced by the tensile and burst 
test results.  Of special interest is that the multiaxial extensibility of the WK1 mesh is 
within the maximum physiologic range of 25% ± 7%.
70
  In contrast, traditional HW 
meshes in the multiaxial mode of deformation produce 16 N/cm extension values well 
below physiologic conditions, with observed values between 6 and 14%.
31,70
   The 
extensibility of the mesh in vivo will be reduced even further due to the formation of the 
composite mesh/tissue complex
73




  As a consequence, hernia meshes must be highly extensible to 
restore the abdominal wall mechanics, rendering them possibly too extensible to be 
efficiently handled during the surgical procedure.  Hence, a mesh which is structurally 
stiff and stable during the surgical procedure, but will transform to a high level of 
extensibility after encapsulation in situ may be critical to achieving both sufficient initial 
handling characteristics as well as physiologic extensibility.  Furthermore, in situ 
placement in a relaxed configuration means that endogenous tension within and around 
the mesh may be established. 
 
Conclusion 
The construction of the WK1 mesh met the suggested additional design criteria of 
being fully-absorbable, maintaining structurally stiffness during the early phases of 
wound repair, and replicating the extensional properties of the abdominal wall during the 
remodeling/maturation phase while providing an adequate level of strength.  The use of 
warp knitting whereby each yarn type was coknit using different knitting patterns allowed 
for the modulation of mesh physicomechanical properties and a configuration allowing 
(1) short-term structural stiffness, (2) a gradual transition of the perceived loads from the 
mesh to local tissue, and (3) long-term compliance with extensional elasticity similar to 
the abdominal wall.  The initially interdependent construction provided a high level of 
structural stiffness and following the substantial degradation of the fast-degrading yarn, 
transitioned to liberate a compliant slow-degrading mesh.  The use of two different 
degradable copolyester yarns facilitated the modulation of the physicomechanical 
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properties while the knit construction determined the resultant porosity, area weight, 
thickness, strength, and extension of the mesh, both during the initial phase when the 
fast-degrading yarn was load bearing, and once the structurally independent, slow-
degrading yarn component was liberated.  The lack of variation in the knit pattern for the 
DM1 mesh made it one-dimensional, producing strength loss with time but showing 
significant structural stiffness with minimal change in extensibility following the 
substantial degradation of the fast-degrading yarn.  Future studies will explore the 
optimization of the high-glycolide yarn, the restoration of homeostatic tension within the 
coknit mesh, and the long-term in vitro response of different warp knit designs based 
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EFFECT OF CHEMICAL COMPOSITION  
AND THERMAL TREATMENT ON THE PROPERTIES OF  





 Lactones, primarily glycolide, lactide, and ε-caprolactone, and the cyclic 
carbonate, trimethylenecarbonate (TMC), represent a class of materials which are 
commercially copolymerized and of significant interest for biomedical applications.  As a 
group of synthetic polymers which are degradable, bioabsorbable, and non-toxic, their 
use as medical devices in the form of yarns to construct sutures and surgical meshes has 
grown substantially over the past four decades.  Due to their similar ring-opening reaction 
mechanism from cyclic monomers, they are often produced as copolymers to achieve 
application specific requirements using their diverse properties.  In the synthesis process, 
the choice of monomer and the relative distribution of monomeric sequence, influences 
the properties of the resultant copolymer.  Due to differences in the surrounding chemical 
environment of the labile ester -linkage, the rate of degradation for each monomer is 
variable.  Since these copolymers are designed -to -degrade, the variables which control 
their in vivo degradation profile, which is often first simulated in vitro, are of special 
interest.  Simply stated, the rate of hydrolysis is modulated, within limitations, and 
balanced against mechanical property requirements using the interdependent variables of 
chemical composition, structural arrangement, and molecular morphology.  Chemical 
composition and monomer sequencing are established during the synthesis process while 
 128 
molecular morphology is subsequently developed via thermomechanical treatment during 
processing.  Of these variables, the choice of monomers is most influential in determining 
absorbable copolymer properties. 
Polyglycolide (PG) is the simplest linear aliphatic polyester.  PG is a fast-
degrading polymer with substantial loss in mechanical properties within 1 month and 
complete mass loss within 6-12 months.
1
  PG is highly crystalline
2
 (46-52%) with a 
relatively high crystallization rate compared to other bioabsorbable polyesters, primarily 
due to its simple, stereoregular structure that forms crystals in a planar zig-zag 
conformation.
3
  As such, it exhibits good mechanical properties and has excellent fiber 
forming ability.  The glass transition temperature (Tg) of PG is typically in the range of 
35-40ºC, as determined by differential scanning calorimetry (DSC). 
PG is often synthesized as the major component in a copolymer, using a more 
hydrolytically stable monomer to temporally extend its function.  Additionally, the 
interjection of a different monomer changes the regular, repeat sequencing of monomer 
units which results in a slightly lower, and/or less perfect, crystallite structure.  The 
random copolymer of 90/10 poly(glycolide-co-lactide) (polyglactin 910) is commonly 
used in biomedical products.  In the form of a multifilament yarn, the strength retention 
of polyglactin 910 has been determined to be slightly longer and absorption sooner than 
that of PG.
4
  The slightly longer strength retention is the result of the more hydrophobic 
nature and lower hydrolysis rate of lactide.  The increased absorption rate has been 
suggested to be the result of differences in morphology (lower amount of and/or less 




Consequently, polyglactin 910 degradation products are generated more quickly and are 
less crystalline which may increase local phagocytosis.
6
  Segmented high-glycolide 
copolymers are also used to produce compliant, slower-degrading monofilament sutures.
7
  
In this case, copolymers consist of a slow-degrading „soft‟ amorphous middle segment 
which is end grafted with a „hard‟, crystalline PG.  Compliance is derived from the core, 
while the stiff, crystalline end segments impart strength.  These materials have shown to 




Poly(L-lactide) (PLL) is semi-crystalline, linear aliphatic polyester which differs 
distinctly from PG by the addition of a pendant methyl group.  The chemical structure of 
PLL is such that an asymmetric carbon atom in the chain backbone can produce two 
atoms with the same elements and bonding pattern but with different spatial arrangement.  
The result is two optically active stereoisomeric forms, D(-) and L(+).  However, in acid 
form the L(+) isomer is the physiologically natural configuration.
2
  As a homopolymer, 
the time required for substantial degradation of PLL is greater than 24 months.
9
  The 
significantly longer degradation time for PLL, compared to PG, can be attributed to the 
pendant methyl group which shields the labile ester group in two ways.
10
  First, steric 
hindrance inhibits the physical access of water molecules to the ester group.  Second, the 
voluminous, hydrophobic methyl group limits the diffusion of water into the polymer due 
to its relatively high Tg.  Compared to PG, the added methyl group increases the Tg of 




 In fiber form, ε-caprolactone and TMC are almost exclusively used as 
toughening, softening, and/or as slower hydrolyzing copolymers in high modulus 
polymers such as glycolide or lactide.  Polymeric TMC (pTMC) is a tacky, amorphous, 
thermoplastic elastomer which has not found application as a structural biomaterial due to 
its poor dimensional stability and low mechanical performance.
1,2
  As a high molecular 
weight homopolymer, pTMC possesses a Tg of -18ºC and can be crystallized only by 
strain induction, which results in a low melt temperature (Tm) of 36°C.
12
  However, used 
as a segment within a copolymer, the extremely tough and compliant pTMC imparts 
flexibility to the device.  For example, this technique has been used for suture materials.
8
  
Other investigated biomaterial applications of pTMC copolymers include drug 
delivery.
13,14
  Polycaprolactone (PCL) is a semicrystalline, low-melting (Tm = 65-70°C), 
linear aliphatic polyester with a Tg of -60ºC.  Unlike pTMC, as a homopolymer, PCL 
exhibits a semi-crystalline morphology.  However, its slow degradation rate and 
moderate mechanical properties have limited its application for use in medical devices.  




There are five primary factors which can be considered as controlling the bulk 
degradation rate of absorbable polymers.  They are chemical bond stability (e.g. esters, 
anhydrides, carbonates), hydrophobicity, steric effects (e.g. Tg, chain interlocking and 
entanglement), local pH or autocatalytic effects, and morphology (e.g. crystallinity, 
porosity).  In addition, external conditions such as temperature and load
16
 are important 
factors but, for biomedical applications, in vitro evaluation is conducted at physiologic 
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temperature and load is not typically a studied variable.  For the investigated copolymers 
in this study, each monomer is a linear, aliphatic polyester, i.e. the cleaved bonds in the 
backbone of the chain are the same.  Furthermore, autocatalytic effects are considered 
minimal for fibers, as they have a high surface to volume ratio, resulting in high diffusion 
rates and thus significant clearing of generated acidic byproducts.  Therefore, of pertinent 
consideration are changes in chemistry, which result in hydrophobic and steric effects, 
and post processing differences, which modify morphology. 
The morphology of absorbable copolymers has significant influence on their end-
use performance.  The fiber formation process of PG produces a two-phase system 
consisting of crystalline and amorphous regions along the fiber axis, with semi-oriented 
amorphous regions running in parallel.
17
  It is well established that degradation 
commences in the amorphous domains.
18
  As summarized by Fu and coworkers,
19
 bulk 
degradation by hydrolysis is governed by two major stages.  First, water molecules 
diffuse into the amorphous regions and hydrolysis results in chain scission.  Primary 
crystalline segments, however, are largely protected due to their tightly packed, ordered 
structure which inhibits water penetration.  The substantial degradation of the amorphous 
regions marks the loss of mechanical properties and initiation of the second stage of 
degradation.  During the second stage, water molecules more slowly cleave accessible 
ester groups, eventually resulting in soluble fragments which are metabolized.  Of 
specific interest to this investigation are the mechanisms of the first stage.  As such, 
factors which affect the accessibility of water to the amorphous domains are fundamental 
to controlling degradation rate and the temporal preservation of mechanical properties. 
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The size, number, location, and perfection of polymer crystallites are governed by 
annealing temperature and time.  In general, an increased degree of crystallinity prolongs 
degradation time; however, crystallite structure can heavily influence the initial and in 
vivo retention of mechanical properties for semicrystalline, absorbable copolymers.   The 
isothermal annealing process, or heat setting, takes place as a result of a thermodynamic 
balance governed by enthalpic and entropic competing events.  At low temperatures, 
molecular mobility is not adequate to allow crystallite formation, while at elevated 
temperatures high levels of kinetic energy prevent secondary bond formation.  
Measureable crystallization rates are generally accepted to occur between (Tm - 10°C) 
and (Tg + 30°K), a range in which the kinetic energy of the polymer chains is conducive 
to crystallite formation.
20
  Within an optimal range, molecular mobility facilitates 
crystallite formation to an already formed nucleus and the resultant crystallite size is 
governed by the rate of chain addition and the provided time interval.
21
  Consequently, 
the temperature and time of isothermal annealing is critically influential to the 
performance of absorbable yarn constructs, as is the characterization of the resultant 
morphology. 
The primary objective of fiber annealing is to modify molecular morphology 
through the rearrangement of secondary bonds.  As such, it is vital to quantify changes to 
the first-order (e.g. melting and crystallization) and second-order (e.g. relaxation events 
such as Tg) transitions.  The analytical techniques of DSC and dynamic mechanical 
analysis (DMA) are complementary in their ability to identify and characterize the 
morphology of semicrystalline fibers.  DSC is particularly proficient at quantifying latent 
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heat changes during first-order transitions.  DMA is well suited to quantify second-order 
transitions which are difficult, or even impossible to characterize by DSC.  It has been 
reported that DMA is 1000 times more sensitive than DSC at detecting glass transition 
temperature.
22,23
  DMA measures the viscoelastic properties of storage modulus (E‟) and 
loss modulus (E‟‟) as a function of temperature and frequency.  The E‟ is reflective of the 
stiffness of the material while the E‟‟ is a measure of damping or the ability of the 
material to absorb energy.  Tan δ is a dependent, calculated value (E”/E‟) and is of 
significant importance.  From an application perspective, tan δ is an indicator of how well 
a material loses energy to molecular rearrangement and internal friction (energy lost as 
heat) or stores elastic energy in bond stretching and rotation.  For semicrystalline 
copolymers the amorphous and crystalline domains are intimately joined, which affects 
the Tg relaxation event.  Typically, any increase in crystallinity results in a broadening of 
the tan δ curve and a shift toward higher temperatures.  The maximum of the tan δ curve 
is used historically in literature as the Tg of the polymer.  Additionally, the E‟‟ curve also 
obtains a maximum during the Tg event.  Consequently, E‟‟ is an independent measure of 
damping and occurs at a lower temperature than the tan δ peak. 
Uncontrolled free shrinkage due to heat prior to use, or in vivo, is undesirable for 
biomedical devices.  The dimensional stability of fibrous constructs is of particular 
concern due to their natural tendency to relax.  Therefore, the annealing process is a key 
step in conferring dimensional stability of the amorphous region through the formation 
and reorganization of crystallites which act as pseudo crosslinks.  However, during 
annealing it is not desirable to lose the orientation imparted during the fiber formation 
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process, which gives the yarn its mechanical properties.  As a result, annealing is often 
conducted under tension to restrict molecular relaxation.  Furthermore, for absorbable 
polymers the temporal in vivo breaking strength retention is significantly affected by 
tension during the annealing process.  Browning and Chu found that PG sutures annealed 
with any level of axial tension always exhibited a lower rate of hydrolytic degradation 
than did freely hung samples.
24,25
  The authors attributed the difference to tie-chain 
molecules acquiring less constrained conformations, resulting in a loss of the orientation 
established during drawing.  Consequently, logic suggests that the relaxed morphology 
would contain more free volume for water diffusion. 
A key objective of the study described in this chapter was the development and 
optimization of a segmented high-glycolide copolymer yarn for use in the construction of 
a bicomponent mesh for hernia repair.  As a medical device, the degradation profile and 
resultant strength loss with time are of significant interest to investigators.  Functionally, 
the high-glycolide copolymer must provide strength retention for greater than 14 days, 
and optimally between 18-24 days, to facilitate the temporal modulation of the mesh 
properties.  This temporal alteration marks the transfer from providing a structurally stiff 
and stable mesh during the inflammation and proliferation stages to a gradual transition 
of external loading to the developing extracellular matrix.  To this end, two copolymers 
were polymerized with subsequent yarn formation and isothermal annealing.  Chemical 
modification between the two copolymers and different annealing conditions were 
investigated to optimize the initial maximum breaking force, temporal in vitro 
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conditioned maximum tensile force profile, and yarn stabilization against dimensional 
changes. 
Materials and Methods 
Polymer Synthesis and Characterization 
Polymer Synthesis 
MG-9 and MG-17 were synthesized as polyaxial, segmented, high-glycolide 
copolymers.  To determine the effect of polymer chemistry, two significant modifications 
were made to the MG-17 copolymer compared to MG-9.  First, the molecular weight of 
the pTMC polymeric initiator was increased.  Second, lactide was replaced by ε-
caprolactone as a comonomer.  A two-step, solid state, ring-opening polymerization was 
used to produce both systems.  The first step produced a trimethylolpropane-initiated, 
trimethylene carbonate (TMC) segment.  Next, the TMC polymeric initiator was end-
grafted using a molar ratio of 95/5 glycolide/caprolactone (G/CL) and 95/5 glycolide/L-
lactide (G/L) for MG-9 and MG-17, respectively.  The weight ratio of the polymer 
initiator to the end-graft was 2/98 in both cases.  A more detailed discussion of the 
polymerization process is described in U.S. Patent No. 7,129,319 (2006). 
Both polymers were isolated, ground (Thomas Wiley mill), and dried and purified 






Determination of Molecular Weight 
 Solution viscosity according to ASTM D2857-95(2007) Standard Practice for 
Dilute Solution Viscosity of Polymers was used to characterize the molecular weight 
using a viscometer (Cannon-Fenske) in a mobile phase of hexafluoroisopropylene (HFIP; 
Sigma-Aldrich, 99.8% grade) for MG-9 and MG-17 by measuring inherent viscosity at 
the standard solution concentration of 0.1 g/dL. 
 
Determination of Thermal Characteristics 
 A differential scanning calorimeter analyzer (DSC; Perkin Elmer, Pyris 6) was 
used to evaluate each polymer‟s melt temperature (Tm) and degree of crystallinity 
characterized in terms of heat of fusion (ΔHm).  A sample weighing between 5-10 mg was 
heated from room temperature to 240°C at a rate of 10°C/min.  Dry nitrogen was used as 
a purge gas to eliminate influences due to oxidation. 
 
Yarn Preparation and Properties 
Melt Extrusion of Multifilament Yarn 
Melt-extruded yarn of MG-9 and MG-17 was processed using similar extrusion 
and in-line drawing conditions.  Each copolymer was processed using a 3/4″ diameter 
screw extruder equipped with a metering gear pump and a 10-hole die.  The processing 
conditions of extruder output, spin head draw-ratio, and in-line orientation were similar 
between the MG-9 and MG-17 extrusions which resulted in nearly identically yarn 
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denier.  In-line orientation was completed using a series of heated Godets at temperatures 
between 25ºC and 90ºC. 
 
Yarn Physical Testing 
 Yarn denier, a unit measure of weight for the size of a bundle of filaments (g/9000 
m), was measured on both yarns by weighing (Mettler-Toledo, MS analytical balance) 50 
m of yarn and scaling this quantity to the equivalent of 9000 m. 
 
Yarn Stabilization by Annealing 
Annealing, or heat setting, was completed by wrapping yarn around an 
expandable rack which had two parallel bars of stainless steel.  Yarn was wrapped in a 
continuous fashion, secured, and a strain of 0.02 was applied by expanding the rack prior 
to annealing.  The annealing time periods of 30, 60, and 180 minutes were used to 
condition yarn at the temperatures of 100ºC, 120ºC, and 140ºC while under a high 
vacuum (< 1.5 torr).  To improve the handling of the yarn during subsequent testing, the 
yarn was plied (2x) together prior to annealing. 
To simplify the description of different yarn annealing conditions the following 
coding was used.  The first letter of the yarn designation is either “C” for MG-9 or “L” 
for MG-17.  Next the annealing temperature is described by A, B, or C for 100°C, 120°C, 
or 140°C, respectively.  Finally, the time associated with the annealing step, either 30, 60, 
or 180 minutes is determined by subsequent identification as 3, 6, or 18.  For example, 
LB18 is MG-17 yarn annealed at 120°C for 180 minutes. 
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Yarn Tensile Mechanical Properties 
 A universal testing machine (MTS, Synergie 200) equipped with a 500 N load cell 
and a set of fiber testing grips were used to measure tensile mechanical properties for 
each yarn.  Measurements were made according to ASTM D2256-09 Standard Test 
Method for Tensile Properties of Yarns by the Single-Strand Method using a gauge length 
of 70 mm and cross-head speed of 2.33 mm/s.  The maximum tensile force (MTF) and 
elongation at that maximum force were obtained from each stress-strain curve. 
 
Yarn Shrinkage Measurement 
Percent shrinkage and shrinkage onset temperature measurements were conducted 
on annealed yarn using a dynamic mechanical analyzer (DMA; Perkin Elmer Pyris 
Diamond DMA) operated in a thermomechanical analysis (TMA) mode.  Using an 8-ply 
yarn (8 ends of yarn total of 10-filaments each), samples were analyzed in a nitrogen 
atmosphere using a tensile mode, 3°C/min heating rate, and a temperature sweep from 
room temperature to 130°C.  The onset temperature and percent yarn shrinkage at 80ºC 
and 120ºC were determined using a constant force of 3 mN. 
 
Yarn Thermomechanical Properties 
 A DMA (Perkin Elmer Pyris Diamond DMA) equipped with a liquid nitrogen 
cooler was used to determine the viscoelastic properties of loss modulus (E‟‟), storage 
modulus (E‟), and tan delta (tan δ) as a function of temperature for each yarn type, and 
for each time and temperature annealing condition.  A temperature sweep was conducted 
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in a nitrogen atmosphere at a heating rate of 2ºC/min from -20ºC to 200ºC.  A minimum 
200 mN force was applied to yarn samples which were strained with a 10 micron cyclic 
amplitude in a tensile mode.  Reported values for the Tg were taken at the peak of the tan 
δ curve for the frequency of 1 Hz.  Tan δ onset temperatures were determined at the 
temperature where the baseline increased to produce a 0.02 shift. 
Additionally, the frequency dependent Tg values for each annealing condition 
were used to calculate the apparent activation energy (Ea) using the Arrhenius method.  
The multiplexed frequencies of 1, 5, 10, and 20 Hz were used to determine the frequency 
dependent Tg value for each yarn sample using the same conditions described previously.  
The Arrhenius equation was used in the following form: 
 
where F is frequency, A is the pre-exponential factor, Ea is the activation energy, R is the 
gas constant (8.314 J/K mol), and T is the temperature in degrees Kelvin.  As such, the 
natural log of frequency plotted against the reciprocal of the corresponding Tg results in a 
line which has a slope equal to the negative of the activation energy divided by the gas 
constant.  The correlation coefficient for each annealing condition was determined to 
measure the strength of a linear relationship between the independent (1/RT) and 
dependent (ln(F)) variables.  
 
In Vitro Conditioned Degradation 
Samples evaluated for mechanical tensile testing following in vitro degradation 
were conditioned using a 0.1 M solution of buffered sodium phosphate in 50 mL tubes 
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(Simport, C571-2) at a 7.2pH.  Buffered sodium phosphate was prepared by adding 23.3 
grams of dibasic (K2HPO4; Sigma-Aldrich, ACS ≥ 98%) potassium phosphate and 9.0 
grams of monobasic (KH2PO4; Sigma-Aldrich, ACS ≥ 98%) potassium phosphate into 2 
liters of deionized water and stirred until dissolution.  A pH meter (Symphony, SB80PI) 
was used to verify a 7.2pH measurement and slight adjustments were made to using 0.5 
N hydrochloric acid (HCl; Sigma-Aldrich, ACS reagent).  Tubes containing a 400 mm 
long piece of yarn were placed in racks and incubated (Innova 4300) in the prepared 
buffer at 37°C under constant orbital-agitation at a speed of 28 revolutions per minute.  
Samples were removed at the predetermined time periods of 7, 10, 14, and 21 days for 
mechanical tensile testing. 
 
Statistical Analysis 
Significant differences in physical properties between the two yarn types were 
completed using an independent, two-tailed Student‟s t-test to compare means.  Two-
factor analysis of variance (ANOVA) was used to test for effects due to annealing 
conditions and yarn type, as well as their interaction, for the mechanical property 
response variables of MTF and elongation at maximum force.  All analysis was 
completed using statistical analysis software (SAS, version 9.2) and p-values < 0.05 were 
considered to be statistically significant. 
 141 
Results 
Polymer Synthesis and Characterization 
Polymerization conditions and analytical data are summarized in Table 3.1.  
Analytically, the results of the changes made to the MG-17 copolymer were evidenced in 
each DSC thermogram, i.e. the peak of the melting endotherm (Tm) and the heat of 
fusion.  MG-17 had a lower melt temperature than MG-9 by approximately 8°C and 
lower degree of crystallinity, with a corresponding drop in ΔHm of 6 J/g. 
Near complete conversion of monomer was realized, as evidenced by the high 
molecular weights (ηIhv) and melt temperatures (Tm) typical of high-glycolide 
copolymers.
26
  Copolymers of equivalent molecular weight, as determined by inherent 




Polymerization Scheme and Analytical Data for MG-9 and MG-17 
 





 TMC TMC 
Initiator, type Trimethylolpropane Trimethylolpropane 
Analytical Data: 
      GPC:  Mn, Mw (kDa) 





2/98  8/92 
Monomers, type
a
  (molar) 95/5 G/CL 95/5 G/L 
Analytical Data:   
Ihv:  (dL/g)
b 1.0 1.0 
      DSC:  Tm  (°C) 223 215 
                 ΔHm (J/g) 94 88 
a, CL = ε-caprolactone, TMC = trimethylene carbonate, G = glycolide, L = l-lactide;  b, HFIP mobile phase 
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The denier for the two copolymer yarns, MG-9 and MG-17, were identical.  
However, the MTF was greater and elongation at that maximum force was lower for the 




Physical and Initial Mechanical Properties of MG-9 and MG-17 Yarn 
 
Description MG-9 MG-17 
Filament count 10 10 
Denier (g/9000m) 142 ± 2 144 ± 2 
Maximum tensile force (N) 11.7 ± 0.4† 14.8 ± 0.5† 
Elongation at maximum force (%) 70 ± 13‡ 47 ± 4‡ 
† ‡ Indicates significant differences in physical or mechanical properties between yarn types (p < .05) 
  
 
Table 3.3 lists the thermal and initial mechanical properties of melt-extruded and 
annealed yarn.  It should be noted that no cold crystallization exotherms were observed in 
any of the first heat thermograms indicating a high level of initial crystallinity.  There 
was an increase in the heat of fusion measurements for both annealed yarn types.  Yarn 
crystallinity for both yarn types increased as a result of all annealing conditions, except 
for MG-9 samples annealed at 140ºC which had minimal change.  Annealing of the MG-
9 yarn had no observable effect on melt temperature; however, the melting temperature of 




Initial Thermal and Mechanical Properties “As Extruded” and Annealed  






Heat of Fusion 
(J/g) 
Maximum 
Tensile Force (N) 
Elongation at 
Maximum Force         
(%) 
MG-9 216 70        11.7 ± 0.4 †       70 ± 13 † 
MG-17 203 60        14.8 ± 0.6 ‡       47 ± 4   ‡ 
CA3 216 78        12.9 ± 0.3 †       53 ± 3   † 
CA6 217 81        12.6 ± 0.4 †       49 ± 4   †    * 
CA18 216 83        12.8 ± 0.3 †       51 ± 7   †    * 
CB3 217 74        13.5 ± 0.2 †       59 ± 4   †◊ 
CB6 217 75        13.5 ± 0.3 †       53 ± 7   † 
CB18 216 75        13.2 ± 0.1 †       49 ± 1   †◊ 
CC3 216 68        12.7 ± 0.5 †◊       49 ± 3   †◊ 
CC6 216 71        11.9 ± 0.6   ◊¤       42 ± 4   †◊¤ 
CC18 216 72          8.7 ± 0.7 †◊¤       31 ± 6   †◊¤* 
LA3 206 67        15.5 ± 0.6       43 ± 5 
LA6 207 65        15.2 ± 0.7       44 ± 3         * 
LA18 206 64        15.8 ± 1.0 ‡       44 ± 2         * 
LB3 206 66        17.1 ± 0.6 ‡◊       41 ± 4 
LB6 207 65        15.2 ± 0.6   ◊       35 ± 5   ‡ 
LB18 207 66        14.6 ± 1.1   ◊       35 ± 10 ‡ 
LC3 206 66        14.3 ± 1.2       33 ± 11 ‡ 
LC6 206 65        13.7 ± 1.2 ‡◊       33 ± 6   ‡ 
LC18 207 65        14.6 ± 0.2   ◊       34 ± 4   ‡    * 
†‡ Indicates a significant difference between the „as extruded‟ and annealed sample for each yarn type (p < .05) 
◊ ¤Indicates a significant differences between different annealing times for a given annealing temperature (p < .05) 
*Indicates no significant difference found between yarn types for the same annealing condition (p < .05) 
 
 
The mechanical behavior of yarn is highly dependent on morphology changes 
during annealing.  The primary observation from the data in Table 3.3 is that annealing 
generally decreased elongation and increased the MTF compared to the „as extruded‟ 
yarn value.  Each MG-9 yarn sample annealed at the temperatures of 100°C and 120°C 
showed a significant increase in MTF and decrease in elongation.  At these temperatures, 
minimal effect due to time was observed. However, when the annealing temperature was 
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increased to 140ºC the effect of each step increase in time produced a reduction in MTF 
and elongation.  For the extreme condition of sample CC18, MG-9 yarn produced the 
lowest MTF and elongation values observed in the study.  The MTF for MG-17 was 
greater than that of MG-9 for the „as extruded‟ and for each annealing condition.  
However, for MG-17 an increase in MTF due to annealing was less pronounced.  For 
example, the LA18 and LB3 were the only samples which had a significant increase in 
MTF after annealing.  Of the two samples, the LB3 sample produced the greatest MTF 
value in the study (p < .003) at 17.1 N. 
Figure 3.1 presents DMA curves for each „as extruded‟ yarn and a typical 
response of each yarn type to annealing.  Figures 3.2 and 3.3 isolate the tan δ response to 
depict the effect of annealing time and temperature, respectively.  A complete set of 
DMA results which includes all annealing conditions for both yarn types is tabulated in 
Table 3.4. 
In Figure 3.1 it can be seen that, for both yarn types, the glass transition region 
encompasses a peak for both the tan δ and E‟‟ curves as well as a significant decrease in 
E‟.  Annealing increased the peak position of the tan δ curve (Tg), increased the breadth 
and reduced the height of the tan δ peak, increased the storage modulus onset 
temperature, and modified the rubbery plateau (region between Tg and Tm) such that 
stiffness was increased.  Comparing the two yarn types, MG-17 and MG-9, it can be seen 
that MG-9 has a lower Tg, peak of the E‟‟ curve, and E‟ reduction onset temperature.  It is 







The storage modulus (E‟), loss modulus (E‟‟), and tan δ response for the “as extruded” 
(top) and annealed (bottom, 120°C for 60 minutes) MG-9 (dashed) and MG-17 (solid) 
yarn.  Depicted data presented as a comparative typical effect of annealing on the 
thermomechanical properties. 
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A direct comparison of the tan δ responses for annealed yarn depicting the effect 
of annealing time and temperature is displayed in Figures 3.2 and 3.3, respectively.  For 
MG-9 yarn, differences in the tan δ curve between annealing times or temperatures was 
minimal.  However, the height, breadth, and peak position of tan δ for MG-17 yarn was 
sensitive to changes in annealing conditions with step increases in temperature showing 
the most significant shifts.  Most notable was the tan δ peak shift toward a lower 





The typical tan δ response of annealed MG-9 and MG-17 yarn depicted for the annealing 
temperature of 120ºC conditioned for the times of 30 (blue), 60 (green), and 180 
(maroon) minutes.  “As extruded” (red) data has been included for comparison. 
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 Of significant interest is the proximity of the onset or shift in the baseline of the 
tan δ curve with reference to physiologic temperature (37°C).  The onset of the Tg 
transition for MG-9 is significantly lower than that of MG-17.  As such, at 37°C the MG-
9 tan δ curve shows changes in the slope of the curve indicating the initiation of 
molecular mobility and increased free volume.  At 37°C, nearly all of the tan δ curves for 
the depicted MG-17 yarn samples have minimal, or no slope, indicating the relaxation 
event of Tg has not initiated.  Exceptions to this finding for MG-17 yarn include the „as 





The typical tan δ response of annealed MG-9 and MG-17 yarn depicted for the annealing 
time of 30 minutes conditioned at the temperatures of 100°C (blue), 120°C (green), and 
140°C (maroon).  “As extruded” (red) data has been included for comparison. 
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The principal observation from the DMA data presented in Table 3.4 is that in all 
cases, initial and annealed, the Tg of MG-17 yarn was greater by 4-6°C than that of MG-9 
yarn.  In addition to changes in peak position of tan δ, changes to the onset temperature of 
tan δ were dramatic following annealing.  The annealing conditions of 100°C for 180 
minutes and 120°C for 30 and 60 minutes produced the greatest onset temperatures for 
both yarn types.  But at the same time, MG-17 produced onset values about 16°C greater 
than that of MG-9.  When the annealing temperature was increased from 120°C to 140°C, 
the tan δ onset temperature initiated earlier for both yarn types.  The peak height of tan δ 




Thermomechanical Properties of “As Extruded” and Annealed MG-9 and MG-17 Yarn 
Determined by DMA 
 












Peak of Loss 
Modulus,  E’’ 
(°C) 
MG-9 62 27 28 0.309 47 54 
MG-17 67 27 34 0.265 49 57 
CA3 65 27 29 0.185 51 57 
CA6 66 28 28 0.185 50 57 
CA18 67 29 35 0.178 50 59 
CB3 66 26 37 0.185 49 58 
CB6 66 27 37 0.174 46 57 
CB18 66 28 34 0.177 49 58 
CC3 65 31 29 0.170 51 57 
CC6 62 25 33 0.175 45 54 
CC18 65 24 33 0.176 47 57 
LA3 71 21 49 0.219 56 62 
LA6 70 23 46 0.218 56 62 
LA18 72 18 53 0.204 60 64 
LB3 72 18 53 0.203 59 63 
LB6 72 20 53 0.191 58 65 
LB18 71 20 50 0.192 56 62 
LC3 69 27 40 0.188 51 58 
LC6 69 31 38 0.188 54 61 
LC18 69 36 30 0.179 51 58 
  
 
Annealing increased yarn dimensional stability as shown by the data listed in 
Table 3.5.  Initially, MG-17 shrank approximately twice the amount as MG-9 yarn.  For 
both yarn types all post-annealed shrinkage measurements were lower than the „as 
extruded‟ initial value (p < .04).  In spite of the dramatic reductions observed for MG-17, 




Percent Shrinkage and Shrinkage Onset Temperature of “As Extruded”  
and Annealed MG-9 and MG-17 Yarn 
 
Sample ID 
Shrinkage at 80°C       
(%) 
Shrinkage at 120°C     
(%) 
Shrinkage Onset 
Temperature               
(ºC) 
MG-9                5.6 ± 0.5                7.1 ± 0.9              43.0 ± 0.9    * 
MG-17              10.2 ± 2.2              14.1 ± 1.3              44.1 ± 1.0    * 
CA3                2.9 ± 0.6 †                5.0 ± 1.0 †              46.7 ± 1.4 † 
CA6                2.2 ± 0.1                4.6 ± 0.3   ‡              46.4 ± 1.0   ‡ 
CA18                1.7 ± 0.2 †                3.5 ± 0.3 †‡              49.9 ± 0.3 †‡ 
CB3                1.6 ± 0.2                2.3 ± 0.2              52.7 ± 0.3 
CB6                1.8 ± 0.4                2.9 ± 0.5              51.3 ± 1.7    * 
CB18                1.6 ± 0.2                2.2 ± 0.3               51.9 ± 0.8 
CC3                2.0 ± 0.3                2.5 ± 0.3              44.8 ± 1.0 † * 
CC6                1.9 ± 0.1   *                2.5 ± 0.3              47.1 ± 1.6 †‡ 
CC18                1.6 ± 0.2                1.9 ± 0.1              42.2 ± 0.7 †‡ 
LA3                6.5 ± 0.5 †              12.7 ± 0.5 †              49.0 ± 1.0 † 
LA6                5.1 ± 1.1 †              11.6 ± 2.0              51.3 ± 0.9 † 
LA18                4.3 ± 0.5 †              11.3 ± 1.3 †              52.4 ± 1.1 † 
LB3                3.5 ± 0.3 †                7.8 ± 0.8 †              50.3 ± 1.6 
LB6                3.6 ± 0.4                7.7 ± 0.8   ‡              50.6 ± 1.0    * 
LB18                2.6 ± 0.4 †                5.9 ± 0.8 †‡              49.4 ± 0.3 
LC3                4.0 ± 0.5 †                7.7 ± 1.2 †              44.8 ± 0.6 † * 
LC6                2.1 ± 0.1 †*                4.0 ± 0.4 †              48.8 ± 1.4 †‡ 
LC18                2.8 ± 0.4 †                4.4 ± 0.7 †              46.3 ± 0.7   ‡ 
†‡ Indicates a significant difference within each yarn type between different annealing times for the indicated annealing 
temperature  (p < .05) 
*Indicates no significant difference found between yarn types for the same treatment conditions (p < .05) 
  
 
At the annealing temperature of 100°C, increased annealing time significantly 
reduced yarn shrinkage for both yarn types.  However, varying the annealing time did not 
produce any differences in shrinkage values for MG-9 at the annealing temperatures of 
120°C and 140°C.  On the contrary, the shrinkage of MG-17 yarn continued to be 
reduced as annealing time increased at the annealing temperatures of 120°C and 140°C.  
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On the whole, MG-17 yarn required greater temperatures and times to influence 
shrinkage measurements, whereas MG-9 yarn was mostly unresponsive to annealing 
conditions beyond a temperature of 100°C for 60 minutes. 
 All temperature onset measurements for annealed samples were greater than the 
„as extruded‟ values (p < .01), with the exception of samples CC18 and LC3.  In these 
two cases, no difference was observed.  In addition, it is interesting to note that for the 
onset temperature there was no difference between the MG-9 and MG-17 „as extruded‟ 
yarn samples.  For MG-9 yarn, annealing at 100°C increased the onset temperature with a 
continuation of this trend as annealing time increased.  Further improvements were 
obtained at the annealing temperature of 120°C; however, at this temperature no 
difference was determined due to time.  MG-17 showed a similar trend, but rather than an 
increase, a slight decrease was observed for each step change in time at the annealing 
temperature of 120°C.  Annealing at 140°C had a negative effect on the shrinkage onset 
temperature for MG-9 and MG-17.  All in all, similar initial and maximum shrinkage 
onset temperatures were observed between the two yarn types of approximately 44°C to 






A typical Arrhenius plot demonstrating the relationship between logarithmic frequency 
and reciprocal peak temperature for the Tg transition. Depicted data is for the annealing 
condition of 120ºC.  Reported linear slope and correlation coefficient data is organized in 
the same configuration as presented in the legend. 
 
 
Figure 3.4 depicts the relationship used to determine the activation energy 
associated with each annealing condition determined by the associated slope (Ea) (data 
for the other annealing temperatures not shown).  In addition, the correlation coefficient 
(R
2




0.970) which validates the Arrhenius relationship.  Figure 3.5 depicts the resulting Ea 






The apparent activation energies of the Tg transition calculated from the slope of the 
Arrhenius plot.  The activation energies for the “as-extruded” samples were 419 kJ/mol 
and 466 kJ/mol for the MG-9 and MG-17, respectively. 
 
 
Several interesting observations can be made from the data in Figure 3.6.  First, 
minimal differences in Ea were observed for data within each yarn type at the three 
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annealing temperatures.  Second, a maximum occurred for both yarn types at the 
temperature of 120°, regardless of annealing time.  Lastly, a clear separation existed 
between the two yarn types with the Ea of the Tg transition for MG-17 substantially 
greater than that of MG-9. 
 
 




The temporal in vitro conditioned maximum tensile force for MG-9 and MG-17 samples 
annealed at 100ºC for 30, 60, and 180 minutes. 
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From inspection of the data in Figures 3.6, 3.7, and 3.8, clearly the annealing 
process increased the temporal in vitro conditioned MTF for both yarn types.  The only 
exception to this observation is the MG-9 sample annealed at 140°C for 180 minutes 
which produced lower MTF values than that of the „as extruded‟ sample.  In all cases, 
MG-9 and MG-17 produced a reduction in strength that was immediate, continuous, and 
almost linear.  However, the rate of that change or slope of the resultant profile was 
variable.  Of specific importance is that MG-17 showed greater MTF values for all 
annealing temperatures and annealing times through 14 days.  MG-9 showed a steeper 
slope that resulted in low MTF values by 14 days and no measurable results by 21 days.  






The temporal in vitro conditioned maximum tensile force for MG-9 and MG-17 samples 
annealed at 120ºC for 30, 60, and 180 minutes. (No significant differences found between 
MG-17 samples at 21 days of in vitro conditioning (p < .05)) 
 
 
At the in vitro time point of 21 days, annealing at 100°C for 180 minutes was not 
significantly different than each of the samples annealed at 120°C (p > .06)  Samples 
annealed at 140°C were significantly lower than any of those annealed at 120°C (p < .01).  
In brief, the longest time period of 180 minutes for the lowest annealing temperature, as 
well as, all of the annealing times at 120°C produced similar, and the highest temporal 
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MTF values for MG-17 yarn.  The temporal in vitro conditioned MTF values for MG-9 






The temporal in vitro conditioned maximum tensile force for MG-9 and MG-17 samples 
annealed at 140ºC for 30, 60, and 180 minutes. (No significant differences found between 
MG-17 samples at 21 days of in vitro conditioning (p < .05)) 
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Discussion 
Three distinct variables were investigated to develop a high-glycolide copolymer 
for use in the construction of a bicomponent mesh.  Specifically, comonomer 
composition, annealing time, and annealing temperature were investigated to determine 
their effect on the initial maximum breaking force, temporal in vitro conditioned 
maximum breaking force profile, and yarn stabilization against dimension changes.  In 
addition to the direct measurement of these study objectives, several analytical techniques 
were employed to better understand morphological differences including thermal 
properties by DSC and viscoelastic properties by DMA.  Significant results related to 
each copolymer and for each investigated annealing time and temperature will be 
discussed. 
As polymerized, MG-17 revealed a clear reduction in Tm and crystallinity 
compared to MG-9.  The peak temperature of the melting event is driven by crystallite 
perfection and thickness.  Chu described that when a PLL comonomer is dispersed in PG, 
the sheet crystalline structure (also described as planar zig-zag) is disturbed because the 
methyl group affects chain packing.
27
  The steric effect from the pendant methyl group of 
PLL protruding outward along the main chain of MG-17 likely interrupts the regular, 
repeat structure between adjacent chains, resulting in a less perfect crystalline structure.  
For comparison, the Tm for a homopolymer of PG is about 225°C.  A commonly used and 
widely investigated copolymer for suture and meshes is polyglactin 910, a random 
copolymer of 90/10 poly(glycolide-co-lactide) which, compared to PG, displays (1) a 




These reported findings are similar to the reduction observed for MG-17.  Following 
melt-extrusion, greater differences in Tm and degree of crystallinity were observed 
between MG-9 and MG-17.  
During processing, each polymer was melted, extruded, and in-line oriented into 
fibers to produce a 10-filament yarn.  As a result, crystallinity is developed which is 
detectable by DSC.  In effect, during the extrusion process molten polymer is cooled 
rapidly, or quenched, which does not allow sufficient time for complete crystallization 
leaving a substantial amorphous fraction that upon reheating will partially crystallize.  An 
inherent characteristic of absorbable polyesters is that their crystallization kinetics are 
relatively slow. As such, the effect of different molecular structures becomes magnified 
as a result of the rapid quenching during the melt-extrusion process.  This difference was 
evident between MG-17 and MG-9.  MG-17 showed a greater difference in Tm between 
the synthesized copolymer and “as extruded” yarn compared to that of MG-9.  
Furthermore, during annealing appreciable increases were observed for MG-17.  As such, 
it is likely that the added kinetic energy facilitated a reorganization of the crystallite 
structure for MG-17 that was initially hindered by the dispersed lactide moiety.  Some 
disturbance was also realized as a result of using PCL as a comonomer in MG-9.  
However, the reduction in Tm and degree of crystallinity was less pronounced due to the 
lack of a bulky side group in the monomers.  It is interesting to note that for MG-9 yarn, 
minimal differences in Tm were observed following annealing.  This was likely the result 
of faster crystallization kinetics which initially produced greater crystallite perfection that 
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did not significantly change during annealing.  Instead only an increase in the degree of 
crystallinity was observed. 
The mechanical tensile properties of MTF and elongation have significant 
influence on the maximum burst force of meshes.  For the investigated yarns, one might 
have hypothesized that MG-17 would elongate more than MG-9 due to the greater weight 
percent of the low Tg and low modulus pTMC macroinitiator in the MG-17.  Results 
indicated the contrary, however; mechanical tensile testing showed that MG-9 yarn 
produced significantly greater elongation.  The interlocking effect of the added lactide 
monomer units between adjacent chains dominated the extensional behavior and negated 
any effect from the greater molecular weight of the pTMC segment.  Likewise, steric 
hindrance and molecular interlocking prevented rotational and translational mobility 
between adjacent chains in the amorphous domain, resulting in greater chain 
entanglement and thus greater MTF for MG-17.  A similar response was observed when 
tercopolymer of PCL, TMC, and PLL with different molar ratios were synthesized.
29
  The 
authors noted that as the content of PLL increased, chain slippage decreased, which 
increased the tensile strength and decreased elongation. 
The temperature position, height, onset temperature, and temperature range of tan 
δ provide quantitative measures which are related to the degree of crystallinity and 
morphology of semicrystalline polymers.  The amorphous and crystalline domains of 
fibers are intimately connected which has an effect on the Tg relaxation.  The temperature 
of the Tg relaxation is a measure of chain rigidity and resistance to segmental molecular 
mobility. As such, segmental movement must overcome chain friction and steric barriers.  
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This interaction is detectable in the breadth, peak, and onset of the Tg transition as 
segmental motion in the amorphous region is constrained or unrestrained due to different 
annealing conditions.  Furthermore, the onset temperature for the reduction in storage 
modulus is also an indicator of how well the amorphous region is constrained by 
annealing to long-range segmental motion.  It should be noted that the values determined 
for Tg using DMA are higher than those determined using the more commonly used DSC 
method.  Other authors have reported the same observation.
19
  This difference lies in the 
fact that each technique measures a different property.  DSC measures differences in 
specific heat while DMA measures thermally induced molecular mobility. 
The Tg transition represents a major physical change to the polymer as it goes 
from a „glassy‟ structure with limited molecular mobility to the „rubbery‟ state with 
increased free volume and chain mobility within the amorphous domain.  A significant 
finding, which has substantial influence on degradation rate, was that the Tg of MG-17 
yarn (69-72°C) was greater by 4-6°C than that of MG-9 (65-66°C).  Again, adding PLL 
increased the barrier to molecular rotation and translation leading to a higher Tg.  Values 
of Tg determined using DMA for a homopolymer of PLG and polyglactin 910 yarn in 
suture form have been reported as 72°C and 74°C, respectively.
30
  Similar to results of 
the present study, the addition of PLL as a comonomer to PG increased the temperature 
of the Tg relaxation event.  Moreover, in a study by Penning and coworkers,
31
 PLL was 
polymerized with a 0.10 and 0.05 molar fraction of PCL or D-lactide, respectively.  Of 
interest was the response of Tg, Tm, and heat of fusion to the addition of each comonomer 
unit.  In the case of PCL, a reduction in all three thermal properties was observed.  
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However, the addition of D-lactide maintained the value of Tg but depressed, even more 
dramatically than PCL, the Tm and heat of fusion values.  Although the major component 
was PLL and not PG as used in the current study, the response was similar to that of MG-
17 and MG-9.  Steric effects from lactide heavily influenced crystallite formation and 
perfection, which significantly lowered the Tm and heat of fusion values.  PCL had the 
same effect but to a lesser degree.  The dramatic reduction in Tg when PCL was 
introduced was explained as being the result of the extremely low Tg of PCL (Tg = -60°C) 
which shifted the Tg a proportional amount to its molar content.  Again, this was similar 
to the Tg response of MG-9.  Since the Tg of D-lactide is the same as L-lactide no 
difference was observed.  Therefore, for the monomers used in the present study, the 
reduction in MG-9 was likely the result of the low Tg of PCL, while the increase in MG-
17 was from the greater Tg of PLL. 
Differences in the amount of soft segment were most noticeable in the DMA 
storage modulus curves.  The finding that the storage modulus was greater for the MG-9 
yarn within the rubbery plateau is related to the amount of soft segment within each 
copolymer and differences in the degree of crystallinity.  Below Tg the stiffness of the 
chain backbone is highly influential on the stiffness of the polymer.  As such, the greater 
proportion of the soft polymeric initiator in MG-17 is a likely cause for the lower E‟ 
response below Tg.  In addition, the height of the rubbery plateau is related to a polymers 
degrees of crystallinity.  Crystallites resist chain slippage which results in a greater elastic 
response.  Compared to MG-9, MG-17 was less crystalline which was concluded from 
DSC measurements. 
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There is a well documented link between degradation rate and crystallinity.
3,32
  
Higher degrees of crystallinity prolong the strength retention profile by inhibiting the 
access of water to molecular chains which are protected within tightly packed crystallites.  
However, crystallinity alone does not dictate degradation rate.  Rather it is the 
accessibility of water to the amorphous domain which is also influenced by molecular 
orientation, Tg, and the hydrophobicity of the constituent monomers.
33
  This study 
illustrates this point; MG-9 was more crystalline yet it showed an increased rate of 
degradation.  The explanation for this finding can be found in differences in Tg. 
Of particular interest to this study is the in vitro conditioned retention of 
mechanical strength as it has the greatest impact on the function of the device.  The 
greater Tg of MG-17 influenced the temporal in vitro conditioned strength retention 
profile.  The affect of Tg on degradation rate is evidenced in the DMA tan δ curve for 
each yarn type and at each annealing condition.  With overall lower Tg values for MG-9, 
the tan δ curve begins to increase sooner than that of MG-17.  From the tan δ onset 
temperature it is clear that MG-9 began to show evidence of the initiation of the Tg 
relaxation event at or below physiologic temperature.  The increase in tan δ marks a 
physical increase in free volume for the copolymer, induced by molecular movement.  A 
consequence of this increased free volume, it would be expected that larger gaps between 
chains would increase the diffusion of water.  This is a significant finding since porosity 
is a major factor which affects degradation rate.  For the majority of the investigated 
annealing conditions, MG-17 does not show any increase in tan δ until 10°C, or more, 
above physiologic temperature.  This finding correlates well with the in vitro conditioned 
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MTF data which indicated that MG-17 in all cases has better in vitro conditioned strength 
retention. 
Changes to the size and shape of a fibrous medical device due to elevated 
temperature during sterilization or shipment is often detrimental to its intended function.  
In addition to undesirable dimensional changes, a relaxed yarn will have modified initial 
and temporal in vivo mechanical properties.  These changes result from the thermal 
relaxation of orientation within the amorphous region which is triggered by entropic 
molecular changes to acquire a lower energy conformation.  In this study, the annealing 
process was found to substantially decrease the amount of shrinkage and increase the 
shrinkage onset temperature.  Although the annealing process imparts resistance to 
deformation from the relaxation of some chains and the crystallization of others, for 
fibers this process is never absolute.  MG-17 exhibited about two times more free 
shrinkage than MG-9.  It is reasonable to expect that steric effects induce stressed chain 
configurations, which were frozen in as the yarn transitioned into the glassy state during 
fiber orientation.  Consequently, MG-17 experienced substantially more thermally 
induced free shrinkage as the stressed chains were allowed to relax into lower energy 
conformations.  In the case of MG-9, the PCL comonomer unit would have imparted 
increased chain flexibility that facilitated chains to assume lower stress levels.  
Furthermore, the greater crystallinity of MG-9 would have better constrained the 
microstructure against relaxation. Regardless, for annealed samples equal to or greater 
than 120°C, the absolute amount of shrinkage at 80°C is low.  For comparison, using a 
similar technique, Fu and coworkers
19
 determined that polyglactin 910 sutures processed 
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and annealed at different conditions produced shrinkage values from 3.3 to 5.1% at 80°C.  
These values are comparable to those obtained for MG-17 and slightly greater than MG-
9.  The temperature at which the shrinkage initiates, i.e. the shrinkage onset temperature, 
is equally important to the dimensional stability of yarn as is the absolute amount of 
shrinkage.  The amount of shrinkage at the onset of shrinkage temperature would be 
expected to be essentially zero at typical end-use (37°C) and sterilization temperatures (< 
42°C); both yarn types met this criterion when annealing was conducted at temperatures 
greater than 120°C. 
Since the rearrangement of polymer chains into crystallites is time dependent, it 
was important to determine the effect of different annealing times on each yarn type.  
Longer annealing times allow more chains to diffuse into suitable orientations for 
crystalline arrangement; thus, the perfection, size, and degree of crystallinity increase 
with increased annealing time.
34
   In this study minimal differences in degrees of 
crystallinity were observed between the annealing times of 30, 60, and 180 minutes, 
indicating that the percent of crystallite formation within both copolymers was achieved 
prior to the lowest time point of 30 minutes.  This result has been observed for the slower 
crystallizing PLL homopolymer.  Molded articles of PLL have been shown to reach 
equilibrium with regard to percent crystallinity by 30 minutes for the same investigated 
annealing temperatures.
35
  However, although differences in amount of crystallinity were 
not observed between each annealing time, changes in morphology were apparent.   
At the studied annealing temperatures and given adequate time, polymer chains 
have sufficient mobility that, below a critical size, small crystallites melt and create larger 
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crystallites that grow at their expense.
36
  Additionally, when annealing conditions in 
which nucleation dominates (lower temperatures), smaller crystals are formed.  When 
few nucleation sites exist and conditions favor crystallite growth, then larger crystallites 
form.
37
  The extent of each condition is time dependent.  Different crystallite sizes were 
evidenced in the mechanical, viscoelastic, and dimensional stability results.  First, 
mechanical tensile testing data showed significant reductions in MTF and elongation as 
annealing time increased, especially at the annealing temperature of 140°C.  Reductions 
in elongation are characteristic of the formation of large crystallites that result in a loss in 
toughness and more brittle mechanical failure.  Similar results were found for PLL films 
annealed at different temperatures and times.
38
 Furthermore, at the lower annealing 
temperature of 100°C, the amount of free shrinkage decreased with annealing time due to 
greater restriction from the reorganization of small crystallites into larger crystallites that 
span greater distances and include more tie chains.  As a result, less dimensional change 
is allowed during free shrinkage.  In addition, for both yarn types the peak of tan δ was 
reduced with time, as larger crystallites result in less viscous flow.  Observations related 
to the annealing time were most notable for the tan δ onset temperature at the extreme 
annealing temperatures of 100°C and 140°C.  For example, longer annealing times at 
100°C showed an increase in onset, while at 140°C a marked reduction was realized.  
Similar results were observed by Loo and coworkers.
21
  In a study using films of 
poly(lactide-co-glycolide) (PLG) where Tg was observed to decrease significantly with 
increased annealing time.  The authors attributed the reduction to a loss in the amorphous 
fraction and the formation of voids as chains were redistributed into local crystallites.  
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Several other authors have noted that for poly(ethylene terephthalate), increased 
crystallinity increases Tg, to a point, and then a further increase to crystallinity results in a 
reduction in Tg.
39-41
   In this study, shifts in Tg were apparent but less dramatic, likely due 
to the highly oriented and crystalline nature of the yarn.  Rather, more dramatic changes 
were noted in the onset of the tan δ event with reductions as annealing temperature and 
time increased.  The effect of this phenomenon was also witnessed in the temporal in 
vitro conditioned strength retention. 
Differences in annealing time had a clear impact on the temporal in vitro 
conditioned MTF profile.  For MG-17 yarn, at the temperature of 100°C the strength 
profile benefited significantly when the time point was increased from 60 to 180 minutes.  
Reductions in the in vitro conditioned strength profile for both yarn types were 
consistently lower when the annealing temperature was increased from 120°C to 140°C.  
These findings were similar to those found for the previously mentioned PLG films.
21
  In 
that study, the degradation rate was reported to decrease for annealing times less than 30 
minutes and increase when annealing time was greater than 30 minutes.  As before, the 
authors attributed the initial decrease in degradation rate to crystallites retarding water 
penetration, followed by a loss in the amorphous fraction which created voids that 
allowed greater water uptake and faster hydrolysis.  Another explanation for the 
increased degradation rate and loss of mechanical strength due to increased crystallinity 
of absorbable polymers has been suggested by Tsuji.
42,43
  Studies showed that for PLL 
films a higher initial crystallinity was found to result in enhanced hydrolysis.  The 
authors suggested that an increased density of hydrophilic terminal carboxyl and 
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hydroxyl groups, which are excluded from crystalline domains, causes loose chain 
packing and an increase in the diffusion rate of water into amorphous domains.  The 
increased degradation rate associated with advanced crystallite formation determined in 
these studies parallel the results of both yarn types in this study, specifically the 
annealing conditions which produced enhanced crystallization.  Namely, annealing at 
140°C produced diminishing in vitro conditioned strength retention with each step 
increase in time. 
As demonstrated, the three annealing temperatures were all influential on the 
properties of both yarn types.  However, the temperature of 120°C increased the 
mechanical properties, Tg, onset temperature for tan δ, onset temperature of E‟, peak of 
the E‟‟ curve, and produced the greatest temporal in vitro strength retention for both MG-
9 and MG-17 yarn.  This data was further supported by the calculated Ea for each yarn 
type and each annealing condition.  The activation energy provides a quantitative 
measurement of the energy required to transition through the thermomechanical 
relaxation event of Tg.  As such, it provides information about how well the amorphous 
region was constrained.  In other words, it is effectively the energy barrier that the 
material has to overcome in order to generate segmental molecular motion on a long-
range scale.  The obtained Ea values were clearly greater for MG-17 and produced a 
maximum at 120°C which corresponded with the copolymer and annealing temperature 
that resulted in the greatest initial strength, highest tan δ onset temperature, and greatest 
in vitro conditioned strength retention.  On the other hand, a reduction in Ea was observed 
at the annealing temperature of 140°C.  Overall, annealing at 140°C resulted in a 
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reduction in properties.  This was most notable in the reduced mechanical properties, 
lower Tg values, and faster degradation rate.  When annealing was conducted at 100°C 
morphology development required the longer time point of 180 minutes to achieve 
marked increases in the onset of tan δ, shrinkage, and a greater strength retention in vitro 
profile.  
For copolymers, two or more inherently incompatible polymer sequences are 
forced to co-exist in a single phase.  The coupling of their properties results in a single Tg 
relaxation which is between each individual segments homopolymer.  The properties of 
the investigated copolymers in this study were largely influenced by the temperature of 
the Tg relaxation.  Steric effects from the addition of the PLL in MG-17 increased Tg, and 
more importantly, the onset temperature of the tan δ transition.  It is difficult to predict 
the in vivo performance of an absorbable yarn based on only a single characteristics as 
there are many interactions; however, in this study the most influential factor on the 
initial and temporal in vitro conditioned strength profile was the replacement of PCL with 
PLL for MG-17. 
Conclusion 
 A high-glycolide yarn was developed for use in a bicomponent mesh for hernia 
repair whereby its function requires strength retention during the inflammatory and 
proliferation period of healing with subsequent gradual transfer of the load to remodeling 
tissue.  Chemical modification resulted in two triaxial, segmented high-glycolide 
copolymers for evaluation, namely MG-9 and MG-17.  Experimental results indicated 
that the addition of L-lactide as a comonomer in MG-17, compared to ε-caprolactone for 
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MG-9, increased Tg, the onset of the tan δ transition, the Ea of the Tg transition, the 
maximum tensile force, and decreased the tensile elongation.  A further aim of this work 
was to determine the isothermal annealing time and temperature which optimized the 
temporal in vitro conditioned strength profile.  In summary, it can be concluded that MG-
17 annealed at a temperature of 120°C for 30 minutes met the desired functional 
requirements and provided the greatest initial maximum tensile force, longest temporal in 
vitro conditioned strength retention, and yarn stabilization against dimensional changes 
induced by unrestrained thermal relaxation. 
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AN INVESTIGATION OF THE TISSUE RESPONSE AND INTEGRATION  
OF AN ABSORBABLE  BICOMPONENT CONSTRUCT  




 When implanted in living tissues, mesh materials elicit a cellular response which 
triggers a tissue reaction that results in the encapsulation of the implant.  The 
characteristics of the tissue encapsulation are variable and largely dependent on the mesh 
design variables of yarn chemistry, yarn form (monofilament or multifilament), yarn size, 
and the physical configuration or knit construction.  Previously, an absorbable 
bicomponent mesh (ABM) comprised of a fast-degrading and slow-degrading yarn was 
shown to modulate mesh temporal physical and biomechanical properties for application 
in hernia repair (Chapters 2 and 5).  As such, the ABM goes through a transition phase 
whereby the structural stiffness of the mesh changes from low extensibility to high 
extensibility given the same force.  This transition is timed to take place between the 
inflammation/proliferation phase and the maturation/remodeling phase of the wound 
healing process.  During the former, the ABM mesh shields the neotissue from 
biomechanical stimulation resulting in an integration process primarily influenced by 
yarn chemistry, yarn form, and knit construction.  In this investigation, a simulated ABM 
knit construct was evaluated to determine the cellular and tissue integration response 
during the transition phase using a rat model. 
Mesh hernia repair efficacy is dependent upon strengthening weak native 
abdominal wall tissue by a strong mesh/tissue complex.  A significant factor in achieving 
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this objective is the integration of the mesh at the host tissue interface.   The acute foreign 
body cellular response to the mesh is initially responsible for the mesh-tissue integration 
process.  For the proposed ABM, the temporal transition period associated with the 
substantial degradation of the fast-degrading yarn is a critical timeframe.  The 
development and optimization of a fast-degrading yarn was shown (Chapter 3) to retain 
strength for greater than 18 days.  As a result, the ABM possesses a transition period 
between 18 and 28 days (Chapter 5).  Efficacy of the ABM is dependent on its integration 
with the host tissue before the mesh transitions to a state of high extensibility.  Significant 
integration of the extracellular matrix (ECM) into polypropylene (PP) and 
polyethyleneterephthalate (PET) meshes has been observed in animal studies, reducing 
abdominal wall compliance 2-3 weeks post implantation.
1
  This temporal change in the 
bending stiffness of the abdominal wall of rats correlated with the histological finding of 
activated fibroblasts and the accumulation of collagen.  In the same study, grades of 
collagen content within the PET mesh steadily increased from 3 days to a maximum at 21 
days, with no subsequent change up to 90 days.  High-glycolide coated meshes are 
associated with vigorous collagen deposition.
2,3
  Partially-absorbable (PA) meshes which 
incorporate a fast-degrading absorbable yarn into a light-weight (LW) PP mesh have been 
shown to induce greater cellular activity and fibrosis within the first 28 days post-implant 
compared to the LW PP mesh alone.
4
  Furthermore, the introduction of high-glycolide 
filaments into a PA mesh increases the quantity of collagen at 21 days compared to PP 
and PET meshes.
5
  Overall, the use of a fast-degrading absorbable polymer results in an 
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intense cellular reaction followed by greater collagen deposition compared with non-
absorbable yarns. 
The tissue response to a new mesh design is often first evaluated in animal 
models.  In vivo evaluations for absorption and tissue response using the gluteal muscle 
of rats as an implantation site has been reported frequently for sutures
6,7
 and tissue 
adhesive analyses.
8
  This animal model provides two implantation sites to facilitate 
paired experimental designs, allowing within animal variability to be minimized when 
comparing the effect of two different implant types.  As a result, the rat gluteal muscle 
model provides a simple method to compare the tissue reaction of different mesh 
materials.  To evaluate the integration of a mesh into the surrounding tissue it is 
important to quantify the extent of encapsulation.  To quantitatively characterize changes 
in the foreign body response with time, a measure of the inner ring of granuloma (i.e. the 
zone of high cellular activity) and the outer ring (i.e. the fibrotic capsule) has been 
suggested by several authors.
4,7,9
  To determine the total amount of collagen deposition 
surrounding an implant, Junge and coworkers used a quantitative method based on the 
selective binding of histological stains to collagen and noncollagenous protein.
5,10
  
Evaluated with histological qualitative observations, quantitative measurements of 
cellular activity and tissue integration provide a mechanism to evaluate device 
performance in vivo. 
In this investigation, a simulated ABM knit construct was implanted in vivo and 
evaluated at 3 and 6 weeks.  As a result, the biological reaction to the simulated ABM 
construct during the early stability phase was closely simulated.  These evaluation time 
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points bracket the transition phase of the proposed ABM to evaluate (1) the extent of 
foreign body response measured as the thickness of the granuloma or zone of high 
inflammatory cell density, (2) the degree of collagen encapsulation measured as capsule 
thickness, and (3) the amount of deposited collagen measured as the collagen/total 
protein ratio.  Additionally, qualitative histological observations coupled with the 
quantitative results provided insight into the anticipated device efficacy.  For comparison, 
a similar construct comprised of PET yarn served as a clinically-relevant control. 
 
Materials and Methods 
Materials 
The polymer synthesis and production of yarn for the investigated polymers of 
MG-17 (Chapter 3) and SMC-7 (Chapter 2) were described previously.  In summary, 
MG-17 is a triaxial, segmented, high-glycolide copolymer that is melt-extruded into a 10-
filament yarn.  SMC-7 is a linear, segmented, high-lactide copolymer that is melt-xtruded 
into a 43-filament yarn.  The denier (g/9000m) of the MG-17 and SMC-7 yarn was 150 
and 86, respectively.  Additionally, a non-absorbable yarn of polyethylene terephthalate 
(PET) was procured for use as a control (Unifi, Dacron, 115 denier, 56-filament). 
 
Implant Construction 
Using MG-17 and SMC-7 yarns, a warp knitted absorbable bicomponent 
construct (ABC) was knit using an 18-gauge raschel knitting machine (American LIBA, 
RACOP TR-6).  To produce the ABC, a single end of MG-17 was plied with two ends of 
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SMC-7 yarn (S1) prior to knitting and wound onto a spool.  Additionally, a three-ply of 
SMC-7 yarn (S2) was wound onto a spool in the same manner.  Prepared spools of yarn, 
S1 and S2, were fed through a tensioning device and then directly into guidebars (GB) 
one and two, respectively.  Knitting was completed by threading S1 and S2 yarn through 
a single guide of each GB such that the construct was produced by knitting around only a 
single needle within the needle bar.  Using the same knitting process, PET yarn was plied 
to closely match the denier of the yarns used to construct the ABC and was knit (knit 
PET termed PETC) using the same knit pattern.  As such, GB 1 was fed with a two-ply 
and GB2 was fed with a three-ply PET yarn. 
The knit ABC and PETC were annealed or heat set by wrapping the knit construct 
around an expandable rack which had two parallel bars of stainless steel.  Yarn was 
wrapped in a continuous fashion, secured, and a strain of 0.02 was applied prior to 
annealing.  Annealing was completed at 120°C for 1/2 hour while under high vacuum (< 
1 torr).  Following annealing, implants were cleaned using ultrasonic agitation (Branson, 
5510) in isopropyl alcohol (Sigma-Aldrich, ACS Plus, A416) for 6 minutes.  An image of 
each mesh construct was obtained using a digital camera (Moticam 2300) attached to a 
microscope (40x, Leica, DME). 
 
Implant Sterilization 
Sterilization of the ABC and PETC implants was completed using a low-
temperature (40°C) ethylene oxide (EtO) cycle (Anderson Scientific Inc., EOGas
TM
 
Series 3 Plus Sterilization Chamber).  Constructs were sealed (FUJI, Impulse OPL-300-
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10) in Tyvek pouches (Oliver-Tolas, 1073B) to facilitate EtO gas diffusion and preserve 
sterility of the device until implantation.  To complete the removal of EtO residuals, 
pouches containing the implants were placed under reduced pressure (< 1.0 torr) for 12 
hours following sterilization.  To protect against ambient exposure and premature 
degradation of the ABC implants, all pouched implants were sealed in foil pouches 
(Oliver-Tolas, TPC-0764B) 
 
Study Design and Surgical Procedure 
 Four adult female Sprague-Dawley rats (approximately 250 grams) were used for 
the cellular and tissue response study.  The study design included two rats for each time 
period (3 and 6 weeks) with one knit construct (ABC and PETC) implanted in each 
gluteal muscle.  This design resulted in two implant sites for each construct at each time 
period.   
All animals were acclimated for a minimum of one week before the surgical 
procedure.  Each rat was pre-medicated with 0.5 mg/kg acepromazine and 0.5 mg/kg 
buprenorphine subcutaneously 15 minutes prior to induction of general anesthesia, which 
was isoflurane in oxygen.  Each rat was shaved and prepped with iodine at the incision 
sites for both gluteal muscles.  Subsequently, each animal was placed in a sterile surgical 
environment, draped, and positioned so that the dorsal area was exposed.  Using a #11 
scalpel blade, a cutaneous stab incision was made at the proximal end of each gluteal 
muscle.  A sterile ABC and PETC implant was drawn through the left and right gluteal 
muscles (one implant in each muscle) using the proximal incision as the entry point.  A 
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segment of approximately 2 cm length of each implant was left in situ.  The cutaneous 
stab incisions were closed with one autoclip (staple) at each of the incision locations.  
Staples were removed 7-10 days post-surgery.  No antibiotic treatment was given before 
or during the treatment. 
At the predetermined time periods of 3 and 6 weeks, two animals were 
administered ½ cc of heparin 15 minutes before being euthanized by carbon dioxide 
asphyxiation.  Immediately following euthanasia, the abdominal aorta was cannulated 
and vascular perfusion was administered by first using saline and then 10% neutral 
buffered formalin (NBF).  Subsequently, the surgical sites were opened and each gluteal 
muscle was excised leaving the implant in situ and undisturbed.  Each gluteal 
muscle/implant was preserved in a sterile, labeled container filled with 10% NBF. 
 
Histological Evaluation 
A transverse section of each NBF fixed tissue sample was trimmed, placed in a 
cassette, labeled, dehydrated, cleared, and embedded in paraffin.  Paraffin-embedded 
tissue samples were sectioned (6 µm), placed on a slide, deparaffinized, and stained 
(Goode Histology Lab, New Brunswick, NJ).  Histological investigations of granuloma 
and fibrotic capsule thickness were performed after staining with hematoxylin 
(Polysciences, #02749) & eosin Y (Polysciences, #09859) (H&E) and Masson‟s 
trichrome (Polysciences, #25088), respectively.  Using a digital camera (National 
Optical, Moticam 2300) attached to a brightfield microscope (400x, Leica Microsystems, 
DME), five pictures of random sites around the irregular tissue/implant interface were 
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captured from five slides per implant site.  Measurements of the granuloma from H&E 
stained sections and fibrotic capsule thickness from Masson‟s trichrome stained sections 
were made using digital image-analysis software (Motic Image Plus, 2.0 ML).  
Measurements (5 slides x 5 locations = 25 measurements) were pooled, resulting in a 
single representative average value for each implant type at each implantation time 
period. 
 
Collagen/Total Protein Ratio 
 The procedure for determining the collagen/protein ratio is described in detail 
elsewhere.
11,12
  In brief, 10% NBF fixed samples were embedded in paraffin and 15 µm 
thick sections were obtained.  Four sections for each sample were deparaffinized and 
maintained in distilled water at 4°C until staining.  Four individual sections were first 
stained with 0.04% Fast Green FCF (Polysciences Inc., C.I. 42053) in saturated picric 
acid (Fisher-Scientific, Aqueous, SP9200) for 15 minutes in a small test tube (10x45 
mm).  The sections were then washed with distilled water and stained with 0.1% Sirius 
red F3B (Polysciences Inc., C.I. 35780) and 0.1% Fast Green FCF at room temperature 
for 30 minutes in a rotary shaker.  Fluids were carefully withdrawn with a disposable 
pipette and the sections were rinsed several times with distilled water until the 
supernatant was colorless.  Subsequently, the dyes were eluted from the sections using 
0.1 N sodium hydroxide (NaOH) in absolute methanol.  The fluid was read using a 
spectrophotometer (PerkinElmer, LAMBDA 35) at the wavelengths corresponding to the 
maximum absorbance of Sirius red (538 nm) and Fast Green (605 nm).  The absorbance 
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of each stain was used to calculate the amount of collagen and noncollagenous protein in 
the samples.  Results were expressed as the ratio of collagen (µg) to total protein (mg).  
Collagen contained within the implant capsule, within and between the muscle cells, and 
surrounding the muscle tissue was included in the measurement.  To limit the influence 
of collagen within and between the muscle cells and surrounding the muscle tissue, 
sections were first stained with Fast Green to maximize the attachment of the dye to 




To study differences in tissue reaction and integration a split plot design analyzed 
by two-factor analysis of variance (ANOVA) to compare means was completed.  Two-
factor ANOVA was used to test for effects due to implant type (ABC or PETC) and in 
vivo time period (3 or 6 weeks), as well as their interaction, for the response variables of 
granuloma thickness, fibrotic capsule thickness, and collagen/total protein ratio.  The 
analysis of collagen data based on a split-plot design limited errors by introducing the 
same background signal into paired measurements for each implant type such that 
differences could be distinguished.  The data for each implant type from each rat at each 
in vivo implantation time period was pooled.  All analysis was completed using statistical 
analyses software (Statistical Analyses Software, v9.2) and a p-value less than 0.05 was 




Figure 4.1 provides comparative images of the ABC and PETC samples following 
stabilization by heat setting.  The same knit pattern and the similar denier of the yarn 





Images of the ABC (left) and PETC (right) showing the knit construction and high aspect 
ratio. (Red scale bar = 0.5 mm) 
 
  
The cellular response of each implant was measured quantitatively using the 
granuloma thickness at the tissue/implant interface.  Figure 4.2 depicts the cellular 
response measurements for the 3 and 6 week post-implantation periods. 
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The granuloma thickness for the ABC and PETC implants at the implantation periods of 
3 and 6 weeks.  
 
 
The PETC produced a small and nonsignificant effect on granuloma thickness (p 
= 0.17) between 3 and 6 weeks in vivo.  On the other hand, the ABC produced a 
significant reduction between 3 and 6 weeks.  At 3 weeks, the thickness of the granuloma 
for the ABC was approximately twice that of the PETC.  However, at 6 weeks the 
average thickness of the cellular response around the ABC had decreased almost four-
fold from 3 weeks to a level which was lower than that of the PETC (p = 0.02). 
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As seen in Figure 4.3, the ABC capsule thickness at 3 weeks was significantly 
greater (p = 0.02) than that surrounding the PETC.  At 6 weeks, the ABC was statistically 
unchanged (p = 0.13) while the average capsule thickness of PETC was greater than that 
produced by the ABC. 
 
 




The capsule thickness for the ABC and PETC implants at the implantation periods of 3 






Histological sections of the tissue/implant interface in rat gluteal muscle for the ABC and 
PETC at 3 (top) and 6 (bottom) weeks post-implantation.  a, e – ABC at 3 weeks showing 
the high cellular activity adjacent to the implant and the formation of collagen 
surrounding the granuloma.  b, f – PETC at 3 weeks surrounded by fewer cells than that 
of the ABC and several capillaries.  c, g – ABC at 6 weeks surrounded by fewer 
inflammatory cells than at 3 weeks and a dense and homogenous collagen capsule.  d, h – 
PETC at 6 weeks showing significantly more collagen formation than that of the ABC.  
(a - d → H&E / e - h → Masson‟s trichrome / original magnification 100x, Black scale 
bars = 100 microns) 
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Histological analysis (Figure 4.4) showed that the ABC and PETC were markedly 
colonized with cells in a zone near the implant filaments and the knit yarn was well 
encapsulated.  Observed effects due to implant type included less cellular activity for the 
PETC at 3 weeks compared to the greater granuloma thickness induced by the ABC.  
However, the PETC produced several capillaries around the implant while new vascular 
constructs were non-existent for the ABC.  At 6 weeks, the major difference between the 
ABC and PETC was the characteristics of the respective collagen capsules.  The ABC 
capsule was highly oriented and dense as highlighted by the dark purple/blue color in 
Masson‟s trichrome stained sections; the capsule was devoid of inflammatory cells.  In 
contrast, the PETC capsule was thick and permeated with cells.  Significant numbers of 
spindle shaped, fibroblasts appeared to infiltrate a less compacted fibrous capsule 
compared to that of the ABC.  From 3 to 6 weeks, the ABC was surrounded by fewer 
inflammatory cells and the capsule was compacted.  The change in time from 3 to 6 
weeks for the PETC resulted in a dramatic increase in the effected zone around the 
implant.  During the studied implantation time period, there was minimal evidence of 
collagen fibers infiltrating the individual filaments for either implant type.  There were no 
signs of substantial mass loss for the fast-degrading yarn of the ABC.  The larger MG-17 
yarn filaments were well dispersed within the much smaller SMC-7 filaments and did not 
change in size or shape by the later time point of 6 weeks. 
The selective binding of Sirius red and Fast Green was used to determine the ratio 
of collagen to total protein within sections of the implant/muscle (Figure 4.5).  No 
difference in the collagen/total protein ratio was determined between 3 and 6 weeks for 
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each implant type.  The amount of collagen around the PETC was found to be on average 
greater at 6 weeks than at 3 weeks, but not significantly different (p = 0.09).  However, 
the amount of detected collagen was different between each implant type at 3 weeks, and 
again at 6 weeks.  At 3 weeks, the collagen/total protein ratio was greater for the ABC 
tissue specimens, while at 6 weeks the PETC tissue specimens contained a greater 
amount of collagen. 
 
 




The collagen/total protein ratio for the ABC and PETC implants at the implantation 







The initial stability and transition phases of the mesh biomechanics are critical 
time periods in evaluating the efficacy of the WK6 absorbable bicomponent mesh (ABM) 
(Chapter 5).  For meshes, the cellular response is initially responsible for the mesh-tissue 
integration process.  However, the level and duration of the inflammatory response can 
delay the quantity and quality of collagen deposition.  In this study, a strong initial (< 3 
weeks) foreign body granuloma representing the accumulation of inflammatory cells was 
observed for the ABC which at 6 weeks was significantly reduced.  Approximately 30% 
of the ABC mass is a high-glycolide yarn; hence, a substantial initial cellular response 
was expected.  Klinge and coworkers investigated the tissue response to fast- and slow-
degrading absorbable surgical meshes.
13
  A fast-degrading mesh revealed an intense 
macrophage response at the mesh/tissue interface that peaked at 14 days, was reduced by 
about four-fold at 21 days, and was reduced to a low level by 90 days.  The inflammatory 
response reported by Klinge was similar to that triggered by the ABC; however, the ABC 
response was shifted approximately one week earlier.  This shift in the ABC response 
may be the result of the additional cellular response to the slow-degrading yarn.  In the 
same article, Klinge reported a lower, but slowly increasing response to the slow-
degrading absorbable mesh.  The simultaneous cellular response against both the 
absorbable components of the ABC may have been additive and contributed to the 
overall observed reaction.  Nevertheless, the cellular response for the ABC was 
significantly diminished, although still present, at the 6 week implantation time period.  
This result is significant.  Although the use of degradable yarns incite an initially strong 
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cellular response, by 6 weeks the inflammatory cell response had subsided to a level 
below that of the non-absorbable PET implant. 
The PETC showed no change in cellular response between 3 and 6 weeks.  
Similarly, an investigation reported in literature, detailing implantation of PET mesh in 
rats showed that the number of macrophages at the mesh/tissue interface did not change 
between 7 and 90 days.
14
  In another study using PET mesh, the total percentage of 
macrophages and giant cells were scored and both were found to peak at 14 days with a 
steady reduction in macrophages, but little change to the number of giant cells through 90 
days.
1
  Overall, the results from the granuloma thickness measurements indicate that 
within the 3 to 6 week time period the ABC elicited an intense initial cellular response 
which was substantially reduced by 6 weeks; whereas, the PETC cellular response was 
initially lower, likely reached steady-state prior to 3 weeks, and was maintained through 
6 weeks. 
Mesh biocompatibility has been reported to be improved when angiogenesis 
accompanies the integration process.
15
  Angiogenesis provides the wound site with a 
conduit for the delivery of inflammatory cells, fluid, and nutrients, while at the same time 
removing metabolic waste.  In this investigation the PETC implants stimulated 
neovascularization at 3 weeks which was sustained at 6 weeks.  On the contrary, the ABC 
implant sites showed no signs of neovascularization.  Neovascularization local to PET 
mesh implants has been reported to be substaintial.
1
  For other mesh-like constructions 
such as vascular grafts, investigations have found that a strong up-regulation of 
inflammatory cytokines is an inhibitor to angiogenesis.
16
  This may explain the lack of 
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neovascularization for the ABC.  The strong inflammatory response observed at 3 weeks 
would likely have produced a strong cytokine response.  If true, the lack of observed 
vascular structures local to the ABC would be consistent with the finding that strong 
inflammatory responses prevent angiogenesis.  For this investigation, the lack of new 
vascular structures for the ABC may be perceived as a positive outcome as the greater 
access of inflammatory cells to the wound site may have increased and prolonged the 
initial strong cellular response. 
A successful hernioplasty requires effective encapsulation of the individual 
bundles of yarn which comprise the mesh to prevent migration and support the local 
tissue.  This event is particularly important for the ABM, which after 6 weeks has 
modulated biomechanical features such that it becomes highly extensible.  The amount of 
collagen between 3 and 6 weeks around the ABC was not found to be different.  
Consequently, the collagen deposition process for the ABC occurs quickly with no 
significant change from 3 to 6 weeks.  However, qualitative changes to the newly 
deposited collagen were apparent from 3 to 6 weeks.  Differences in the collagen capsule 
from 3 to 6 weeks included a reduction in the average capsule thickness (nonsignificant 
change, p = 0.13) surrounding the implant.  As such, the collagen deposition upon 
entering the transition phase (3 weeks) was already established, but the density and 
orientation increased, which was likely the result of the decreased cellular reaction and 
cytokine production.  This observation is important since the collagen capsule must 
possess high mechanical strength, which would be facilitated by a dense and oriented 
structure.  In other words, collagen of high mechanical quality rather than high quantity is 
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optimal.  In contrast, the deposition of collagen increased for the PETC during the studied 
implantation time period.  Unlike the ABC, the capsule formation of the PETC consisted 
of significant amount of low density connective tissue containing many apparent spindle 
shaped fibroblasts.  Consequently, the tissue response was characteristic of a wound 
healing process that results in excessive fibrosis. 
Excessive fibrosis surrounding non-absorbable hernia meshes is well 
documented
17-20
 and is associated with many complications.
14,21-26
  Although collagen 
formation is critical to mesh efficacy, the amount of collagen present at the wound site is 
not a good indicator of mechanical integrity.  For example, it has been demonstrated that 
large amounts of collagen encapsulating a mesh does not prevent recurrence.
1,27
  Loose, 
disorganized collagen which is delayed from reorganization by inflammation lacks 
strength facilitated by the reorganization and crosslinking process.  The ABC appeared to 
down-regulate cellular activity and collagen synthesis which are characteristic markers 
for the initiation of the next wound healing phase of collagen remodeling.  In contrast, the 
high number of proliferating fibroblasts, lack of change in the number of inflammatory 
cells, and intensifying collagen production are consistent with features describing a 
chronic foreign body response against the PETC.  Although fast-degrading absorbable 
polymers have been shown to result in an intense cellular reaction followed by greater 
collagen deposition compared with non-absorbable yarns,
2-5
 the segmented, copolyester 
yarns used in this study evaluated from 3 to 6 weeks did not show greater collagen 
deposition than the PET control.  The observed difference in tissue reaction between MG-
17 and the typical random structured, high-glycolide yarn (e.g. Vicryl) may be in the rate 
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of acidic byproduct production or differences in the temporal fragmentation of the yarn, 
which may shift or reduce fibroblast chemotaxis and/or modify fibroblast phenotype.  
The exact mechanism requires investigation and may hold promise in improving the 
biocompatibility of absorbable meshes. 
 
Conclusion 
Using the ABC as a model of the ABM, the results of this study suggest that 
during the transition phase of the ABM a moderate, but decreasing cellular response and 
the mesh will be well encapsulated without excessive fibrosis.  ABC granuloma thickness 
values representing the accumulation of inflammatory cells were lower at 6 weeks 
compared to that of the non-absorbable PETC control.  Capsule thickness and 
collagen/total protein ratio measurements indicated that the ABC was well integrated 
with a dense, compacted, concentrically oriented capsule.  In contrast, the PETC tissue 
samples had evidence of excessive fibrosis, including a thicker, less dense capsule which 
was with infiltrated fibroblasts.  Although the results must be interpreted with caution due 
to the limited number of animals and observation time points, the ABC showed a down-
regulation of the inflammatory process and good integration.  Additionally, it must be 
stated that results obtained from small animal models have limited translation to clinical 
outcomes; however, the developed knit construct implanted in a gluteal muscle rat model 
does provide a baseline to evaluate relative differences in tissue reaction and implant 
integration for future mesh designs. 
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A COMPARISON OF THE CLINICALLY RELEVANT BIOMECHANICAL 
PROPERTIES OF WARP KNIT, FULLY ABSORBABLE  
BICOMPONENT MESHES WITH TRADITIONAL  




 Mesh hernioplasty is the most common general surgical procedure with more than 
1 million procedures performed annually worldwide.
1-3
  For the last two decades, a so-
called “tension-free” mesh surgical procedure has been considered the gold standard for 
any sizable hernia defect.
4
  The majority of the hernia repairs are completed using meshes 
constructed from non-absorbable polymers, primarily polypropylene (PP), and to a lesser 
extent polyethylene terephthalate (PET).   Although the tension-free, non-absorbable 
mesh approach to hernia repair has been reported to reduce the incidence of recurrence 
compared to primary repair,
5-7
 traditional mesh physicomechanical properties and their 
presence in a permanent biomaterial that alters the biomechanics of the abdominal wall 
has produced several well documented long-term clinical complications.
8-18
  Moreover, 
recent data suggests that while the percentage of inguinal hernia repairs completed with 
meshes has increased dramatically, the percentage of recurrence has only slightly 
decreased.
19,20
  In fact, questions still remain if current meshes are properly designed
21
 
and if recurrence rates are actually reduced or simply delayed as a result of the use of 
traditional meshes.
19,22-24
  Consequently, there still exists an unmet need for a mesh which 
exhibits improved biocompatibility for the repair of abdominal wall defects. 
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A novel hernia mesh design concept which uses a bicomponent, fully absorbable 
mesh that temporally modulates biomechanical properties to meet the expected needs of 
the wound healing process has been suggested (Figure 5.1).
25
  To this end, a bicomponent 
fully absorbable mesh has been developed which provides (1) short-term structural 
stiffness, (2) a gradual transition phase, and (3) long-term force-extensional properties 
similar to the abdominal wall (Chapter 2).  As a critical component of the device, a fast-
degrading, segmented, high-glycolide yarn was developed which has a temporal 
degradation profile that overlaps the expected commencement of the wound strength 






The modulated mechanical characteristics of a bicomponent mesh superimposed with the 




The wound healing process is dynamic with overlapping phases, each of which 
has different biomechanical needs.  A mesh which considers the temporal phases of the 
wound healing process by providing structural stability to the developing extracellular 
matrix and facilitating mechanical stimulation to remodeling collagen may be required to 
improve mesh biocompatibility.  To accomplish this objective a mesh must modulate 
properties with a load transition period (LTP) that is timed to coincide with the 
commencement of wound strength.  Following the transition phase, a compliant mesh 
must prevent stress shielding and allow local tissue to adapt to the perceived external 
loading conditions during the remodeling/maturing process.  After a sufficient time 
period (> 9 months), the slow-degrading mesh should lose integrity and gradually 
transition the load completely to the repair site.  As such, this temporal progression of the 
wound healing process may produce self-sustaining, functional tissue that resists 
recurrence. 
 Abdominal wall biomechanics are complex and largely unknown.  Theoretical 
calculations suggest that a maximum load of 16 N/cm is developed within the abdominal 
wall.
26
  Cobb and coworkers, using bladder pressure to approximate intra-abdominal 
pressure found that the activities of coughing and jumping may result in a maximum load 
of 27 N/cm.
27
  Using the value of 16 N/cm, measurements of harvested abdominal wall 
tissue from male cadavers produced an extension in the sagittal plane of 25% ± 7% and 
transverse plane of 15% ± 7%.
28
  Song and coworkers, using carbon dioxide insufflation 
within the peritoneal cavity, measured a 15 % increase in area with approximately twice 
the strain in the sagittal plane compared to the transverse plane (10.5% vs. 5%).
29
  Other 
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studies have confirmed that the abdominal wall is twice as stiff in the transverse direction 
as in the sagittal direction.
30
   The investigated shutter mechanism at the inguinal canal 
suggests the mesh must be able to accommodate uniaxial deformation.
31
  Investigations 
by Peiper and coworkers suggests that the transversalis fascia is predominately loaded by 
intra-abdominal pressure.
32
  As such, the mesh must distend in multiaxial directions to a 
distributed perpendicular load.  Nevertheless, it is well accepted that the abdominal wall 
is a composite laminate structure of connective tissue which allows expansion or 
contraction in multiple planes simultaneously.
33
  Logic suggests that a mesh placed on the 
abdominal wall will be required to accommodate uniaxial distension (lateral forces from 
muscle/aponeurotic structures) and non-isotropic, multiaxial distension (intra-abdominal 
pressure).  Consequently, the evaluation of mesh biomechanics should include uniaxial 
(tensile) and multiaxial (burst) modes of deformation.  Furthermore, since the mesh does 
not act alone but rather as a mesh/tissue complex, it is clinically pertinent to measure 
mesh biomechanics as a composite structure. 
Mesh biomechanics are determined by the design variables of yarn chemistry and 
the textile characteristics of knit construction (knit pattern, stitch density, secondary 
processing), yarn type (monofilament or multifilament), and yarn size (diameter/denier).  
Collectively, these design variables control the clinically-relevant mesh properties of area 
weight, porosity, suture pullout force, tear resistance, flexural rigidity, maximum burst 
force, and the force-extension profile (FEP) response.  Each mesh property is regulated 
by at least one, but generally two or more design variables.  As a consequence of the 
number of design variables and the significant interaction between variables on each 
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mesh property, a countless number of mesh designs are possible.  As a result, hernia 
meshes differ widely in physical and biomechanical properties.  For example, reported 
data for several commercially available hernia meshes showed that extension at 16 N/cm 
values varied from 3.5% to 31.0%.
28
  This extreme variation in functional characteristics 
highlights the importance of careful consideration for the impact of each design variable 
on biomechanics.  For a given yarn chemistry and knit construction, the biomechanical 
properties will be drastically different when the fiber type is changed from monofilament 
to multifilament.  The same is true for yarn size; however, knit construction is the most 
influential variable on mesh biomechanical properties. 
Usher introduced the first knitted, monofilament, PP mesh into clinical practice in 
1963.
34
  It was estimated in 2000 that 80% of the 750,000 inguinal procedures performed 
in the United States use the same material and basic mesh design invented by Usher 
almost four decades earlier.
35-37
  Today the overwhelming major of meshes used 
worldwide are still monofilament PP meshes.  Recently, the use of light-weight (LW) 
meshes has received significant attention in literature
37,38
 as a replacement to the so called 
“heavy-weight” (HW) traditional monofilament PP mesh.  The LW mesh concept focuses 
on lowering area weight and changing the knit construction to an open structure (larger 
pore sizes).  Additionally, some LW mesh constructions incorporate absorbable yarn to 
produce a partially absorbable (PA) mesh which loses 50%, or more, of original mass in 
vivo.  The primary objective for the addition of absorbable yarn is to augment the strength 
and bending stiffness of the mesh to improve handling characteristics and reduce the 
long-term foreign body reaction and fibrosis.
39-42
  However, this concept has been 
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challenged and it has been suggested that mesh area weight alone is not a good metric for 
biocompatibility.
43,44
  Nonetheless, large pore sizes from 1 - 5 mm and area weights that 
are 25-40% of HW meshes are typical of LW meshes.  Most LW mesh designs use 
monofilament PP yarn and some match the extension of the abdominal wall at the 
maximum physiologic condition (16 N/cm).
26,28
  As a result, LW meshes restrict 
abdominal wall mobility less than HW meshes
45
 and there is evidence that their use 
results in less chronic groin pain.
46-51
  LW mesh explants from animal studies have 
demonstrated good tissue incorporation and mechanical strength.
52
  In one study, explants 
from a canine animal model using LW and HW mesh produced comparable mesh/tissue 
strength after 90 days even though the LW mesh possessed 3.6 times lower initial 
strength.
53
  However, randomized clinical trial results using LW mesh have not been 
encouraging.  Several clinical studies using LW meshes have shown no reduction in 
patient complications,
2,54-57
 and others have noted an increase in recurrence rates.
58-60
  In 
essence, data from animal studies indicate that LW meshes may improve the quality of 
collagen within the mesh and clinical data suggest patients experience less chronic pain; 
though this may be, there is no clear clinical advantage with regard to minimizing long-
term complications and recurrence. 
Key objectives of the presented study are (1) to characterize the temporal 
modulation of the clinically-relevant physical and biomechanical mesh properties of two 
different absorbable bicomponent mesh (ABM), and (2) to compare the physical and 
biomechanical properties of the investigated ABM with traditional meshes used for 
hernia repair. 
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Materials and Methods 
Mesh Materials and Construction 
Traditional Meshes 





 (PET).  Both meshes are manufactured by Ethicon, Inc.  Prolene
®
 is a 





knit from multifilament PET yarn using a knit pattern that produces 
a light-weight, open pore construction which contrasts that of Prolene
®
.  Each mesh 
approximates the upper and lower bounds for the physical and mechanical properties 
associated with traditional meshes. 
 
Absorbable Yarns 
The polymer synthesis and production of yarn for the polymers of MG-17 
(Chapter 3) and SMC-7 were previously described (Chapter 2).  In summary, MG-17 is a 
triaxial, segmented, high-glycolide polymer that is melted extruded into a 10-filament 
yarn.  SMC-7 is a linear, segmented, high-lactide polymer that is melt-extruded into a 43-
filament yarn.  The denier (g/9000 m) of the MG-17 and SMC-7 yarn is 150 and 86, 
respectively. 
 
Absorbable Bicomponent Mesh 
Warp knitting was completed by co-knitting two different knit patterns, then 
setting with heat to stabilize each mesh construction.  Using MG-17 and SMC-7 yarns, 
 205 
warp knitted absorbable bicomponent meshes (ABM), WK6 and WK7, were prepared 
using a two-step process of warping yarn onto beams and knitting meshes using a raschel 
knitting machine (American LIBA, RACOP TR-6).  The warping process began with 
preparing packages of each yarn type which were loaded into a creel and wound onto 
beams using a warper (American LIBA, GE203A).   A total of 90 ends of yarn were 
wound onto four beams, two holding a two-ply SMC-7 yarn and two holding a single-ply 
MG-17 yarn.   Meshes were constructed using different knit patterns for the SMC-7 yarn 
between the two constructions of WK6 and WK7. 
To accommodate heat setting on circular mandrels, flat mesh sheets were edge 
sewn into a tube using a standard sewing machine (Brother International, LX3125) and 
high-strength polyethylene terephthalate yarn.  Knit mesh of both types was heat set by 
stretching the tubular mesh over a stainless steel circular mandrel.  Heat setting was 
completed at 120°C for 1/2 hour while under high vacuum (< 1 torr).  Meshes were then 
cut from the mandrel to produce a stabilized sheet of mesh which was 210 mm wide.  
Digital images of the PP, PET, and ABM were obtained using a digital camera (Cannon 
USA, EOS 20D) equipped with a macro lens and mounted on a stand.  In addition, 
images were obtained of each ABM following the removal of the MG-17 yarn.  Meshes 
of the SMC-7 yarn only were obtained by removing the MG-17 yarn from each ABM by 





Simulated Mesh/Tissue Complex Construction and Properties 
Simulated mesh/tissue complex (SMTC) samples of each investigated mesh were 
prepared by constructing a silicone/mesh composite structure.  Part A and B of the 
silicone elastomer (NuSil Technology, Med 4950) were mixed in equal parts using a 1 
liter stainless steel kettle and mechanical paddle wheel stirring apparatus.  To facilitate 
the diffusion of water into the silicone, 10% by weight of polyethylene glycol (PEG; 
Sigma-Aldrich, Mn = 4,600) was added and evenly dispersed during the mixing process.   
Silicone/mesh composites were molded using four stacked stainless steel plates (20 x 20 
cm) of 1.5 mm thickness. The centers of the middle two plates were cut out (10 x 10 cm) 
which created the cavity of the mold.  Mesh was placed between the middle two mold 
plates, filled with the uncured silicone/PEG elastomer, compressed for 10 minutes under 
a pressure of 2.4 MPa  (Carver Press, Model 3895), placed under reduced pressure (< 2.5 
torr) for 1/2 hour to remove trapped air pockets, and cured at 45°C for 7 days.   Cured 
SMTC samples were 3.5 ± 0.2 mm thick, with the mesh centrally located with respect to 
the thickness. 
 
Mesh Physical Properties 
Accelerated In Vitro Conditioned Degradation 
Long-term mesh physical properties, simulated by using only the SMC-7 yarn 
component of the mesh, were determined for WK6 and WK7 meshes following the 
degradation and removal of the MG-17 yarn under accelerated in vitro degradation 
conditions.  A 0.1 M solution of buffered sodium phosphate was pH adjusted using 5.0 M 
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sodium hydroxide (Sigma-Aldrich, cat#221465) to a target value of 12.0pH.  Using the 
prepared medium, samples were incubated in 50 mL tubes (VWR International, 
cat#14231-880) at 50ºC under static conditions for 7-9 days until the MG-17 component 
was significantly hydrolyzed.  Thereafter, samples were scoured in isopropyl alcohol 
under ultrasonic agitation (Branson, 5510) to remove MG-17 yarn fragments followed by 
drying under reduced pressure (< 1.5 torr) to a constant weight. 
 
Mesh Area Weight 
The determination of mesh area weight followed option C in ASTM D3776-07 
standard test method for mass per unit area of fabric.  Specifically, the area weight for 
each mesh construction was determined by first using a lever arm fabric cutter to cut 10 
cm x 15 cm rectangular samples of annealed mesh.  Each sample was then weighed 
(Mettler Toledo, AB204-S) to the nearest one thousands of a gram.  The following 




 For meshes, thickness is measured as the distance between the upper and lower 
surfaces of two plates compressed against the mesh and subjected to a specified pressure.  
Mesh thickness was determined using the procedure as outlined in the ASTM D1777-96 
standard test method for thickness of textile materials.  Using a lever arm fabric cutter, 
random 57 mm x 57 mm square samples of the annealed mesh were obtained for 
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evaluation.  Each sample was measured in the center of the mesh swatch using a 
comparator (B.C. Ames, 05-0191) gauge.  The comparator gauge was equipped with a 
28.7 mm diameter foot and used a 9 ounce weight to apply the standardized pressure to 
the mesh. 
 
Weight Ratio of the Bicomponent Constituents 
 The relative weight ratio of the fast and slow degrading component was 
determined by solvent extraction of SMC-7 from the composite using dichloromethane 
(DCM).   Three random 57 mm x 57 mm square samples of annealed mesh were obtained 
and weighed (Mettler Toledo, AB204-S).  Next, all three samples were placed in 200 mL 
of DCM for 30 minutes while under constant orbital agitation at room temperature.  
Samples were removed from DCM, rinsed using acetone, and dried under reduced 
pressure (< 1 torr) to a constant weight.  The initial weight of the three composite 
samples (Wi) and the final weight of the MG-17 yarn component (Wf) were used in the 




 Mesh porosity was characterized as (1) a percentage of the mesh covered by pores 
and as (2) the mean pore size.  Photographic images were obtained using a microscope 
equipped with a camera (Cannon USA, EOS 20D) and evaluated using NIS Elements 
(Nikon Instruments, Inc) software.  The total pore area, or open apertures, for each mesh 
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was calculated from an obtained image that contained at least 20 large apertures.  
Manipulation of the images was performed by high-contrast colorizing of the pores 
followed by software determination of the color covered area.  Using this information, 
the fraction of area covered by pores compared to the total area was determined as a 
percentage.  Using the same image, individual pores were analyzed with respect to area.  
Since pore shapes are highly variable, both within and among different meshes, the area 
of individual pores were recalculated to an equivalent average pore diameter and reported 
as such. 
 
Mesh Mechanical Properties 
In Vitro Conditioned Degradation 
Samples evaluated for mechanical testing following in vitro degradation were 
conditioned using a 0.1 M solution of buffered sodium phosphate in 50 mL tubes at a 
7.2pH.  Buffered sodium phosphate was prepared by adding 23.3 grams of dibasic 
(K2HPO4; Sigma-Aldrich, ACS ≥ 98%) potassium phosphate and 9.0 grams of 
monobasic (KH2PO4; Sigma-Aldrich, ACS ≥ 98%)) potassium phosphate into 2 liters of 
deionized water and stirred until dissolution.  A pH meter (Symphony, SB80PI) was used 
to verify a 7.2pH measurement and slight adjustments were made to using 0.5 M 
hydrochloric acid (HCl; Sigma-Aldrich, ACS reagent).  Tubes (VWR International, 
cat#14231-880) containing buffer and 4 to 5 mesh samples were placed in racks and 
incubated at 37°C under constant orbital-agitation (Innova 4300) at a speed of 28 
revolutions per minute.  Mesh samples were removed at predetermined time periods of 1, 
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2, 3, 4, 8, 12, 16, 20, 28, 34, and 39 weeks for mechanical properties testing.  For SMTC 
samples, in vitro conditioning was conducted for one day (initial) to hydrate the silicone 
and at the predetermined time period of 8 weeks. 
 
Tensile Properties 
Tensile testing of 2.5 cm wide strips of mesh and SMTC samples was conducted 
using a universal testing machine (MTS, Synergie 100) equipped with a 500 N load cell 
and a set of wedge grips (Chatillon, GF-9).   Each sample was tested using a gauge length 
of 25.4 mm and constant cross-head traverse of 2.33 mm/s.  FEP data was extracted from 
the system software (TestWorks 4.0) to construct FEP curves. 
 
Burst Properties 
Burst mechanical testing of mesh and SMTC samples was conducted using a 
universal testing machine (MTS, Synergie 200) equipped with a 1 kN load cell.  The ball 
burst test fixture geometry was determined from ASTM D3787-07 standard test method 
for bursting strength of textiles-constant-rate-of-traverse ball burst test.  The MTS 
machine was connected to a data acquisition computer and software (TestWorks 4.0) that 
recorded the force and displacement of the steel ball.  Tests were performed using a 2.54 
cm/min constant-rate-of-traverse for the ball.  Prior to the initiation of the test, a 0.1 N 
preload force was placed against the mesh by the ball.  For each test the maximum burst 
force obtained during the test (N) and the extension at 71N load (mm) were recorded.  
The extension at 71 N was used to determine the elongation at 16 N/cm.  The value of 71 
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N is derived from the diameter of the opening in the clamp plate (4.44 cm x 16 N/cm = 
71 N).  A detailed explanation of the mathematical expression which relates the linear 
travel of the ball (mm) to the extension at 16 N/cm (%), can be found in Appendix A.  
FEP data for each investigated mesh and SMTC was exported from the data acquisition 
software to construct FEP curves. 
 
Mesh Flexural Stiffness 
 Mesh flexural stiffness was measured according to the cantilever test method as 
described in option A of ASTM D1388 standard test method for stiffness of fabrics.  Test 
samples were cut to the dimension of 20 mm x 150 mm in the course and wale directions.  
Test specimens were slid at a constant speed of 120 mm/min until the edge of the 
specimen deflected under its own mass and touched the knife edge, which was set to a 
41.5  angle.  The length of the overhang, to the nearest 0.1 cm, was measured on the 
knife edge scale at the point of contact and recorded as the overhang length (OL).  The 
mass per unit area (w) was expressed in mg/cm
2
.  The following formulas were used to 
calculate the bending length and flexural stiffness: 
  Bending length c = OL / 2 (cm) 




Suture Pullout Force 
The suture pullout force test was completed using a universal testing machine 
(MTS, Synergie 200) and a set of wedge grips (Chatillon, GF-9).   Using a lever arm 
fabric cutter, fourteen 20mm x 50mm samples were cut from each mesh type, seven 
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samples with the 50mm length direction corresponding to the course direction and the 
other seven in the wale direction. In the course direction, half of each sample was 
clamped in the lower wedge jaw and a 2/0 monofilament polypropylene suture was 
threaded through the mesh at a distance of 6-9 mm from the upper edge.  The ends of the 
suture were secured in the upper wedge grip and the test was completed at a speed of 75 
mm/min.  The maximum force obtained during the test was recorded for each sample. 
 
Tear Resistance 
Tear resistance testing was conducted using a universal testing machine (MTS, 
Synergie 200) and a set of wedge grips (Chatillon, GF-9).  Samples measuring 30 mm x 
80 mm were cut in the wale and course directions for each mesh type.  To initiate the 
location of the tear, a 10 mm deep defect was created from one edge at the midpoint of 
the 80 mm long side.  Each mesh was secured in the grips with the 10-mm slit centered 
between a 20 mm gauge length.  Testing was conducted at 50 mm/min and the maximum 
force obtained during the test was recorded. 
 
Statistical Analysis 
Significant differences in physical properties between initial and in vitro 
conditioned ABM and the traditional meshes were completed using a student‟s t-test to 
compare means.  For temporal in vitro conditioned ABM, a two-factor analysis of 
variance (ANOVA) was used to test for effects due to time and mesh construction for the 
response variables of maximum burst force (MBF) and extension at 16 N/cm.  All 
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analysis was completed using statistical analysis software (SAS, version 9.2) and a p-
value less than 0.05 was considered to be significant. 
 
Results 
Mesh Materials and Construction 
Figure 5.2 provides comparative images of each mesh construction. Figure 5.3 
provides comparative images of each traditional mesh, PP and PET, and each ABM 
construction, both initially and following the accelerated in vitro conditioned degradation 













Images of the knit construction for the WK6, WK7, PP, and PET meshes.  (a) WK6 mesh 
(b) WK7 mesh (c) SMC-7 yarn component of the WK6 mesh (d) SMC-7 yarn component 
of the WK7 mesh (e) PET
 
mesh (f) PP mesh (Red scale bars = 1 mm) 
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Mesh Physical Properties 
Table 5.1 lists the clinically-relevant physical properties of each evaluated mesh.  
The WK6 and WK7 meshes were also evaluated following accelerated in vitro 
conditioning to assess the long-term physical properties following the substantial 




Initial and In Vitro Conditioned Mesh Physical Properties for the ABM, PET, and PP (n = 


















Initial 530  ± 30 138  ± 3 34.4 ±  1.7 698 ± 27  281 - 1068 
In Vitro 
Conditioned 
362 ± 12† 82 ± 4† 37.7 ± 1.4 1180 ± 64 368 - 1568 
WK7 
Initial 626 ± 15  146 ± 2   21.8 ± 0.6  543 ± 20† 230 - 1063 
In Vitro 
Conditioned 
351 ± 10† 102 ± 2 24.7 ± 1.9 601 ± 43† 252 - 1173 
PET 266 ± 13  41 ± 2  59.8 ± 2.0  930 ± 43 827 - 983 
PP 514 ± 10  83 ± 6†  44.9 ± 1.7  555 ± 21† 445 - 752 
*Ratio of constituents determined by solvent extraction of SMC-7 for the ABM: WK6 = 41 ± 1%; WK7 = 31 ± 1% 
† Indicates corresponding samples that were not found to be significantly different (p > .05) 
 
 
The mesh thickness was significantly reduced following in vitro conditioning for 
both ABM.  The thickness of the ABM were initially thicker than PP (514 µm) but after 
in vitro conditioning the WK6 and WK7 meshes were thinner with values of 362 µm and 
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351 µm, respectively.  The in vitro conditioned area weight measurement for the WK6 
was significantly lower than that of WK7 and not different than PP.  The thickness and 
area weight of PET was substantially lower than any other evaluated mesh. 
Following the in vitro conditioned degradation of MG-17, the mean pore diameter 
for the WK6 mesh increased from 698 µm to 1180 µm (p<.001) which increased the 
maximum value of the range by 47%, from 1068 µm to 1568 µm.  To a lesser degree, the 
WK7 mesh showed a significant increase in pore area (p = 0.022) with a marginally 
significant change in mean pore diameter (p = 0.053).  In addition, for the WK7 mesh the 
maximum value of the range slightly increased by 11% from 1063 µm to 1173 µm.  The 
pore area for the traditional meshes was significantly greater than either ABM.  However, 
the mean pore diameter for the in vitro conditioned WK6 was greater than all of the other 
evaluated meshes at 1180 µm.  The pore diameter for WK7 and PP were not different (p 
> .102) and were significantly smaller than those of the WK6 and PET.  Overall, the in 
vitro conditioned WK6 had the largest pore diameter with the largest pores being 37% 
and 52% greater than PET and PP, respectively. 
 
Mesh Mechanical Properties 
Mesh mechanical properties listed in Tables 5.2 and 5.3 were evaluated to 
determine differences in initial strength, stiffness, and extensibility for each mesh using 
clinically-relevant test methods.  PET produced the lowest and most isotropic suture 
pullout force, tear resistance, and flexural stiffness of the investigated meshes.  The ABM 
and PP mesh were at least twice the value of PET for each of the tested mechanical 
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properties.  The ABM and PP produced significant resistance to tearing.  Of the three 
meshes, a mean range of 78.4 N to 146.9 N was observed.  Flexural stiffness 
measurements indicated that PP mesh was significantly stiffer than all of the other 




Suture Pullout Force, Tear Resistance, and Flexural Stiffness Data for the ABM and 
Traditional Meshes (n = 7) 
 
Property  WK6 WK7 PP PET 





Mean 54.0• 37.0‡ 48.3• 37.2‡ 49.5• 67.5 14.7† 14.1† 
SD 3.8 3.2 2.6 4.0 9.4 7.6 1.1 1.9 
Min 46.7 34.1 45.1 30.8 39.0 55.7 12.8 11.0 




Mean 78.4 132.1‡ 95.4 146.9‡ 137.2‡ 112.1 47.4† 34.8† 
SD 8.2 13.9 8.8 8.8 22.9 14.4 5.2 4.1 
Min 68.7 107.9 81.7 132.6 118.5 90.3 37.5 30.1 




Mean 234.2‡ 299.0‡ 177.3 272.2‡ 645.4 454.8 22.5† 8.5† 
SD 31.7 85.1 44.1 48.4 31.2 89.2 3.4 0.8 
Min 195.2 199.4 111.2 192.6 605.4 342.1 17.4 7.4 
Max 301.1 450.5 257.1 340.4 700.5 580.5 26.0 9.6 




Burst Test Data for the ABM and Traditional Meshes (n=7) 
 
 




Mean 421 602 839 184 
SD 23 26 61 4 
Min 393 582 774 179 




Mean  5.5†     6.1† ‡  6.4‡ 11.6 
SD 0.3 0.2 0.9 0.4 
Min 5.2 5.9 5.8 11.3 
Max 5.8 6.4 7.6 12.1 
† ‡ Indicates corresponding samples that are not significantly different (p > .05) 
 
 
From the burst test data it is obvious that the maximum burst force between each 
evaluated mesh varied considerably.  PP mesh was the strongest, producing about 4.5 
times the resistance to central burst as that of PET mesh.  The ABM were markedly 
different as well with 421 N and 602 N burst force values for the WK6 and WK7 meshes, 
respectively.  However, the WK6, WK7, and PP meshes all exhibited similar extensibility 
at 16 N/cm.  In addition to being the weakest, PET mesh was the most extensible 
producing nearly twice the extension at 16 N/cm as each of the other meshes. 
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† ‡ Indicates samples from 8 to 39 weeks that have significantly different burst force than those recorded at the 4 week 




The temporal in vitro conditioned maximum burst force for the ABM during mechanical 
burst testing (7.2pH, 37ºC).  Initial burst test data obtained for PET and PP, as well as the 
maximum physiologic burst force at 16 N/cm, has been included for comparison (n = 
minimum of 4). 
  
 
Figures 5.4 and 5.5 depict the effect of in vitro conditioned degradation on 
temporal changes in maximum burst force and extension at 16 N/cm.  The failure of mesh 
burst test samples was centrally located and at no time did the mesh slip between the 
plates.  At each time period, the WK7 mesh exhibited a significantly greater maximum 
burst force (all p < .001) with mean values at least 62 N greater than that of the WK6 
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mesh.  Both ABM experienced a significant reduction in maximum burst force during the 
first 2 weeks (all p < .005) which was followed by an inflection and slight increase in 
maximum burst force from 2 to 4 weeks.   Beyond 4 weeks, the WK6 mesh produced a 
reduction in burst force at 28 weeks which was unchanged through 39 weeks (9 months).  
Beyond 4 weeks, the WK7 mesh first realized a significant reduction at 39 weeks (p = 
.011).  Both ABM types showed maximum burst force values at 39 weeks which were at 
least twice that of the maximum physiologic burst force. 
 
† ‡ Indicates a significant difference from the previous time period for the WK6 (†) and WK7 (‡) meshes (p < .05) 




The temporal in vitro conditioned extension at 16 N/cm for the ABM during mechanical 
burst testing (7.2pH, 37ºC).  Burst extension at 16 N/cm test data obtained for PET and 
PP have been included for comparison.  In addition, the minimum physiologic extension 
at 16 N/cm (25% ± 7%) has been shown as a reference (n =  minimum of 4). 
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 Figure 5.5 depicts the extension at 16 N/cm for the ABM during burst testing.  
For the first 14 days of in vitro conditioning, the ABM possessed an unchanged, low 
level of extension (all p > .266) that was similar to that of the PP mesh.  In the subsequent 
days, a transition in the extension at 16 N/cm for the ABM was realized between the time 
periods of 2 and 8 weeks and 2 and 4 weeks for the WK6 and WK7 meshes, respectively.  
Beyond 8 weeks, no change for either ABM was observed (all p > .123).  No difference 
in extension at 16 N/cm was observed between the ABM from 8 to 34 weeks.   
Furthermore, both ABM approximated the minimum physiologic extension at 16 N/cm 
(18%) of the abdominal wall after 4 weeks and maintained this degree of extensibility 
through 39 weeks.  Although not statistically significant until after 34 weeks, the mean 






FEP data for burst testing of ABM, PET, and PP meshes.  ABM results are shown of 
initial phase (stability phase), at 3 weeks (transition phase), and at 8 weeks (remodeling 
phase) of in vitro conditioning (7.2pH, 37ºC).  The dotted red line represents the range 




In Figure 5.6, FEP data in the burst test mode is depicted for the resistive 
mechanical force of different meshes over the entire range of applied strain until failure.  
With the exception of the 3 week in vitro data for the ABM, each set of data exhibited a 
curved profile which transitioned to a linear response until failure.  However, the 
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curvature, transition point, and slope of the linear portion of each profile were drastically 
different among the meshes and within the different in vitro time periods of the ABM.  In 
general, the different profiles can be segregated into three groups of high, moderate, and 
low structural stiffness.  The first group contains the initial ABM (stability phase) and PP 
mesh.  Each of these meshes produced profiles that exhibited an initial curvature with a 
transition by 5% extension into a high stiffness, linear response until failure at a force 
significantly above the physiologic maximum value.  The moderate group contained the 3 
week in vitro conditioned ABM (transition phase) and PET mesh.  PET was slightly less 
resistant up to about 12% extension where its stiffness increased at a greater rate than the 
ABM.  The ABM showed an almost linear response with a level of structural stiffness 
that divided its initial and long-term FEP response.  Finally, the third group consisted of 
only the 8 week in vitro conditioned ABM.  Each ABM started with a low level of 
stiffness that gradually transitioned into a linear response.  The 8 week in vitro 
conditioned ABM were the only samples which passed through the range of force-
extension values which represented the maximum physiologic loading condition of the 
abdominal wall. 
 
Simulated Mesh/Tissue Complex Properties 
 Figures 5.7 through 5.10 depict the burst and tensile FEP response of mesh and 
SMTC samples using ABM and traditional meshes.  Results showed that the resistive 
force to an applied strain increased for SMTC samples.  However, for meshes that 
showed high structural stiffness, the relative difference between the mesh and 
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corresponding SMTC sample was negligible.  For example, the high degree of mesh 
structural stiffness dominated the resultant FEP for SMTC samples during the burst 






FEP data for multiaxial burst testing of SMTC using traditional meshes.  The dotted red 
line represents the force-extension range associated with the maximum physiologic 




In Figures 5.7 and 5.8, only the 8 week in vitro conditioned ABM produced a FEP 
which exhibited lower stiffness than the simulated matrix (silicone) up to approximately 
10-12% of mesh extension.  Burst tested 8 week in vitro conditioned ABM samples 
passed through the range of force-extension values which represented the maximum 
physiologic loading condition of the abdominal wall.  However, the WK6 SMTC 
produced a FEP profile that was almost linear with an extension at 16 N/cm and was 
slightly below the maximum physiologic range (~ 15%).  In comparison, the WK7 








FEP data for multiaxial burst testing of SMTC using ABM.  Data are from the initial 
(stability phase) and the 8 week (remodeling phase) in vitro conditioned samples (7.2pH, 
37ºC).  The dotted red line represents the force-extension range associated with the 
maximum physiologic loading condition of the abdominal wall (16 N/cm). 






FEP data for uniaxial tensile testing of SMTC using PET and PP mesh in the course 
direction.  The dotted red line represents the maximum abdominal wall loading condition 
(16 N/cm). (25.4 mm extension represents a strain equal to 1) 
 
  
FEP data for uniaxial tensile testing depicted in Figures 5.9 and 5.10 showed that, 
for low strain values, the 8 week in vitro conditioned ABM exhibited lower stiffness than 
the simulated matrix.  Similar to the result observed during burst testing, the WK6 SMTC 
possessed a greater degree of extension at 16 N/cm than did the WK7 SMTC.  Unlike the 
response for burst testing, PET mesh produced an initial low stiffness FEP response for 
uniaxial testing which was below the simulated matrix.  In the form of a SMTC, the PET 
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mesh possessed increased stiffness, but did maintain a level of extensibility similar to the 
WK6 SMTC.  The PP mesh was stiffer than the simulated matrix for all strain values in 






FEP data for uniaxial tensile testing of SMTC using ABM in the course direction.  
Depicted data for the initial (stability phase) and the 8 week (remodeling phase) in vitro 
conditioned samples (7.2pH, 37ºC).  The dotted red line represents the maximum 
abdominal wall loading condition (16 N/cm). (25.4 mm extension represents a strain 
equal to 1) 
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Discussion 
Biocompatibility is a complex concept that continues to evolve as research 
uncovers the cause and effect relationship of biochemical and biomechanical influences 
on the pathology of disease and wound healing.  The active stimulation or 
suppression/allowance of biological responses, consideration for cellular signaling 
through biochemical and biomechanical pathways, and recognition that the inertness of 
the biomaterial is not the only mediator of biocompatibility have increasingly been 
recognized as important design considerations.  Historically, HW meshes have been 
designed to produce a perceived mechanically robust repair site, due to their significant 
strength, and to have minimal interaction with the biological environment due to the use 
of inert PP monofilament yarn.  However, these meshes have not taken into account the 
concepts of establishing early wound site stability and restoring physiologic abdominal 
wall biomechanics in the long-term.  The influence of mesh biomechanics on the cellular 
and extracellular matrix (ECM) responses of the wound healing process may be critical to 
improving mesh biocompatibility. 
As a primary design objective, a surgical mesh must exhibit mechanical properties 
that prevent acute catastrophic failure of the device.  In particular, the mesh should have 
mechanical integrity such that the mesh does not centrally burst, tear from an edge, or 
allow the suture to pull through an edge.  ABM exceeded mean suture retention values 
reported for fascia (16.9 N).
61
  Furthermore, suture pullout force and tear resistance 
values for the ABM were significantly greater than PET, comparable to that of PP, and 
similar to values reported elsewhere.
38,62
  All and all, reports of the mechanical failure of 
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traditional meshes are uncommon; the mechanical strength properties of the ABM mesh 
were greater than PET and similar to PP.  Hence, the mechanical integrity of the ABM is 
expected to resist acute failure.  In spite of the rare reports of traditional mesh acute 
mechanical failure, mesh complications due to planar migration and tissue erosion is a 
documented complication. 
Logic suggests that a mismatch between the implant flexural stiffness and the 
surrounding tissue will cause erosion in the latter.  Results of this study were consistent 
with other findings that HW PP monofilament meshes possess high flexural stiffness.
63
  
As a result, HW meshes have significant structural memory with a limited ability to 
conform to anatomical structures.
64
  As a consequence, the use of HW meshes has been 
implicated in tissue erosion with potentially severe complications.
65
   For example, the 
mesh can erode into the abdominal cavity causing visceral adhesions and/or fistula 
formation.
19
  Yarn form, type, and construction are mesh design factors which affect 
flexural stiffness.  Multifilament yarn morphology provides flexibility and drapability 
which is essential to the conformation of the mesh to anatomical structures.  Despite the 
potential clinical advantages, the use of multifilament yarn for meshes has been limited 
due to reports of increased infection rates.
66-70
  Therefore, stiff monofilament meshes 
have gained favor but with the unintended consequence of increased flexural stiffness and 
reduced extensibility.  The very fine filament and open pore construction of the PET 
mesh produced substantially lower flexural stiffness values than all of the other tested 
meshes.  Flexural stiffness measurements show that the ABM provides a high level of 
conformity even during the initial noncompliant stability phase.  Although flexural 
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stiffness measurements were not made on in vitro conditioned samples of the ABM, 
stiffness values close to those determined for PET would be expected due to the similar 
multifilament, open pore construction.  As a result, the likelihood of the mesh to erode 
through adjacent tissue layers would be reduced.  With respect to infection, the 
absorbable multifilament yarn used to construct the ABM may have less susceptibility to 
infection than meshes constructed from nonabsorbable multifilament yarn.  For instance, 
the fast-degrading yarn creates a dynamically changing mesh surface with the substantial 
loss of approximately one-third of the meshes mass within 3 months.  Moreover, the 
median interval for late-term infection has been reported to be 2 years;
71
 at this time 
period the slow-degrading mesh component will be substantially degraded and 
macrophages will have access to any harbored bacteria.  In a similar manner, absorbable 
suture (Vicryl
®
) has been documented to be more effective at preventing surgical site 
infection than a nonabsorbable suture.
72
   
Although the design of meshes to resist maximum physiologic conditions is 
critical to preventing acute device failure, improved biocompatibility will likely be 
achieved from evaluating and optimizing sub-failure mesh biomechanics.  It is common 
to characterize the extension of hernia meshes using a single data point (extension at 16 
N/cm) representing the maximum physiologic loading condition; however, to date the 
FEP response of meshes has been given minimal attention.  The evaluation of FEP data 
illustrates mesh biomechanics at sub-failure or normal physiologic conditions.  
Unfortunately the exact FEP of the abdominal wall is not well established.  However, 
current knowledge indicates that the profile passes through a range of extension values 
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associated with the maximum physiologic condition.  For burst testing, the strength and 
force-extension response of each mesh has relevance within an evaluation window 
bounded by the maximum physiologic force
26
 (< 71 N for 16 N/cm) and the maximum 
expected physiologic extension at that force (< 32%).
28
  For uniaxial tensile testing it 
should be noted that only low to moderate (strain < 1) levels of uniaxial deformation are 
clinically -relevant.  Significant changes to the mesh length/width aspect ratio are limited 
clinically by secured mesh edges and pores, which are infiltrated with tissue. 
To better simulate the in vivo environment, sub-failure biomechanical FEP data 
for each mesh was investigated in a simulated mesh/tissue complex (SMTC) model at 
physiologic loading conditions.  The silicone simulated matrix does not precisely 
replicate ECM biomechanics; rather, it provides a synthetic analog which is reproducible 
and homogenous to evaluate the effect of ECM infiltration on different mesh designs.  As 
such, the SMTC can illustrate mesh stress shielding of the matrix and alterations in mesh 
biomechanics due to the wound healing process. 
Early wound stability facilitated by the mesh may be an important factor in the 
timely resolution of the wound healing process.  The healing processes for soft tissue 
where significant amounts of granulation tissue are formed, as is the case for secondary 
intention dermal wounds, require early wound stability.  A scab functions to provide 
stability to a dermal wound site and to temporarily shield the fragile soft tissue from 
external insults.
73
  Also, the importance of initial implant stability during bone healing is 
increasingly being recognized.  Primary stability of the implant for the first 2-3 weeks, 
which facilitates secondary stability created by the deposition of bone, expedites the 
 233 
wound healing process for endosseous implants.
74
  In a similar manner, the ABM will 
provide stability until the ECM is anchored into the surrounding tissue.  The initial 
healing response to a foreign body, such as a mesh, includes high cellular activity with 
abundant deposition of fragile, immature collagen as the body attempts to isolate the 
implant.  During the inflammation and early in the proliferation phase, the developing 
collagen has practically no strength and an externally applied strain can disrupt the 
developing ECM and vascular constructs.  Therefore, stabilization of the neotissue will 
minimize disruptions that slow the wound healing process and stimulate the production of 
pro-inflammatory cytokines. 
Compared to traditional meshes, the observed significant resistance to uniaxial 
and multiaxial induced strain by the ABM will improve early stability of neotissue.  The 
FEP response for multiaxial burst testing of the ABM, PET, and PP meshes using the 
SMTC model showed a high degree of stress and strain shielding.  Additionally, the 
ABM SMTC also significantly resisted deformation during uniaxial tensile testing.  This 
unique biomechanical response is the result of the knit pattern of the interpenetrating fast-
degrading yarn which constrained pore deformation.  Consequently, the ABM shielded 
an externally applied strain by resisting the relative displacement of mesh pores in 
multiple axes.  As such, during the initial phases of wound healing the ABM more 
closely emulated the stiffness of a woven, rather than a knitted structure.  This novel 
biomechanical stability may have clinically -relevant advantages such as reduced 
recurrence rates and less mesh contraction (Chapter 2).  In addition, the structural 
stability of such a knitted structure improves surgical handling and placement.  Following 
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the early stability phase for the ABM, the substantial degradation of the fast-degrading 
yarn temporally modulates biomechanical properties such that load is partially, and 
eventually fully, transferred to the ECM. 
The ABM concept results in two load transfer periods (LTP) to the local tissue 
with a gradual transition of the perceived load at 2-3 weeks and again at greater than 9 
months.  The importance of fracture stability with properly timed subsequent mechanical 
stimulation in the bone healing process has been realized for decades.  More recently, 
research in tissue engineering, and more specifically mechanobiology, has reinforced the 
importance of mechanical stimulation in soft tissue, and to a lesser extent the importance 
of early stability.  An intermediate LTP is required to achieve the modulation of 
biomechanical properties from a single implant.  The use of a fast-degrading yarn 
facilitated the ability of the ABM to temporally alter biomechanical properties of the 
mesh at a LTP which coincides with the expected development of collagen integrity.  In 
vivo this phenomenon has been reported in a rat model to initiate at 2-3 weeks following 
the surgical procedure and is associated with significant collagen infiltration.
26
  
Abdominal wall fascial defects have a rapid healing capacity that results in fast strength 
recovery;
75,76
 for example, fascial wounds in rabbits were observed to rapidly increase in 
strength from 1 to 6 weeks.  At 6 weeks the wound strength was 40-70% the strength of 
unwounded tissue.
77
  Douglas investigated the strength recovery for an incision in the 
lumbar aponeurosis of a rabbit model and found that the strength increased 20% after 2 
weeks, 50% after 1 month, and after 6 months the strength reached a plateau at 60 – 80% 
compared to the unwounded control.
78
  Furthermore, in this study the in vitro 
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investigation of the second LTP determined that the high-lactide yarn mesh provided 
better than 9 months of strength retention, with meaningful strength retention expected 
for greater than 12 months.   Under mechanically stimulated, aseptic wound healing 
conditions after 9 months the wound site will achieve significant and near maximum 
strength.  In a previous canine study the use of a LW mesh was able to produce a 
mesh/tissue complex that resulted in a burst strength several fold greater than the mesh 
itself after 90 days.
53
  The significant increase in strength was attributed to collagen 
quality.  The quality and strength of the resultant tissue will be heavily influenced by the 
biomechanical cues provided during the collagen maturation process. 
Although the understanding of how fibroblasts respond to mechanical signals is 
incomplete, it is clear that mechanical stimulation is required and is responsible for hard 
and soft tissue adaptation.  Tissue adaptation results routinely following wound healing, 
just as physiological changes in morphology follow tissue functional requirements.  
Collagenous connective tissue remodeling is influenced by a complex combination of 
crosslinking degree and collagen type, which alter structure, composition, and 
mechanical properties.
79
  Fibroblasts sense mechanical changes in their ECM 
environment, transducer mechanical signals into chemical information, and integrate 
these signals with growth factor derived stimuli to achieve specific changes in gene 
expression.
80
  For fibroblasts in connective tissue, the production and modification of the 
ECM is a primary response to changes in the mechanical environment.  For biological 
systems this is a continuous evolutionary process so as to attain, and maintain, a steady 
state or homeostatic condition.  Conversely, abnormal mechanical loading conditions 
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alter cellular function that changes ECM function, eventually leading to a diseased 
state.
81,82
  As such, for meshes the ECM regulation pathway requires endogenous tension 
or tensional homeostasis within the mesh/tissue complex. 
Homeostatic conditions for collagenous structures include endogenous tension 
with continuous dynamic cycling.  The 8 week in vitro conditioned ABM produced low 
mechanical resistance at low strain levels.  It is interesting to note that the profile of the 
ABM is similar to that reported for collagenous structures, with a low-resistance, highly 
extensible “toe” region, curved transition region, and a steep, linear region characteristic 
of high stiffness.  A similar response, with a shorter “toe” region, has been reported to be 
also exhibited by scar tissue.
83
  A similar mesh biomechanical response was observed for 
the 8 week in vitro conditioned ABM and is required to establish endogenous tension 
within the interpenetrating extracellular matrix (ECM).  Furthermore, the 8 week in vitro 
conditioned response for the ABM possessed less resistance than the simulated matrix for 
strain values less than 10%.  Therefore, at low physiologic strain levels the ECM will 
share in resisting the applied stress and perceive the applied strain such that homeostatic, 
endogenous tension will be established.  This characteristic is novel and derived from the 
unique co-knit construction.  Following the substantial degradation of the fast-degrading 
yarn, the resultant slow-degrading mesh became highly extensible, likely due to (1) the 
removal of the constraint on pore deformation, (2) the space once occupied by the fast-
degrading yarn creating voids between knit loops, resulting in a loose knit structure, and 
(3) the mesh constructed from the slow-degrading yarn being liberated in a relaxed and 
constrained state.  Furthermore, theses mesh structural changes take place subsequent to 
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the mesh being “set” within a load bearing ECM.  This temporal change in biomechanics 
results in the preservation of the mesh configuration and may resist early changes in mesh 
stiffness due to cyclic strain hardening.
84
  Collectively, these mesh structural changes 
facilitate biomechanical stimulation of the ECM due to the unique observed multiaxial 
mesh extension. 
To achieve biomechanical stimulation the mesh must not stress shield the ECM.  
When a mesh is several orders of magnitude stiffer than the surrounding ECM, the mesh 
bears most of the stress and dictates the strain response.  As a result, under these 
conditions minimal strain is perceived by the ECM.  Using the SMTC model, stress 
shielding was determined to result when (1) the mesh produced a stiffer FEP than that of 
the simulated matrix, and (2) the FEP for the mesh and corresponding SMTC were nearly 
identical.  Stress shielding was observed in the FEP response of the traditional meshes 
with the exception of PET tensile tested samples.  The most commonly used HW meshes 
produce 16 N/cm extension values less than 14%, with several equal to or below 
7%.
26,28,85
  This inherent mesh stiffness, combined with increased stiffness following 
tissue integration, is purported to be responsible for substantial abdominal wall restriction 
and subsequent complications.
86
  In contrast, 8 week in vitro conditioned ABM produced 
the only FEP to pass through the range of physiologic extension values associated with 
16 N/cm.  Traditional hernia meshes do not possess the ability to accommodate 
multiaxial deformation, as suggested by the high degree of stiffness observed during 
burst testing.  For example, if the abdominal wall were subjected to a strain of 5% the PP 
and PET meshes would resist with a force of 70 N and 30 N, respectively.   On the other 
 238 
hand, the WK6 and WK7 meshes resisted with less than a 5 N force, resulting in a 14-
fold and 6-fold reduction compared to the PP and PET meshes.  When the WK6 and 
WK7 meshes were evaluated in the SMTC model, the resistive forces were 24 N and 34 
N, respectively.  The observed difference in force values between the mesh and SMTC is 
the load transferred or perceived by the matrix.  For the same conditions, the traditional 
meshes resisted with a force of 46 N and 83 N for the PET and PP, respectively.  Again, 
the traditional meshes were significantly stiffer than the ABM. 
Synthetic materials and biologic tissues more often fail by repetitive sub-failure 
loading than by a single maximal loading event.  A mesh attached to the abdominal wall 
must be able to replicate multiaxial strains to avoid stress concentrations at the margins of 
the mesh in response to abdominal wall distention.  Mismatch in the FEP of the 
mesh/tissue complex and local tissue is clinically believed to be a significant contributing 
factor in mesh failures.  Due to the stiffness of traditional meshes, recurrent hernias 
develop 99% of the time at the margins of the mesh/tissue complex.
38,87-89
  It is likely that 
a fatigue mechanism is a contributing factor in late-term marginal mesh-fascial 
dehiscence.  Fatigue failure occurs as a result of cyclical loading, where the level of stress 
is well below ultimate failure loads.  However, the number of cycles to failure is a 
function of the level of stress.  As previously discussed, for a given strain value the 
resistive force for a stiff mesh will be greater by several orders of magnitude.  As a result, 
differences in the FEP of the mesh/tissue complex and surrounding tissue at physiologic 
cyclic loading will create high shear stresses at the marginal interface.  Consequently, the 




  In contrast, the observed compliance, especially at low strain 
values, of the ABM would minimize the gradient in stiffness between the local tissue and 
the mesh/tissue complex and reduce the likelihood of recurrence. 
The 8 week in vitro conditioned ABM and traditional meshes produced greater 
resistance to strain when evaluated in a SMTC.  Although constructed with different co-
knit patterns, the FEP for each ABM was remarkably similar at both the initial and 8 
week in vitro conditioned time periods.  However, a significant difference was observed 
between the 8 week in vitro conditioned WK6 SMTC and WK7 SMTC samples.   The 
WK6 SMTC produced less resistance to an applied strain in uniaxial and multiaxial 
testing than did the WK7 mesh.  The observed difference is likely the result of the larger 
pores of the WK6 mesh.  When a mesh is stressed, the mesh filaments show minimal if 
any elongation, while the mesh itself produces significant extension from geometric 
deformation of the pores.  The infiltration of each pore resists pore deformation, but for 
larger pores the effect was less pronounced as less resistance was likely realized by the 
more extensible silicone matrix. 
In part, the inability of nonabsorbable meshes to modulate their biomechanical 
properties during integration with the surrounding tissue in a temporal manner that 
coincides with the functional needs of the wound healing process and approximates 
physiologic biomechanical conditions has limited the efficacy of nonabsorbable meshes.  
The use of the SMTC model illustrates the need for highly compliant meshes to obtain 
mesh biomechanics that do not stress shield the ECM.  The observed lack of long-term 
compliance will continue to hinder the biocompatibility of traditional meshes.  
 240 
Consequently, advances in hernia mesh technology will likely come from the use of 
highly compliant meshes that approximate abdominal wall biomechanics and establish 
some level of tensional homeostasis.  However, nonabsorbable LW meshes, which have 
improved compliance over HW meshes, have inferior surgical handling 
characteristics
91,92
 and lack the ability to facilitate early wound stability. 
 
Conclusion 
The ideal hernioplasty requires, in part, that the mesh provides support to the 
wound site without mechanical failure, conforms to anatomical structures, and that it 
facilitates a wound healing response which prevents recurrence.  The latter is primarily 
influenced by mesh biomechanics and is a primary determinant of biocompatibility.  In 
this study, a focused comparison of the sub-failure biomechanical properties for two 
ABM employing different constructions and traditional meshes was completed.  The in 
vitro conditioned biomechanics of the ABM indicated each mesh provided (1) improved 
stability compared to traditional meshes during the inflammation and proliferation 
phases, and (2) approximated the biomechanics of the abdominal wall and established 
tensional homeostasis within the mesh/tissue complex during the remodeling/maturation 
phase.  These ABM properties were derived from the unique co-knit construction and 
facilitated by the use of two copolyester yarns possessing different degradation profiles.  
Using a simulated mesh/tissue complex (SMTC) model, quantitative changes in mesh 
biomechanics were determined which demonstrated mesh stress shielding and significant 
resistive forces at low strain values for traditional meshes.  Consequently, a highly 
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extensible mesh was shown to be required to closely replicate abdominal wall 
biomechanics following simulated tissue integration.  However, the two evaluated ABM 
constructs differed in extensibility using the SMTC model with an apparent dependence 
on pore size.  Following encapsulation using the SMTC model, the ABM with larger 
pores was found to produce less resistance to an applied strain in uniaxial and multiaxial 
distention.   Overall, the results of the present study suggest that the ABM concept will 
temporally augment the wound healing process by establishing stability to the developing 
neotissue during the inflammation and proliferation phase and restoration of abdominal 
wall biomechanics and tensional homeostasis during the remodeling and maturation 
phase.  The temporal modulation of biomechanics observed for the ABM may augment 
the natural healing process and improve the clinical outcome of mesh hernioplasty. 
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In these dissertation studies a warp knit mesh was developed for application in 
hernia repair using (1) absorbable yarns with fast- and slow-degradation profiles and (2) a 
novel knit construction such that the knit pattern for each degradable yarn is 
interdependent.  These preliminary studies suggest that the developed mesh temporally 
modulated physicomechanical properties such that the mesh (1) possessed short-term 
structural stiffness, (2) provided a gradual transition phase, and (3) possessed long-term 
compliance with force-extension properties similar to the abdominal wall.  In the 
development of the degradable copolyester yarns, the use of dynamic mechanical analysis 
to characterize the glass transition temperature, and the associated activation energy, was 
shown to predict in vitro strength retention and used to optimize the strength profile of 
the fast-degrading yarn.  Furthermore, an in vitro model was developed to prototype the 
mesh/tissue complex which illustrated the importance of a highly-extensible mesh 
construction to match physiologic abdominal wall biomechanics.  Finally, a simple model 
for evaluating tissue reaction was developed which showed that the cellular response was 
reduced and collagen integration was compact and concentrically oriented around an 
absorbable bicomponent construct which simulated the subject mesh during an evaluation 









Completion of this hernia mesh research provides direction for future studies.  To 
further this research, future work could be conducted to: 
 Remove the external fibrous tissue from the gluteal muscle prior to tissue 
processing to reduce the noise associated with collagen/total protein 
measurements in the rat gluteal muscle model for future studies. 
 Develop an animal model that can reproduce hernia recurrence to evaluate the 
efficacy of the absorbable bicomponent mesh. 
 Investigate the effect of mesh structural stability on the wound contraction 
process. 
 Develop an in vitro model to characterize the distribution of load to multiple 
suture attachment points for an externally applied force during the stability phase 
of the absorbable bicomponent mesh. 
 Conduct in vivo studies to determine the long-term relative contribution of 
facilitating endogenous tension and mechanical stimulation on collagen type, 
density, orientation, and crosslinking surrounding the absorbable bicomponent 
mesh. 
 
 
